ES2395213T3 - Intravascular occlusion devices guided by a percutaneous catheter - Google Patents
Intravascular occlusion devices guided by a percutaneous catheter Download PDFInfo
- Publication number
- ES2395213T3 ES2395213T3 ES97922307T ES97922307T ES2395213T3 ES 2395213 T3 ES2395213 T3 ES 2395213T3 ES 97922307 T ES97922307 T ES 97922307T ES 97922307 T ES97922307 T ES 97922307T ES 2395213 T3 ES2395213 T3 ES 2395213T3
- Authority
- ES
- Spain
- Prior art keywords
- fabric
- medical device
- molding element
- molding
- diameter
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12099—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
- A61B17/12109—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12099—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
- A61B17/12122—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder within the heart
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
- A61B17/12168—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device having a mesh structure
- A61B17/12172—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device having a mesh structure having a pre-set deployed three-dimensional shape
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
- A61B17/12168—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device having a mesh structure
- A61B17/12177—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device having a mesh structure comprising additional materials, e.g. thrombogenic, having filaments, having fibers or being coated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/01—Filters implantable into blood vessels
- A61F2/0105—Open ended, i.e. legs gathered only at one side
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B21—MECHANICAL METAL-WORKING WITHOUT ESSENTIALLY REMOVING MATERIAL; PUNCHING METAL
- B21F—WORKING OR PROCESSING OF METAL WIRE
- B21F45/00—Wire-working in the manufacture of other particular articles
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B21—MECHANICAL METAL-WORKING WITHOUT ESSENTIALLY REMOVING MATERIAL; PUNCHING METAL
- B21F—WORKING OR PROCESSING OF METAL WIRE
- B21F45/00—Wire-working in the manufacture of other particular articles
- B21F45/008—Wire-working in the manufacture of other particular articles of medical instruments, e.g. stents, corneal rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00526—Methods of manufacturing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
- A61B2017/00575—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for closure at remote site, e.g. closing atrial septum defects
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
- A61B2017/00575—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for closure at remote site, e.g. closing atrial septum defects
- A61B2017/00592—Elastic or resilient implements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
- A61B2017/00575—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for closure at remote site, e.g. closing atrial septum defects
- A61B2017/00606—Implements H-shaped in cross-section, i.e. with occluders on both sides of the opening
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
- A61B2017/00575—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for closure at remote site, e.g. closing atrial septum defects
- A61B2017/00615—Implements with an occluder on one side of the opening and holding means therefor on the other
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00831—Material properties
- A61B2017/00867—Material properties shape memory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/95—Instruments specially adapted for placement or removal of stents or stent-grafts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/01—Filters implantable into blood vessels
- A61F2002/016—Filters implantable into blood vessels made from wire-like elements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/01—Filters implantable into blood vessels
- A61F2002/018—Filters implantable into blood vessels made from tubes or sheets of material, e.g. by etching or laser-cutting
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30003—Material related properties of the prosthesis or of a coating on the prosthesis
- A61F2002/3006—Properties of materials and coating materials
- A61F2002/30092—Properties of materials and coating materials using shape memory or superelastic materials, e.g. nitinol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2210/00—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2210/0014—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof using shape memory or superelastic materials, e.g. nitinol
- A61F2210/0019—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof using shape memory or superelastic materials, e.g. nitinol operated at only one temperature whilst inside or touching the human body, e.g. constrained in a non-operative shape during surgery, another temperature only occurring before the operation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2220/00—Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2220/0025—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
- A61F2220/0041—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements using additional screws, bolts, dowels or rivets, e.g. connecting screws
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0002—Two-dimensional shapes, e.g. cross-sections
- A61F2230/0004—Rounded shapes, e.g. with rounded corners
- A61F2230/0006—Rounded shapes, e.g. with rounded corners circular
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0063—Three-dimensional shapes
- A61F2230/0069—Three-dimensional shapes cylindrical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0063—Three-dimensional shapes
- A61F2230/0073—Quadric-shaped
- A61F2230/0078—Quadric-shaped hyperboloidal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0063—Three-dimensional shapes
- A61F2230/0073—Quadric-shaped
- A61F2230/008—Quadric-shaped paraboloidal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2240/00—Manufacturing or designing of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2240/001—Designing or manufacturing processes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Surgery (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Vascular Medicine (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medical Informatics (AREA)
- Reproductive Health (AREA)
- Cardiology (AREA)
- Mechanical Engineering (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Surgical Instruments (AREA)
- Prostheses (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Materials For Medical Uses (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Dispositivos de oclusión intravascular guiados por un catéter percutáneo Intravascular occlusion devices guided by a percutaneous catheter
I. CAMPO DE LA INVENCIÓN I. FIELD OF THE INVENTION
[0001] La presente invención se refiere, en general, a dispositivos intravasculares para tratar ciertas afecciones médicas y, más particularmente, se refiere a dispositivos de oclusión intravascular para el tratamiento de Defectos Septales Auriculares (de aquí en adelante ASD) y Ductus Arterioso Permeable (de aquí en adelante PDA). Los dispositivos realizados según la invención son particularmente adecuados para su suministro, por medio de un catéter o similar, a una localización remota en un sistema vascular de un paciente o en vasos análogos dentro del cuerpo de un paciente. [0001] The present invention relates, in general, to intravascular devices for treating certain medical conditions and, more particularly, it relates to intravascular occlusion devices for the treatment of Atrial Septal Defects (hereinafter ASD) and Permeable Arterious Ductus (hereinafter PDA). The devices made according to the invention are particularly suitable for delivery, by means of a catheter or the like, to a remote location in a patient's vascular system or in analogous vessels within a patient's body.
II. DESCRIPCIÓN DEL ESTADO DE LA TÉCNICA II. DESCRIPTION OF THE STATE OF THE TECHNIQUE
[0002] Se usa una amplia variedad de dispositivos intravasculares en diversos procedimientos médicos. Ciertos dispositivos intravasculares, tales como catéteres y alambres guía, se usan en general, simplemente, para suministrar fluidos u otros dispositivos médicos a posiciones específicas dentro del cuerpo de un paciente, tal como un sitio selectivo dentro del sistema vascular. Otros dispositivos, frecuentemente más complejos, se usan para tratar afecciones específicas, tales como los dispositivos usados para eliminar las oclusiones vasculares o para tratar defectos septales y similares. [0002] A wide variety of intravascular devices are used in various medical procedures. Certain intravascular devices, such as catheters and guidewires, are generally used simply to deliver fluids or other medical devices to specific positions within a patient's body, such as a selective site within the vascular system. Other devices, often more complex, are used to treat specific conditions, such as devices used to eliminate vascular occlusions or to treat septal defects and the like.
[0003] En ciertas circunstancias, puede ser necesario ocluir un vaso de un paciente, por ejemplo, para detener el flujo de sangre por una arteria a un tumor u otra lesión. Actualmente, esto se consigue, comúnmente, insertando sencillamente, por ejemplo, partículas de Ivalon (nombre comercial de partículas de oclusión vascular) y secciones cortas de muelles helicoidales en una localización deseada dentro de un vaso. Estos “agentes de embolización” llegarán, eventualmente, a alojarse en el vaso, frecuentemente flotando corriente abajo desde el sitio en el que son liberados antes de bloquear el vaso. Este procedimiento está a menudo limitado en su utilidad, en parte debido a la incapacidad para posicionar con precisión los agentes de embolización. [0003] In certain circumstances, it may be necessary to occlude a patient's vessel, for example, to stop the flow of blood through an artery to a tumor or other lesion. Currently, this is commonly achieved by simply inserting, for example, Ivalon particles (trade name of vascular occlusion particles) and short sections of helical springs at a desired location within a vessel. These "embolization agents" will eventually become lodged in the vessel, frequently floating downstream from the site where they are released before blocking the vessel. This procedure is often limited in its usefulness, partly due to the inability to accurately position the embolization agents.
[0004] Se han usado por médicos catéteres de tipo globo, parecidos al dado a conocer por Landymore y otros en la Patente U.S. Nº. 4.836.204, para ocluir temporalmente un defecto septal hasta que el paciente se estabilice suficientemente para técnicas quirúrgicas a corazón abierto. También se han usado catéteres de tipo globo, desacoplables para bloquear vasos de pacientes. Cuando se usa un catéter de este tipo, se lleva un globo expandible en un extremo distal de un catéter. Cuando el catéter es guiado a la posición deseada, el globo se llena con un fluido hasta que llene sustancialmente el vaso y llegue a estar alojado en el mismo. Pueden emplearse resinas, tales como un acrilonitrilo, que endurecerán dentro del globo, para fijar permanentemente el tamaño y la forma del globo. El globo puede ser entonces separado del extremo del catéter y dejado en el sitio. [0004] Balloon-type catheters, similar to those disclosed by Landymore et al. Have been used by U.S. Pat. . 4,836,204, to temporarily occlude a septal defect until the patient is sufficiently stabilized for open heart surgical techniques. Balloon catheters, decoupling, have also been used to block patient vessels. When such a catheter is used, an expandable balloon is carried at a distal end of a catheter. When the catheter is guided to the desired position, the balloon is filled with a fluid until it substantially fills the vessel and becomes lodged therein. Resins, such as an acrylonitrile, which will harden inside the balloon can be used to permanently fix the size and shape of the balloon. The balloon can then be separated from the end of the catheter and left in place.
[0005] Sin embargo, esta embolización por globo es también propensa a ciertos problemas de seguridad. Por ejemplo, si el globo no se llena lo suficiente, no se fijará firmemente al vaso y puede girar o ir a la deriva corriente abajo dentro del vaso a otra posición, de forma muy similar a los agentes de embolización sueltos antes mencionados. Con el fin de evitar este problema, los médicos pueden sobrellenar los globos; no es infrecuente que los globos se rompan y liberen la resina en la corriente sanguínea del paciente. [0005] However, this balloon embolization is also prone to certain security problems. For example, if the balloon is not filled enough, it will not be firmly attached to the vessel and can drift or drift downstream inside the vessel to another position, much like the loose embolization agents mentioned above. In order to avoid this problem, doctors can overfill balloons; It is not uncommon for balloons to break and release the resin in the patient's bloodstream.
[0006] Se han propuesto en el pasado dispositivos, filtros y trampillas mecánicas de embolización, algunos de los cuales se dan a conocer por King y otros, Patente U.S. Nº. 3.874.388; Das, Patente U.S. Nº. 5.334.217; y Marks, Patente U.S. Nº. 5.108.420. Estos dispositivos se precargan en el introductor o catéter de administración y no son fácilmente cargables por el médico. Además, durante el despliegue de estos dispositivos, la recaptura por el catéter portador es difícil, si no imposible, limitando de este modo la eficacia de estos dispositivos. [0006] Embolization devices, filters and mechanical hatches have been proposed in the past, some of which are disclosed by King et al., U.S. Pat. . 3,874,388; Das, U.S. Patent . 5,334,217; and Marks, U.S. Patent . 5,108,420. These devices are preloaded into the introducer or administration catheter and are not easily chargeable by the doctor. In addition, during the deployment of these devices, recapture by the carrier catheter is difficult, if not impossible, thereby limiting the effectiveness of these devices.
[0007] El documento WO 97/31672, que es estado de la técnica en virtud del Artículo 54(3) EPC, da a conocer un aparato de oclusión cardiovascular autoexpansible en el que se instalan fibras adicionales en el núcleo del dispositivo. [0007] WO 97/31672, which is a state of the art under Article 54 (3) EPC, discloses a self-expanding cardiovascular occlusion apparatus in which additional fibers are installed in the core of the device.
[0008] Además, aunque algunos de estos dispositivos demuestran ser oclusores eficaces, también tienden a ser bastante caros y con tiempos de fabricación largos. Por ejemplo, algunos filtros sanguíneos intravasculares están formados de una pluralidad de patas de forma especial que están adaptadas para llenar el vaso y clavarse en las paredes vasculares. En la fabricación de la mayoría de tales filtros, las patas deben formarse individualmente y luego unirse laboriosamente entre sí, frecuentemente requiriendo acoplamiento a mano, para ensamblar el filtro final. Esto, no sólo requiere significativa mano de obra cualificada, y por ello aumenta los costes de tales dispositivos, sino que el hecho de que cada artículo deba ser hecho a mano tiende a hacer más difícil el control de calidad. Esta misma dificultad y coste de fabricación no se limitan a tales filtros, sino que se experimentan también en muchos otros dispositivos intravasculares. [0008] In addition, although some of these devices prove to be effective occluders, they also tend to be quite expensive and with long manufacturing times. For example, some intravascular blood filters are formed of a plurality of specially shaped legs that are adapted to fill the vessel and dig into the vascular walls. In the manufacture of most such filters, the legs must be individually formed and then laboriously joined together, often requiring hand coupling, to assemble the final filter. This not only requires significant skilled labor, and therefore increases the costs of such devices, but the fact that each item must be made by hand tends to make quality control more difficult. This same difficulty and manufacturing cost are not limited to such filters, but are also experienced in many other intravascular devices.
[0009] Al usar estos dispositivos para ocluir un ASD, la presión y, por lo tanto, la posibilidad de desplazamiento del dispositivo aumenta con el cuadrado del tamaño de la comunicación. Consecuentemente, estos dispositivos deben tener un faldón de retención muy grande. Con frecuencia, la posición del ASD dicta el tamaño del faldón de retención. Por consiguiente, existe la necesidad de un oclusor de ASD que pueda fabricarse con un faldón de retención relativamente pequeño. También, la forma de los dispositivos del estado de la técnica (por ejemplo cuadrados, triángulos, pentágonos, hexágonos y octógonos) requiere una mayor área de contacto, con esquinas que se extienden a la pared libre de la aurícula. Cada vez que la aurícula se contrae (100.000 veces por día aproximadamente), los hilos internos de los dispositivos del estado de la técnica se doblan, creando fracturas de fatiga estructural en, aproximadamente, el 30 por ciento de todos los casos. Además, los dispositivos anteriores requieren un catéter de introducción French 14-16, haciendo imposible tratar con estos dispositivos a niños afectados con defectos congénitos. [0009] By using these devices to occlude an ASD, the pressure and, therefore, the possibility of displacement of the device increases with the square of the size of the communication. Consequently, these devices must have a very large retention skirt. Often, the position of the ASD dictates the size of the retention skirt. Therefore, there is a need for an ASD occluder that can be manufactured with a relatively small retention skirt. Also, the shape of state-of-the-art devices (for example squares, triangles, pentagons, hexagons and octagons) requires a larger contact area, with corners extending to the free wall of the atrium. Each time the atrium contracts (approximately 100,000 times per day), the internal threads of state-of-the-art devices bend, creating fractures of structural fatigue in approximately 30 percent of all cases. In addition, the above devices require a French 14-16 introduction catheter, making it impossible to treat children affected with congenital defects with these devices.
[0010] En consecuencia, sería ventajoso proporcionar un dispositivo de embolización fiable, que a la vez sea fácil de desplegar mediante un catéter French 6-7, y que pueda ser colocado con precisión en un vaso. Sería también deseable proporcionar un dispositivo recuperable, para despliegue en un vaso en el cuerpo de un paciente, que a la vez sea económico y produzca resultados constantes reproducibles. [0010] Accordingly, it would be advantageous to provide a reliable embolization device, which at the same time is easy to deploy by means of a French 6-7 catheter, and that can be accurately placed in a vessel. It would also be desirable to provide a recoverable device, for deployment in a vessel in a patient's body, which is both economical and produces consistent reproducible results.
[0011] La invención proporciona un dispositivo médico plegable como el definido en la reivindicación 1. [0011] The invention provides a folding medical device as defined in claim 1.
[0012] La presente invención proporciona un dispositivo fiable de oclusión intravascular, que puede formarse para tratar, por ejemplo, Defectos Septales Auriculares (de aquí en adelante ASD) y Ductus Arterioso Permeable (de aquí en adelante PDA). Al formar estos dispositivos intravasculares, a partir de un tejido metálico elástico, se dispone una pluralidad de filamentos elásticos, estando los hilos formados por trenzado para crear un material elástico que puede ser tratado térmicamente para fijar sustancialmente una forma deseada. Este tejido trenzado se deforma luego para ajustarse, en general, a una superficie de moldeo de un elemento de moldeo, y el tejido trenzado se trata térmicamente en contacto con la superficie del elemento de moldeo a una temperatura elevada. El tiempo y la temperatura del tratamiento térmico se seleccionan para fijar sustancialmente el tejido trenzado en su estado deformado. Tras el tratamiento térmico, el tejido se retira del contacto con el elemento de moldeo y retendrá sustancialmente su forma en el estado deformado. El tejido trenzado así tratado define un estado expandido de un dispositivo médico que puede ser desplegado mediante un catéter dentro de un canal en el cuerpo de un paciente. [0012] The present invention provides a reliable intravascular occlusion device, which can be formed to treat, for example, Atrial Septal Defects (hereinafter ASD) and Permeable Arterial Ductus (hereinafter PDA). By forming these intravascular devices, from an elastic metallic fabric, a plurality of elastic filaments are disposed, the strands being formed by braiding to create an elastic material that can be heat treated to substantially fix a desired shape. This braided fabric is then deformed to generally conform to a molding surface of a molding element, and the braided fabric is heat treated in contact with the surface of the molding element at an elevated temperature. The time and temperature of the heat treatment are selected to substantially fix the braided fabric in its deformed state. After heat treatment, the fabric is removed from contact with the molding element and will substantially retain its shape in the deformed state. The braided tissue so treated defines an expanded state of a medical device that can be deployed through a catheter into a channel in a patient's body.
[0013] Realizaciones adicionales de la presente invención proporcionan también formas específicas para dispositivos médicos que pueden hacerse para tratar procedimientos médicos predeterminados. Tales dispositivos de la invención están formados de un tejido metálico trenzado y tienen una configuración expandida y una configuración plegada. En uso, un catéter guía puede posicionarse en un canal en el cuerpo de un paciente, y hacerse avanzar para colocar el extremo distal del catéter adyacente en un sitio de tratamiento, para tratar una afección fisiológica. Un dispositivo médico, formado en una forma predeterminada y hecho de acuerdo con el proceso descrito arriba, puede ser plegado e insertado en el lumen del catéter. El dispositivo es impulsado a lo largo del catéter hasta salir del extremo distal, con lo cual, debido a su propiedad de memoria tenderá a regresar sustancialmente a su estado expandido adyacente al sitio de tratamiento. De acuerdo con una primera de estas realizaciones, un dispositivo médico generalmente alargado tiene una parte media generalmente tubular y un par de partes de diámetro expandido, con una parte de diámetro expandido posicionada en cualquier extremo de la parte media. En otra realización, el dispositivo médico es generalmente en forma de campana, con un cuerpo alargado que tiene un primer extremo afilado y un segundo extremo mayor, presentando el segundo extremo un disco de tejido que estará orientado, generalmente, perpendicular a un eje de un canal cuando se despliegue dentro del mismo. [0013] Additional embodiments of the present invention also provide specific forms for medical devices that can be made to treat predetermined medical procedures. Such devices of the invention are formed of a braided metal fabric and have an expanded configuration and a folded configuration. In use, a guide catheter can be positioned in a canal in a patient's body, and advanced to place the distal end of the adjacent catheter in a treatment site, to treat a physiological condition. A medical device, formed in a predetermined manner and made in accordance with the process described above, can be folded and inserted into the lumen of the catheter. The device is driven along the catheter until it exits the distal end, whereby, due to its memory property, it will tend to return substantially to its expanded state adjacent to the treatment site. According to a first of these embodiments, a generally elongated medical device has a generally tubular middle part and a pair of expanded diameter parts, with an expanded diameter part positioned at either end of the middle part. In another embodiment, the medical device is generally bell-shaped, with an elongated body having a first sharp end and a second major end, the second end presenting a tissue disc that will be oriented, generally, perpendicular to an axis of a channel when deployed within it.
BREVE DESCRIPCIÓN DE LOS DIBUJOS BRIEF DESCRIPTION OF THE DRAWINGS
Las figuras 1A y 1B describen cada una de ellas un tejido metálico adecuado para su uso en la invención; Figures 1A and 1B each describe a metallic fabric suitable for use in the invention;
la figura 2A es una vista lateral, con las piezas desmontadas, de un elemento de moldeo que tiene insertado un tramo de un tejido metálico adecuado para uso en la formación de un dispositivo médico de acuerdo con la invención; Figure 2A is a side view, with the parts removed, of a molding element having a section of a metal fabric suitable for use in the formation of a medical device according to the invention;
la figura 2B es una vista en perspectiva, con las piezas demontadas, del elemento de moldeo mostrado en la figura 2A; Figure 2B is a perspective view, with the parts broken, of the molding element shown in Figure 2A;
la figura 3A es una vista en perspectiva, mostrando el elemento de moldeo de las figuras 2A y 2B en un estado parcialmente ensamblado; Figure 3A is a perspective view, showing the molding element of Figures 2A and 2B in a partially assembled state;
la figura 3B es una vista cercana de una parte de la zona resaltada de la figura 3A, mostrando la compresión del tejido metálico en una de las cavidades del elemento de moldeo; Figure 3B is a close view of a part of the highlighted area of Figure 3A, showing the compression of the metal fabric in one of the cavities of the molding element;
la figura 4 es una vista en sección, mostrando el elemento de moldeo de las figuras 2A y 2B en un estado ensamblado, y con el tejido metálico formado dentro de las cavidades de los elementos de moldeo; Figure 4 is a sectional view, showing the molding element of Figures 2A and 2B in an assembled state, and with the metal fabric formed within the cavities of the molding elements;
la figura 5A es una vista lateral de un dispositivo médico; Figure 5A is a side view of a medical device;
la figura 5B es una vista del extremo del dispositivo médico; Figure 5B is an end view of the medical device;
las figuras 6A-6C son una vista lateral, una vista de extremo y una vista en perspectiva, respectivamente, de un dispositivo médico; Figures 6A-6C are a side view, an end view and a perspective view, respectively, of a medical device;
la figura 7 es una vista lateral en sección, de un elemento de moldeo adecuado para formar el dispositivo médico mostrado en las figuras 6A-6C; Figure 7 is a sectional side view of a molding element suitable for forming the medical device shown in Figures 6A-6C;
la figura 8 es una ilustración esquemática, mostrando el dispositivo de las figuras 6A-6C desplegado en un puente central del sistema vascular de un paciente; Figure 8 is a schematic illustration, showing the device of Figures 6A-6C deployed in a central bridge of a patient's vascular system;
la figura 9A es una vista lateral de un dispositivo médico; Figure 9A is a side view of a medical device;
la figura 9B es una vista del extremo del dispositivo médico mostrado en la figura 9A; Figure 9B is an end view of the medical device shown in Figure 9A;
la figura 10A es una vista lateral de un elemento de moldeo, adecuado para formar la realización de las figuras 9A y 9B; Figure 10A is a side view of a molding element, suitable for forming the embodiment of Figures 9A and 9B;
la figura 10B es una vista en sección de otro elemento de moldeo, adecuado para formar la realización de las figuras 9A y 9B; Figure 10B is a sectional view of another molding element, suitable for forming the embodiment of Figures 9A and 9B;
la figura 10C es una vista en sección de otro elemento de moldeo, adecuado para formar la realización de las figuras 9A y 9B; Figure 10C is a sectional view of another molding element, suitable for forming the embodiment of Figures 9A and 9B;
la figura 11 es una vista en sección parcial ampliada, de un dispositivo ASD, mostrado estirado y extendiéndose parcialmente fuera del lumen de un catéter portador; Figure 11 is an enlarged partial sectional view of an ASD device, shown stretched and partially extending out of the lumen of a carrier catheter;
la figura 12 es una vista parcial en sección de un dispositivo PDA, del tipo mostrado en las figuras 6a-6c, en donde el dispositivo PDA es mostrado estirado y extendiéndose parcialmente fuera del lumen de un catéter portador; Figure 12 is a partial sectional view of a PDA device, of the type shown in Figures 6a-6c, wherein the PDA device is shown stretched and partially extending out of the lumen of a carrier catheter;
la figura 13 es una vista ampliada en alzado lateral, de un dispositivo ASD, mostrado en su configuración preformada; Figure 13 is an enlarged side elevation view of an ASD device, shown in its preformed configuration;
la figura 14 es una vista en alzado lateral del dispositivo ASD de la figura 13, mostrado ligeramente estirado y lleno de fibras de poliéster; Figure 14 is a side elevational view of the ASD device of Figure 13, shown slightly stretched and filled with polyester fibers;
la figura 15 es una vista parcial en alzado lateral en sección, del dispositivo ASD de la figura 13, mostrado estirado y lleno de fibras de poliéster; Figure 15 is a partial side elevational view in section of the ASD device of Figure 13, shown stretched and filled with polyester fibers;
la figura 16 es una vista en alzado y en sección parcial, del dispositivo ASD de la figura 13, mostrado posicionado dentro de un ASD del corazón de un paciente; Figure 16 is an elevational and partial sectional view of the ASD device of Figure 13, shown positioned within an ASD of a patient's heart;
la figura 17 es una vista ampliada en alzado lateral, de un dispositivo ASD según la invención, mostrado en su configuración preformada; y Figure 17 is an enlarged side elevation view of an ASD device according to the invention, shown in its preformed configuration; Y
la figura 18 es una vista en alzado lateral, del dispositivo ASD de la figura 16, mostrado estirado y lleno de fibras de poliéster. Figure 18 is a side elevation view of the ASD device of Figure 16, shown stretched and filled with polyester fibers.
[0015] La presente invención proporciona un dispositivo de oclusión intravascular, dirigido por un catéter percutáneo, para uso en puentes en cuerpos de pacientes, tales como canales vasculares, tractos urinarios, conductos biliares y similares. Al formar un dispositivo médico por medio del método de la invención, se dispone un tejido metálico 10. El tejido está formado de una pluralidad de filamentos con una orientación relativa predeterminada entre los filamentos. Las figuras 1A y 1B ilustran dos ejemplos de tejidos metálicos que son adecuados para uso en el método de la invención. [0015] The present invention provides an intravascular occlusion device, directed by a percutaneous catheter, for use in bridges in patient bodies, such as vascular channels, urinary tracts, bile ducts and the like. When forming a medical device by means of the method of the invention, a metallic fabric 10 is arranged. The fabric is formed of a plurality of filaments with a predetermined relative orientation between the filaments. Figures 1A and 1B illustrate two examples of metal fabrics that are suitable for use in the method of the invention.
[0016] En el tejido de la figura 1A, los filamentos metálicos definen dos juegos de filamentos esencialmente paralelos, en general helicoidales, teniendo los filamentos de un juego una “mano”; es decir, una dirección de giro opuesta a la del otro juego. Esto define un tejido generalmente tubular, conocido en la industria textil como trenza tubular. Tales trenzas tubulares son bien conocidas en las técnicas textiles y encuentran algunas aplicaciones en el campo de dispositivos médicos como tejidos tubulares, por ejemplo para reforzar la pared de un catéter guía o de diagnóstico. Dado que tales trenzas son bien conocidas, no necesitan ser explicadas aquí extensamente. [0016] In the fabric of Figure 1A, the metallic filaments define two sets of essentially parallel filaments, generally helical, the filaments of a set having a "hand"; that is, a direction of rotation opposite to that of the other game. This defines a generally tubular fabric, known in the textile industry as tubular braid. Such tubular braids are well known in textile techniques and find some applications in the field of medical devices such as tubular tissues, for example to reinforce the wall of a guide or diagnostic catheter. Since such braids are well known, they do not need to be explained here extensively.
[0017] El paso de los filamentos de hilo (es decir, el ángulo definido entre las espiras del hilo y el eje de la trenza) y el avance del tejido (es decir, el número de vueltas por unidad de longitud) puede ajustarse como se desee para una aplicación particular. Por ejemplo, si el dispositivo médico a formar es para usarse para ocluir el canal en el que se coloca, el paso y el avance del tejido tenderán a ser mayores que si el dispositivo pretende simplemente filtrar fluido corporal que pasa a través del mismo. [0017] The passage of the filaments of yarn (ie, the defined angle between the turns of the yarn and the axis of the braid) and the advance of the fabric (ie, the number of turns per unit length) can be adjusted as desired for a particular application. For example, if the medical device to be formed is to be used to occlude the channel in which it is placed, the passage and advancement of the tissue will tend to be greater than if the device simply seeks to filter body fluid that passes through it.
[0018] Por ejemplo, al usar una trenza tubular, como la mostrada en la figura 1, para formar un dispositivo como el ilustrado en las figuras 5A y 5B, una trenza tubular de unos 4 mm de diámetro, con un paso de unos 50° y un avance de cerca de 74 (por pulgada lineal), parecerían adecuados para fabricar dispositivos usados para ocluir canales del orden de unos 2 mm a unos 4 mm de diámetro interior, tal como se detalla más adelante en relación con la realización de las figuras 5A y 5B. [0018] For example, by using a tubular braid, such as that shown in Figure 1, to form a device such as that illustrated in Figures 5A and 5B, a tubular braid about 4 mm in diameter, with a pitch of about 50 ° and an advance of about 74 (per linear inch), would seem suitable for manufacturing devices used to occlude channels of the order of about 2 mm to about 4 mm inside diameter, as detailed below in relation to the realization of the Figures 5A and 5B.
[0019] La figura 1B ilustra otro tipo de tejido que es adecuado para uso en el método de la invención. Este tejido es un tejido más convencional y puede tomar la forma de una lámina plana tejida, tricotada o similar. En la tela tejida mostrada en la figura 1B también hay dos juegos 14 y 14’ de filamentos, generalmente paralelos, estando un juego de filamentos orientados en un ángulo, por ejemplo generalmente perpendicular (con una trama de unos 90°), con respecto al otro juego. Como se ha indicado, el paso y el avance de este tejido (o, en el caso de un tejido tricotado, el avance y el modelo del punto, por ejemplo punto liso o punto doble) pueden ser seleccionados para optimizar las propiedades deseadas del dispositivo médico final. [0019] Figure 1B illustrates another type of tissue that is suitable for use in the method of the invention. This fabric is a more conventional fabric and can take the form of a knitted, knitted or similar flat sheet. In the woven fabric shown in Figure 1B there are also two sets 14 and 14 'of filaments, generally parallel, a set of filaments oriented at an angle, for example generally perpendicular (with a plot of about 90 °), with respect to the another game. As indicated, the passage and advance of this fabric (or, in the case of a knitted fabric, the advance and the pattern of the point, for example plain or double point) can be selected to optimize the desired properties of the device. final doctor
[0020] Los filamentos de hilo del tejido metálico usado en el presente método, deberían estar formados de un material que a la vez sea elástico y que pueda ser tratado térmicamente para fijar sustancialmente una forma deseada. Los materiales que son adecuados para este propósito incluyen una aleación de baja expansión térmica en base a cobalto, conocido en el sector de la invención como Elgeloy, “superaleaciones” de alta resistencia y alta temperatura, en base a níquel disponibles comercialmente en Haynes International bajo el nombre comercial Hastelloy; aleaciones tratables térmicamente, en base a níquel, vendidas bajo el nombre Incoloy por International Nickel; y un número de aceros inoxidables de diferentes grados. El factor importante al elegir un material adecuado para los hilos es que los hilos retengan una cantidad adecuada de la deformación inducida por la superficie de moldeo (como se describe más adelante) cuando se someten a un tratamiento térmico predeterminado. [0020] The wire filaments of the metallic fabric used in the present method should be formed of a material that is both elastic and can be heat treated to substantially fix a desired shape. Materials that are suitable for this purpose include a cobalt-based low thermal expansion alloy, known in the field of the invention as Elgeloy, high strength and high temperature "super alloys" based on nickel commercially available from Haynes International under the trade name Hastelloy; heat treatable alloys, based on nickel, sold under the name Incoloy by International Nickel; and a number of stainless steels of different grades. The important factor in choosing a suitable material for the threads is that the threads retain an adequate amount of deformation induced by the molding surface (as described below) when subjected to a predetermined heat treatment.
[0021] Una clase de materiales que reúnen estos requisitos son las llamadas aleaciones con memoria de forma. Tales aleaciones tienden a tener un cambio de fase inducido por temperatura, que hará que el material tenga una configuración preferida que puede ser fijada calentando el material por encima de una cierta temperatura de transición, para inducir un cambio en la fase del material. Cuando la aleación se enfría de nuevo, la aleación “recordará” la forma en la que estaba durante el tratamiento térmico y tenderá a asumir esa configuración a menos que se le impida hacerlo. [0021] A class of materials that meet these requirements are so-called shape memory alloys. Such alloys tend to have a temperature-induced phase change, which will cause the material to have a preferred configuration that can be set by heating the material above a certain transition temperature, to induce a change in the phase of the material. When the alloy cools again, the alloy will "remember" the way it was during heat treatment and will tend to assume that configuration unless it is prevented from doing so.
[0022] Una aleación con memoria de forma, particularmente preferida para uso en el presente método, es nitinol, una aleación aproximadamente estequiométrica de níquel y titanio, que puede incluir otras cantidades menores de otros metales para conseguir las propiedades deseadas. Las aleaciones de NiTi, tales como nitinol, incluyendo las composiciones y requisitos de manipulación apropiados, son bien conocidas en la técnica, por lo que no necesitan ser tratadas aquí en detalle. Por ejemplo, las Patentes U.S. 5.067.489 (Lind) y 4.991.602 (Amplatz y otros) explican el uso de las aleaciones de NiTi con memoria de forma en alambres de guía. Tales aleaciones de NiTi son preferidas, al menos en parte, porque están comercialmente disponibles y se sabe más sobre el manejo de tales aleaciones que de otras aleaciones conocidas con memoria de forma. Las aleaciones de NiTi son también muy elásticas –se dice que son “superelásticas” o “seudoelásticas”. Esta elasticidad ayudará a que un dispositivo de la invención vuelva a una configuración expandida prefijada para el despliegue. [0022] A shape memory alloy, particularly preferred for use in the present method, is nitinol, an approximately stoichiometric alloy of nickel and titanium, which may include other smaller amounts of other metals to achieve the desired properties. NiTi alloys, such as nitinol, including the appropriate compositions and handling requirements, are well known in the art, so they do not need to be discussed here in detail. For example, U.S. Pat. 5,067,489 (Lind) and 4,991,602 (Amplatz et al.) Explain the use of NiTi alloys with shape memory in guidewires. Such NiTi alloys are preferred, at least in part, because they are commercially available and more is known about the handling of such alloys than of other known shape memory alloys. NiTi alloys are also very elastic - they are said to be "superelastic" or "pseudo-elastic." This elasticity will help a device of the invention return to an expanded configuration preset for deployment.
[0023] Al formar un dispositivo médico según la invención, se corta una pieza de un tamaño apropiado del tejido metálico, a partir de la pieza mayor de tejido que se ha formado, por ejemplo, trenzando filamentos de hilo para formar una trenza tubular larga. Las dimensiones de la pieza de tejido a cortar dependerán, en gran parte, del tamaño y forma del dispositivo médico a formar a partir de la misma. [0023] When forming a medical device according to the invention, a piece of an appropriate size of the metallic fabric is cut, from the larger piece of tissue that has been formed, for example, braiding filaments of yarn to form a long tubular braid . The dimensions of the piece of tissue to be cut will depend, in large part, on the size and shape of the medical device to be formed therefrom.
[0024] Al cortar el tejido a las dimensiones deseadas, habrá que asegurarse de que el tejido no se deshilache. En el caso de trenzas tubulares formadas de aleaciones NiTi, por ejemplo, los filamentos de hilo individuales tenderán a volver a su configuración fijada térmicamente a menos que se les impida. Si la trenza es tratada térmicamente para fijar los filamentos en la configuración trenzada, tenderán a permanecer en la forma trenzada y únicamente los extremos se deshilacharán. Sin embargo, puede ser más económico formar simplemente la trenza sin tratar la trenza térmicamente, puesto que el tejido será tratado térmicamente de nuevo al formar el dispositivo médico, como se ha indicado arriba. [0024] When cutting the fabric to the desired dimensions, make sure that the fabric does not fray. In the case of tubular braids formed of NiTi alloys, for example, the individual wire filaments will tend to return to their thermally fixed configuration unless prevented. If the braid is heat treated to fix the filaments in the braided configuration, they will tend to remain in the braided form and only the ends will fray. However, it may be more economical to simply form the braid without treating the braid thermally, since the tissue will be heat treated again when forming the medical device, as indicated above.
[0025] En tales tejidos de NiTi sin tratar, los hilos tenderán a volver a su configuración no trenzada y la trenza puede deshacerse bastante rápidamente, a menos que los extremos del tramo de la trenza cortados para formar el dispositivo estén retenidos entre sí. Un método que se ha demostrado útil para impedir que la trenza se deshaga es sujetar la trenza con unas sujeciones en dos ubicaciones, y cortar la trenza para dejar un tramo de la trenza con unas sujeciones (15 en la figura 5A) en uno y otro extremo, definiendo por lo tanto eficazmente un espacio vacío en un tramo sellado de tejido. Estas sujeciones 15 mantendrán unidos los extremos de la trenza cortada e impedirán que la trenza se deshaga. [0025] In such untreated NiTi fabrics, the threads will tend to return to their unbraided configuration and the braid can be undone quite quickly, unless the ends of the braid section cut to form the device are held together. One method that has proven useful to prevent the braid from falling apart is to hold the braid with some fasteners in two locations, and cut the braid to leave a stretch of the braid with some fasteners (15 in Figure 5A) in one and the other extreme, thus effectively defining an empty space in a sealed stretch of tissue. These fasteners 15 will hold the ends of the cut braid together and prevent the braid from falling apart.
[0026] Alternativamente, se puede soldar con soldadura fuerte, blanda o con aportación, o fijar juntos de otra forma los extremos del tramo deseado (por ejemplo, con un material orgánico cementoso biocompatible), antes de cortar la trenza. Aunque se ha demostrado que soldar con soldadura fuerte y blanda las aleaciones de NiTi es bastante difícil, los extremos pueden soldarse, por ejemplo, por soldadura por puntos con un soldador láser. [0026] Alternatively, it can be welded with brazing, soft welding or contribution, or together fixing the ends of the desired section together (for example, with a biocompatible cementitious organic material), before cutting the braid. Although it has been shown that welding with NiTi alloys with hard and soft soldering is quite difficult, the ends can be welded, for example, by spot welding with a laser welder.
[0027] Se presentan los mismos problemas cuando se usa una lámina plana de tejido como la tela tejida mostrada en la figura 1B. Con este tejido, el tejido puede ser doblado sobre sí mismo para formar un rebaje o depresión y el tejido puede sujetarse con sujeciones alrededor de este rebaje para formar una bolsa vacía (no mostrada) antes de que el tejido se corte. Si se desea mantener el tejido en una configuración generalmente plana, puede ser necesario soldar los cruces de los hilos adyacentes a la periferia de la pieza deseada de tejido antes de cortar esa pieza de la lámina mayor. Conectar así los extremos de los hilos entre sí evitará que los tejidos formados de aleaciones con memoria de forma sin tratamiento y similares se deshagan durante el proceso de formación. [0027] The same problems arise when a flat sheet of fabric is used as the woven fabric shown in Figure 1B. With this tissue, the tissue can be folded over itself to form a recess or depression and the tissue can be held with fasteners around this recess to form an empty bag (not shown) before the tissue is cut. If it is desired to keep the fabric in a generally flat configuration, it may be necessary to weld the crossings of the wires adjacent to the periphery of the desired piece of fabric before cutting that piece of the larger sheet. Connecting the ends of the wires together will prevent the tissues formed of alloys with memory without treatment and the like from falling apart during the formation process.
[0028] Una vez que se ha obtenido una pieza del tejido metálico con el tamaño apropiado, el tejido se deforma para ajustarse en general a una superficie de un elemento de moldeo. Como se apreciará más completamente de la siguiente explicación en relación con las figuras 2-10, deformar así el tejido reorientará las posiciones relativas de los hilos del tejido metálico, desde su orden inicial a una segunda configuración reorientada. La forma del elemento de moldeo debería seleccionarse para deformar el tejido a, sustancialmente, la forma del dispositivo médico deseado. [0028] Once a piece of metal fabric with the appropriate size has been obtained, the fabric is deformed to generally conform to a surface of a molding element. As will be seen more fully from the following explanation in relation to Figures 2-10, thus deforming the fabric will reorient the relative positions of the metal fabric threads, from their initial order to a second reoriented configuration. The shape of the molding element should be selected to deform the tissue to substantially the shape of the desired medical device.
[0029] El elemento de moldeo puede ser una pieza única, o puede estar formado por una serie de piezas de moldeo que juntas definen la superficie a la que el tejido se ajustará en general. El elemento de moldeo puede situarse dentro de un espacio incluido por el tejido o puede ser externo a tal espacio, o puede incluso estar tanto dentro como fuera de tal espacio. [0029] The molding element may be a single piece, or it may be formed by a series of molding pieces that together define the surface to which the fabric will generally fit. The molding element can be placed within a space included by the fabric or it can be external to such space, or it can even be both inside and outside such space.
[0030] Con el fin de ilustrar un ejemplo de cómo un molde tal puede estar configurado y cómo puede usarse de acuerdo con el método de la invención, se hará referencia a las figuras 2-5. En las figuras 2-4, el elemento de moldeo 20 está formado por un número de piezas separadas que pueden unirse entre sí para completar el elemento de moldeo 20. Al usar tal elemento de moldeo multi-pieza, el molde puede montarse alrededor del tramo de corte del tejido 10, deformando por lo tanto el tejido para ajustarse en general a la superficie (o superficies) deseada(s) del elemento de moldeo. [0030] In order to illustrate an example of how such a mold can be configured and how it can be used according to the method of the invention, reference will be made to Figures 2-5. In Figures 2-4, the molding element 20 is formed by a number of separate pieces that can be joined together to complete the molding element 20. By using such a multi-piece molding element, the mold can be mounted around the section of cutting the fabric 10, thereby deforming the fabric to generally conform to the desired surface (or surfaces) of the molding element.
[0031] En el elemento de moldeo ilustrado en las figuras 2-4, la tela metálica 10 se deforma para ajustarse en general a una superficie del elemento de moldeo 20, comprendiendo el elemento de moldeo una sección central 30 y un par de placas extremas 40. Haciendo referencia en primer lugar a la sección central 30, la sección central está deseablemente formada por mitades opuestas 32, 32 que pueden separarse entre sí con el fin de introducir el tejido metálico 10 en el molde. Aunque estas dos mitades 32, 32 son mostradas en los dibujos como estando completamente separadas entre sí, debe entenderse que estas mitades puede estar interconectadas, como por medio de una bisagra o similar, si se desea. Cada una de las mitades opuestas del elemento de moldeo 20, mostrado en los dibujos de las figuras 2 y 3, incluye un par de rebajes semicirculares opuestos a cada lado de una cresta que definen una abertura en general semicircular. Cuando las dos mitades se ensamblan para formar el dispositivo, como se ve mejor en la figura 3, las aberturas semicirculares en las mitades opuestas 32, 32 encajan para definir una abertura de formación generalmente circular 36 que pasa a través de la sección central 30. De manera similar, los rebajes semicirculares en las dos mitades forman conjuntamente un par de rebajes centrales generalmente circulares 34, disponiéndose uno de tales rebajes en cada cara de la sección central. [0031] In the molding element illustrated in Figures 2-4, the metal web 10 is deformed to generally conform to a surface of the molding element 20, the molding element comprising a central section 30 and a pair of end plates 40. Referring first to the central section 30, the central section is desirably formed by opposite halves 32, 32 that can be separated from each other in order to introduce the metallic fabric 10 into the mold. Although these two halves 32, 32 are shown in the drawings as being completely separated from each other, it should be understood that these halves may be interconnected, as by means of a hinge or the like, if desired. Each of the opposite halves of the molding element 20, shown in the drawings of Figures 2 and 3, includes a pair of opposite semicircular recesses on each side of a crest defining a generally semicircular opening. When the two halves are assembled to form the device, as best seen in Figure 3, the semicircular openings in the opposite halves 32, 32 fit together to define a generally circular formation opening 36 that passes through the central section 30. Similarly, the semicircular recesses in the two halves together form a pair of generally circular central recesses 34, one of such recesses being arranged on each face of the central section.
[0032] La forma y dimensiones generales de la sección central pueden variarse como se desee; es generalmente el tamaño de los rebajes centrales 34 y de la abertura de formación 36 lo que define el tamaño y la forma de la zona media del dispositivo terminado, como se explica más adelante. Si así se desea, cada mitad 32 puede ser provista con un saliente manualmente aprehensible 38. En la realización mostrada en los dibujos, este saliente 38 se dispone en una posición situada lejos de las caras que hacen tope de las respectivas mitades. Tal saliente manualmente aprehensible 38 permitirá simplemente a un operador unir más fácilmente las dos mitades para definir los rebajes 34 y la abertura de formación 36. [0032] The shape and general dimensions of the central section can be varied as desired; it is generally the size of the central recesses 34 and the formation opening 36 that defines the size and shape of the middle area of the finished device, as explained below. If so desired, each half 32 may be provided with a manually apprehensible projection 38. In the embodiment shown in the drawings, this projection 38 is disposed in a position located away from the abutment faces of the respective halves. Such manually apprehensible projection 38 will simply allow an operator to more easily join the two halves to define the recesses 34 and the formation opening 36.
[0033] La sección central está adaptada para conectar de forma cooperativa un par de placas finales 40 para formar el dispositivo deseado. En la realización mostrada en las figuras 2 y 3, la sección central 30 tiene un par de caras planas externas 39 cada una de las cuales está adaptada para ser conectada por una cara interna 42 de una de las dos placas finales 40. Cada placa final incluye un disco de compresión 44 que se extiende en general lateralmente hacia dentro de la cara interna 42 de la placa final. Este disco de compresión 44 debería ser dimensionado para permitir que sea recibido dentro de uno de los rebajes centrales 34, en una y otra cara de la sección central 30. Por razones explicadas más ampliamente más adelante, cada disco de compresión 44 incluye una cavidad 46 para recibir un extremo del tramo del tejido metálico 10. [0033] The central section is adapted to cooperatively connect a pair of end plates 40 to form the desired device. In the embodiment shown in Figures 2 and 3, the central section 30 has a pair of external flat faces 39 each of which is adapted to be connected by an internal face 42 of one of the two end plates 40. Each end plate It includes a compression disc 44 which generally extends laterally into the inner face 42 of the end plate. This compression disc 44 should be sized to allow it to be received within one of the central recesses 34, on either side of the central section 30. For reasons explained more fully below, each compression disc 44 includes a cavity 46 to receive one end of the section of the metallic fabric 10.
[0034] También pueden disponerse uno o más canales 48 para recibir pernos y similares a través de cada placa final y a través de la sección central 30. Al pasar pernos a través de estos canales 48, uno puede ensamblar el elemento de moldeo 20 y retener el tejido metálico en la forma deseada durante el proceso del tratamiento térmico, como se describe más adelante. [0034] One or more channels 48 can also be arranged to receive bolts and the like through each end plate and through the central section 30. By passing bolts through these channels 48, one can assemble the molding element 20 and retain the metallic fabric in the desired shape during the heat treatment process, as described below.
[0035] Al utilizar el elemento de moldeo 20 mostrado en las figuras 2-4, un tramo del tejido metálico 10 puede ser posicionada entre las mitades opuestas 32 de la sección central 30. En los dibujos del elemento de moldeo 20 de las figuras 2-4, el tejido metálico 10 es una trenza tubular como la ilustrada en la figura 1A. Debería disponerse un tramo suficiente de la trenza tubular para permitir que el tejido se ajuste a la superficie de moldeo, como se explica más adelante. También, como antes se ha indicado, debería tenerse cuidado para fijar los extremos de los filamentos de hilo que definen la trenza tubular con el fin de impedir que el tejido metálico se deshaga. [0035] By using the molding element 20 shown in Figures 2-4, a section of the metal fabric 10 can be positioned between the opposite halves 32 of the central section 30. In the drawings of the molding element 20 of the figures 2 -4, the metallic fabric 10 is a tubular braid as illustrated in Figure 1A. A sufficient section of the tubular braid should be provided to allow the tissue to fit the molding surface, as explained below. Also, as indicated above, care should be taken to fix the ends of the strands of yarn that define the tubular braid in order to prevent the metallic tissue from falling apart.
[0036] Una porción central del tramo de la trenza metálica puede situarse dentro de una de las dos mitades de la abertura de formación 36 y las mitades opuestas 32 de la sección central pueden juntarse para hacer tope entre ellas, para contener una parte central de la trenza metálica dentro de la abertura de formación central 36 a través de la sección central. [0036] A central portion of the metal braid section can be placed within one of the two halves of the forming opening 36 and the opposite halves 32 of the central section can be joined to abut each other, to contain a central part of the metal braid inside the central forming opening 36 through the central section.
[0037] La trenza tubular tenderá a tener un diámetro natural relajado que se define, en gran parte, cuando se forma la trenza tubular. A menos que la trenza tubular se deforme de otra manera, cuando los filamentos de hilo están en su estado relajado tenderán a definir un tubo generalmente hueco con el diámetro predeterminado. El diámetro externo de la trenza relajada puede ser, por ejemplo, de unos 4 mm. El tamaño relativo de la abertura de formación 36 en la sección central 30 del elemento de moldeo y el diámetro externo natural relajado de la trenza tubular pueden variarse como se desee para lograr la forma deseada del dispositivo médico en formación. [0037] The tubular braid will tend to have a relaxed natural diameter that is defined, in large part, when the tubular braid is formed. Unless the tubular braid is otherwise deformed, when the filaments of yarn are in their relaxed state they will tend to define a generally hollow tube with the predetermined diameter. The outer diameter of the relaxed braid can be, for example, about 4 mm. The relative size of the formation opening 36 in the central section 30 of the molding element and the relaxed natural outer diameter of the tubular braid can be varied as desired to achieve the desired shape of the medical device in formation.
[0038] En la realización mostrada en las figuras 2 y 3, el diámetro interno de la abertura de formación 36 es óptimamente ligeramente menor que el diámetro externo natural relajado de la trenza tubular 10. Por lo tanto, cuando las dos mitades 32, 32 se ensamblan para formar la sección central 30, la trenza tubular 10 se comprimirá ligeramente dentro de la abertura de formación 36. Esto ayudará a asegurar que la trenza tubular se ajuste a la superficie interna de la abertura de formación 36, que define una parte de la superficie de moldeo del elemento de moldeo 20. [0038] In the embodiment shown in Figures 2 and 3, the internal diameter of the forming opening 36 is optimally slightly smaller than the relaxed natural outer diameter of the tubular braid 10. Therefore, when the two halves 32, 32 are assembled to form the central section 30, the tubular braid 10 will be compressed slightly into the forming opening 36. This will help ensure that the tubular braid conforms to the inner surface of the forming opening 36, which defines a part of the molding surface of the molding element 20.
[0039] Si así se desea, se puede disponer también una sección interna de moldeo generalmente cilíndrica (no mostrada). Esta sección de moldeo interna tiene un diámetro ligeramente más pequeño que el diámetro interno de la abertura de formación 36. En uso, la sección de moldeo interna se coloca dentro del tramo del tejido metálico, por ejemplo, separando manualmente los filamentos de hilo del tejido para formar una abertura a través de la cual puede ser pasada la sección interna de moldeo. Esta sección interna de moldeo debería estar posicionada dentro de la trenza tubular en una posición donde estará dispuesta dentro de la abertura de formación 36 de la sección central cuando el elemento de moldeo se ensamble. Debería haber un espacio suficiente entre la superficie externa de la sección interna de moldeo y la superficie interna de la abertura de formación 36 para permitir recibir entre ellas los filamentos de hilo del tejido 10. [0039] If desired, an internal section of generally cylindrical molding (not shown) can also be provided. This internal molding section has a diameter slightly smaller than the internal diameter of the forming opening 36. In use, the internal molding section is placed within the section of the metal fabric, for example, by manually separating the filaments of yarn from the fabric to form an opening through which the internal molding section can be passed. This internal molding section should be positioned within the tubular braid in a position where it will be disposed within the forming opening 36 of the central section when the molding element is assembled. There should be sufficient space between the external surface of the internal molding section and the internal surface of the forming opening 36 to allow the filaments of yarn 10 to be received between them.
[0040] Usando esta sección de moldeo interna, las dimensiones de la porción central del dispositivo médico acabado pueden ser controladas con bastante exactitud. Esta sección de moldeo interna puede ser necesaria en circunstancias en las que el diámetro natural externo relajado de la trenza tubular 10 es menor que el diámetro interno de la abertura de formación 36 para asegurar que la trenza se ajusta a la superficie interna de la abertura de formación. Sin embargo, no se cree que sería necesaria una tal sección interna de moldeo si el diámetro natural externo relajado de la trenza fuera mayor que el diámetro interno de la abertura de formación 36. [0040] Using this internal molding section, the dimensions of the central portion of the finished medical device can be controlled quite accurately. This internal molding section may be necessary in circumstances where the relaxed outer natural diameter of the tubular braid 10 is smaller than the internal diameter of the forming opening 36 to ensure that the braid conforms to the inner surface of the opening of training. However, it is not believed that such an internal molding section would be necessary if the relaxed outer natural diameter of the braid was larger than the internal diameter of the forming opening 36.
[0041] Como se ha indicado antes, los extremos de la trenza tubular deberían estar fijados con el fin de evitar que la trenza se deshaga. Cada extremo del tejido metálico 10 se recibe deseablemente dentro de una cavidad 46 formada en una de las dos placas finales 40. Si se usa una sujeción (15 en la figura 2), la sujeción puede dimensionarse para ser recibida de forma relativamente cómoda dentro de una de estas cavidades 46 con el fin de unir eficazmente el extremo del tejido a la placa final 40. Las placas finales pueden entonces ser conducidas hacia la sección central 30 y una hacia otra hasta que el disco de compresión 44 de cada placa final se recibe dentro de un rebaje central 34 de la sección central 30. El elemento de moldeo puede entonces fijarse en posición, pasando pernos o similares a través de los canales 48 en el elemento de moldeo y bloqueando conjuntamente los diversos componentes del elemento de moldeo apretando una tuerca sobre tal perno (no mostrado). [0041] As indicated above, the ends of the tubular braid should be fixed in order to prevent the braid from falling apart. Each end of the metal fabric 10 is desirably received within a cavity 46 formed in one of the two end plates 40. If a fastener (15 in Figure 2) is used, the fastener can be sized to be received relatively comfortably within one of these cavities 46 in order to effectively join the end of the fabric to the end plate 40. The end plates can then be led to the central section 30 and towards each other until the compression disc 44 of each end plate is received within a central recess 34 of the central section 30. The molding element can then be fixed in position, passing bolts or the like through the channels 48 in the molding element and jointly blocking the various components of the molding element by tightening a nut on such bolt (not shown).
[0042] Como se ve mejor en la figura 3A, cuando una placa final es empujada hacia la sección central 30, esto comprimirá la trenza tubular 10 generalmente a lo largo de su eje. Cuando la trenza tubular está en su configuración relajada, como se ilustra en la figura 1A, los filamentos de hilo que forman la trenza tubular tendrán entre sí una primera orientación relativa predeterminada. A medida que la trenza tubular se comprime a lo largo de su eje, el tejido tenderá a ensancharse alejándose del eje, como se ilustra en la figura 4. Cuando el tejido se deforma así, cambiará la orientación relativa de los filamentos de hilo del tejido metálico. Cuando el elemento de moldeo está finalmente ensamblado, el tejido metálico se ajustará en general a la superficie de moldeo de este elemento. [0042] As best seen in Figure 3A, when an end plate is pushed towards the central section 30, this will compress the tubular braid 10 generally along its axis. When the tubular braid is in its relaxed configuration, as illustrated in Figure 1A, the strands of yarn that form the tubular braid will have a predetermined first relative orientation to each other. As the tubular braid is compressed along its axis, the fabric will tend to widen away from the axis, as illustrated in Figure 4. When the fabric deforms well, the relative orientation of the strands of tissue yarn will change. metal. When the molding element is finally assembled, the metal fabric will generally conform to the molding surface of this element.
[0043] En el elemento de moldeo 20 mostrado en las figuras 2-4, la superficie de moldeo está definida por la superficie interna de la abertura de formación, las superficies internas del rebaje central 34 y las caras de los discos de compresión 44 que están recibidos dentro de los rebajes 34. Si se usa una sección de moldeo interna, la superficie cilíndrica externa de esa sección puede también considerarse una parte de la superficie de moldeo del elemento de moldeo 20. En consecuencia, cuando el elemento de moldeo 20 está completamente ensamblado, el tejido metálico tenderá a asumir una configuración con forma algo similar a unas “pesas de gimnasio”, con una sección central relativamente estrecha dispuesta entre un par de secciones finales bulbosas, quizás incluso con forma de disco, como se ve mejor en la figura 4. [0043] In the molding element 20 shown in Figures 2-4, the molding surface is defined by the internal surface of the forming opening, the internal surfaces of the central recess 34 and the faces of the compression discs 44 which they are received within the recesses 34. If an internal molding section is used, the external cylindrical surface of that section can also be considered a part of the molding surface of the molding element 20. Consequently, when the molding element 20 is completely assembled, the metallic fabric will tend to assume a configuration shaped somewhat similar to "gym weights", with a relatively narrow central section arranged between a pair of bulbous end sections, perhaps even disk-shaped, as best seen in Figure 4
[0044] Debería entenderse que la forma específica del elemento particular de moldeo 20 mostrado en las figuras 2-4 pretende producir un dispositivo médico útil de acuerdo con el presente método, pero que podrían usarse otros elementos de moldeo con diferentes configuraciones de forma. Si se desea una forma más compleja, el elemento de moldeo puede tener más piezas, pero si se configura una forma más simple, el elemento de moldeo puede tener incluso menos piezas. El número de piezas en un elemento de moldeo dado y las formas de esas piezas serán dictados casi totalmente por la forma del dispositivo médico deseado, dado que el elemento de moldeo debe definir una superficie de moldeo a la que el tejido metálico se adaptará generalmente. [0044] It should be understood that the specific form of the particular molding element 20 shown in Figures 2-4 is intended to produce a useful medical device according to the present method, but that other molding elements with different shape configurations could be used. If a more complex shape is desired, the molding element may have more pieces, but if a simpler form is configured, the molding element may have even fewer parts. The number of pieces in a given molding element and the shapes of those pieces will be dictated almost entirely by the shape of the desired medical device, since the molding element must define a molding surface to which the metallic fabric will generally adapt.
[0045] En consecuencia, el elemento de moldeo específico 20 mostrado en las figuras 2-4 pretende simplemente ser un ejemplo específico de un elemento de moldeo adecuado para formar un particular dispositivo médico útil. Elementos de moldeo adicionales con diferentes diseños para producir diferentes dispositivos médicos se explican más adelante en relación con, por ejemplo, las figuras 8 y 10. Dependiendo de la forma deseada del dispositivo médico que se forme, la forma y configuración de otros elementos de moldeo específicos pueden ser fácilmente diseñadas por expertos con conocimientos corrientes en la técnica. [0045] Accordingly, the specific molding element 20 shown in Figures 2-4 is simply intended to be a specific example of a molding element suitable for forming a particular useful medical device. Additional molding elements with different designs to produce different medical devices are explained below in relation to, for example, Figures 8 and 10. Depending on the desired shape of the medical device that is formed, the shape and configuration of other molding elements Specific ones can be easily designed by experts with ordinary knowledge in the art.
[0046] Una vez que el elemento de moldeo 20 está ensamblado con el tejido metálico, ajustándose en general a una superficie de moldeo de ese elemento, el tejido puede ser sometido a un tratamiento térmico mientras permanece en contacto con esa superficie de moldeo. Este tratamiento térmico dependerá en gran parte del material del que están formados los filamentos de hilo del tejido metálico, pero el tiempo y la temperatura del tratamiento térmico deberían seleccionarse para fijar básicamente el tejido en su estado deformado, es decir, en el que los filamentos de hilo están en su configuración relativa reorientada y el tejido se adapta en general a la superficie de moldeo. [0046] Once the molding element 20 is assembled with the metal fabric, generally adjusting to a molding surface of that element, the fabric can be subjected to heat treatment while remaining in contact with that molding surface. This heat treatment will depend largely on the material from which the wire filaments of the metallic fabric are formed, but the time and temperature of the heat treatment should be selected to basically fix the fabric in its deformed state, that is, in which the filaments of yarn are in their relative configuration reoriented and the fabric is generally adapted to the molding surface.
[0047] El tiempo y temperatura del tratamiento térmico pueden variar en gran medida dependiendo del material usado para formar los filamentos de hilo. Como se ha indicado antes, una clase preferida de materiales para formar los filamentos de hilo son las aleaciones con memoria de forma, siendo particularmente preferido el nitinol, una aleación de níquel titanio. Si se usa nitiniol para hacer los filamentos de hilo del tejido, los filamentos de hilo tenderán a ser muy elásticos cuando el metal esté en su fase austenítica; frecuentemente se hace referencia a esta fase muy elástica como fase “superelástica”o “seudoelástica”. Al calentar el nitinol por encima de una cierta temperatura de transición de fase, puede fijarse la estructura cristalina del nitinol metal cuando está en su fase austenítica. Esto tenderá a “fijar” la forma del tejido y la configuración relativa de los filamentos de hilo en las posiciones en las que se mantienen durante el tratamiento térmico. [0047] The time and temperature of the heat treatment can vary greatly depending on the material used to form the filaments of yarn. As indicated above, a preferred class of materials for forming the wire filaments are shape memory alloys, with nitinol, a nickel titanium alloy being particularly preferred. If nitiniol is used to make the yarn filaments of the fabric, the yarn filaments will tend to be very elastic when the metal is in its austenitic phase; Frequently, this very elastic phase is referred to as the "super-elastic" or "pseudo-elastic" phase. By heating the nitinol above a certain phase transition temperature, the crystalline structure of the nitinol metal can be fixed when it is in its austenitic phase. This will tend to "fix" the shape of the fabric and the relative configuration of the filaments of yarn in the positions in which they are maintained during the heat treatment.
[0048] Son bien conocidos en la técnica tratamientos térmicos de hilo de nitinol adecuados para fijar una forma deseada. Se usan, por ejemplo, bobinas helicoidales de nitinol en una serie de aplicaciones médicas, tales como en formar las bobinas que se llevan comúnmente en tramos distales de alambres de guía. Existe un cuerpo amplio de conocimientos para formar nitinol en tales dispositivos médicos, de modo que no hay necesidad de tratar aquí en gran detalle sobre los parámetros de un tratamiento térmico para el tejido de nitinol, preferido para uso en la presente invención. [0048] Nitinol wire heat treatments suitable for fixing a desired shape are well known in the art. For example, nitinol helical coils are used in a number of medical applications, such as forming the coils that are commonly carried in distal sections of guidewires. There is a broad body of knowledge to form nitinol in such medical devices, so there is no need to discuss here in great detail the parameters of a heat treatment for nitinol tissue, preferred for use in the present invention.
[0049] Brevemente, sin embargo, se ha encontrado que mantener un tejido de nitinol a unos 500°C hasta unos 550°C, durante un periodo de alrededor de 1 hasta unos 30 minutos, dependiendo de la blandura o dureza del dispositivo a hacer, tenderá a fijar el tejido en su estado deformado, es decir en el que se ajusta a la superficie de moldeo del elemento de moldeo. A temperaturas menores, el tiempo de tratamiento térmico tenderá a ser mayor (por ejemplo, cerca de una hora a unos 350°C) y a temperaturas más elevadas el tiempo tenderá a ser más corto (por ejemplo, unos 30 segundos a unos 900°C). Estos parámetros pueden variarse como sea necesario para acomodar variaciones en la composición exacta del nitinol, tratamiento térmico previo del nitinol, propiedades deseadas del nitinol en el artículo finalizado y otros factores que serán bien conocidos por los expertos en este campo. [0049] Briefly, however, it has been found that maintaining a nitinol tissue at about 500 ° C to about 550 ° C, for a period of about 1 to about 30 minutes, depending on the softness or hardness of the device to be made , will tend to fix the fabric in its deformed state, that is to say in which it conforms to the molding surface of the molding element. At lower temperatures, the heat treatment time will tend to be longer (for example, about one hour at about 350 ° C) and at higher temperatures the time will tend to be shorter (for example, about 30 seconds at about 900 ° C ). These parameters may be varied as necessary to accommodate variations in the exact composition of nitinol, prior heat treatment of nitinol, desired properties of nitinol in the finalized article and other factors that will be well known to those skilled in this field.
[0050] En lugar de confiar en el calentamiento por convección o similar, también se conoce en la técnica aplicar una corriente eléctrica al nitinol para calentarlo. En la presente invención, esto puede conseguirse, por ejemplo, enganchando electrodos a las sujeciones 15, provistas en uno y otro extremo del tejido metálico ilustrado en la figura [0050] Instead of relying on convection heating or the like, it is also known in the art to apply an electric current to the nitinol to heat it. In the present invention, this can be achieved, for example, by attaching electrodes to the fasteners 15, provided at either end of the metal fabric illustrated in the figure.
5. El hilo puede entonces calentarse mediante calentamiento por resistencia de los hilos, con el fin de conseguir el tratamiento térmico deseado, el cual tenderá a eliminar la necesidad de calentar el elemento completo de moldeo a la temperatura de tratamiento térmico deseada con el fin de calentar el tejido metálico a la temperatura deseada. 5. The wire can then be heated by resistance heating of the wires, in order to achieve the desired heat treatment, which will tend to eliminate the need to heat the entire molding element to the desired heat treatment temperature in order to heat the metal fabric to the desired temperature.
[0051] Tras el tratamiento térmico, el tejido se retira del contacto con el elemento de moldeo y conservará sustancialmente su forma en un estado deformado. Cuando se usa el elemento de moldeo 20 ilustrado en las figuras 2-4, los pernos (no mostrados) se pueden desmontar y las diversas piezas del elemento de moldeo pueden ser desmontadas esencialmente en el proceso inverso al de ensamblaje del elemento de moldeo. Si se usa una sección interna de moldeo, esta sección de moldeo puede retirarse de forma muy parecida a la usada para colocarse dentro del tejido metálico generalmente tubular al montar el elemento de moldeo 20, como se ha detallado antes. [0051] After heat treatment, the tissue is removed from contact with the molding element and will substantially retain its shape in a deformed state. When the molding element 20 illustrated in Figures 2-4 is used, the bolts (not shown) can be disassembled and the various parts of the molding element can be disassembled essentially in the reverse process of assembling the molding element. If an internal molding section is used, this molding section can be removed much like that used to be placed inside the generally tubular metal fabric when assembling the molding element 20, as detailed above.
[0052] Las figuras 5A y 5B ilustran una realización de un dispositivo médico 60, que puede hacerse usando el elemento de moldeo 20 de las figuras 2-4. Como se ha expuesto antes, el dispositivo de la figura 5 es particularmente adecuado para usarse para ocluir un canal dentro del cuerpo de un paciente y estos diseños tienen ventajas particulares en su uso como dispositivos de oclusión vascular. [0052] Figures 5A and 5B illustrate an embodiment of a medical device 60, which can be done using the molding element 20 of Figures 2-4. As discussed above, the device of Figure 5 is particularly suitable for use to occlude a channel within a patient's body and these designs have particular advantages in their use as vascular occlusion devices.
[0053] El dispositivo de oclusión vascular 60 de la figura 5A incluye una parte media generalmente tubular 62 y dos de partes de diámetro expandido 64. Una parte de diámetro expandido se dispone en ambos extremos de la porción media, generalmente tubular, 62. En la realización mostrada en las figuras 5A y 5B, las partes de diámetro expandido 64 incluyen una cresta 66 situada hacia medio camino de sus tramos. [0053] The vascular occlusion device 60 of Figure 5A includes a generally tubular middle part 62 and two of expanded diameter parts 64. An expanded diameter part is disposed at both ends of the generally tubular middle portion, 62. In In the embodiment shown in Figures 5A and 5B, the expanded diameter portions 64 include a ridge 66 located halfway to their sections.
[0054] Las dimensiones relativas de la sección tubular media y las partes de diámetro expandido pueden variarse como se desee. En esta particular realización, se pretende usar el dispositivo médico como un dispositivo de oclusión vascular para interrumpir de manera sustancial el flujo de sangre a través de un vaso sanguíneo de un paciente. Cuando se despliega el dispositivo 60 dentro de un vaso sanguíneo de un paciente, como se detalla más adelante, se posiciona dentro del vaso de tal modo que su eje generalmente coincida con el eje del vaso. La forma de pesas de gimnasio del presente dispositivo está pensada para limitar la capacidad del dispositivo de oclusión vascular 60 para girar un ángulo respecto al eje del vaso sanguíneo, para asegurar que permanece básicamente en la misma posición en la que el operador lo despliega dentro del vaso. [0054] The relative dimensions of the middle tubular section and the expanded diameter parts may be varied as desired. In this particular embodiment, it is intended to use the medical device as a vascular occlusion device to substantially interrupt the flow of blood through a patient's blood vessel. When the device 60 is deployed within a patient's blood vessel, as detailed below, it is positioned within the vessel such that its axis generally coincides with the axis of the vessel. The shape of gym weights of the present device is intended to limit the capacity of the vascular occlusion device 60 to rotate an angle with respect to the axis of the blood vessel, to ensure that it remains basically in the same position in which the operator deploys it within the glass.
[0055] Con el fin de encajar de manera relativamente fuerte en el lumen del vaso sanguíneo, debería seleccionarse el diámetro máximo de las partes de diámetro expandido 64 (lo que ocurre a lo largo de la cresta media 66 en esta realización) de tal modo que sea al menos tan grande como el diámetro del lumen del vaso en el que va a ser desplegado, y óptimamente sea ligeramente mayor que ese diámetro. Cuando se implanta dentro del vaso del paciente, el dispositivo de oclusión vascular 60 se encajará en el lumen en dos ubicaciones separadas. El dispositivo 60 es deseablemente más largo según su eje que la dimensión de su diámetro mayor. Esto evitará sustancialmente que el dispositivo de oclusión vascular 60 gire dentro del lumen un ángulo respecto a su eje, impidiendo básicamente que el dispositivo se desplace y caiga girando a lo largo del vaso con sangre fluyendo por el vaso. [0055] In order to fit relatively tightly into the lumen of the blood vessel, the maximum diameter of the expanded diameter portions 64 (which occurs along the middle crest 66 in this embodiment) should be selected in such a way that is at least as large as the diameter of the lumen of the vessel in which it will be deployed, and optimally slightly larger than that diameter. When implanted into the patient's vessel, vascular occlusion device 60 will fit into the lumen in two separate locations. The device 60 is desirably longer along its axis than the dimension of its larger diameter. This will substantially prevent the vascular occlusion device 60 from rotating within the lumen at an angle to its axis, basically preventing the device from moving and falling along the vessel with blood flowing through the vessel.
[0056] Los tamaños relativos de la parte media generalmente tubular 62 y la parte de diámetro expandido 64 del dispositivo de oclusión vascular 60, pueden variarse como se desee para cualquier aplicación particular. Por ejemplo, el diámetro exterior de la parte media 62 puede variar entre cerca de un cuarto hasta cerca de un tercio del diámetro máximo de las partes de diámetro expandido 64 y la longitud de la parte media 62 puede comprender cerca de un 20% hasta cerca de un 50% de la longitud total del dispositivo. Aunque estas dimensiones son adecuadas si el dispositivo 60 va a ser usado solamente para ocluir un vaso vascular, debe entenderse que estas dimensiones pueden variarse si el dispositivo va a ser usado en otras aplicaciones, así como si se tiene la intención de usar el dispositivo simplemente como un filtro vascular más que para ocluir sustancialmente todo el vaso, o para que el dispositivo se despliegue en un canal diferente en el cuerpo de un paciente. [0056] The relative sizes of the generally tubular middle part 62 and the expanded diameter part 64 of the vascular occlusion device 60 may be varied as desired for any particular application. For example, the outer diameter of the middle part 62 may vary between about a quarter to about one third of the maximum diameter of the expanded diameter parts 64 and the length of the middle part 62 may comprise about 20% to about 50% of the total length of the device. Although these dimensions are suitable if the device 60 is going to be used only to occlude a vascular vessel, it should be understood that these dimensions can be varied if the device is to be used in other applications, as well as if it is intended to use the device simply as a vascular filter rather than to substantially occlude the entire vessel, or for the device to be deployed in a different channel in a patient's body.
[0057] La ratio de dimensión (es decir, la proporción de la longitud del dispositivo respecto a su diámetro o anchura máximo) del dispositivo 60 ilustrado en las figuras 5A y 5B es deseablemente, al menos, alrededor de 1,0, prefiriéndose un intervalo de alrededor de 1,0 hasta unos 3,0 y siendo particularmente preferida una ratio de dimensión de unos 2,0. Tener una mayor ratio de dimensión tenderá a evitar que el dispositivo gire de manera generalmente perpendicular a su eje, lo que puede denominarse como rodar dando tumbos. Siempre que el diámetro exterior de las partes de diámetro expandido 64 del dispositivo sea suficientemente grande para asentar el dispositivo de manera suficientemente segura contra el lumen del canal en el que el dispositivo se despliega, la incapacidad del dispositivo para girar dando tumbos ayudará a mantener el dispositivo implantado precisamente donde se ha situado dentro del sistema vascular del paciente o en cualquier otro canal en el cuerpo del paciente. Alternativamente, tener partes de diámetro expandido que tienen diámetros naturales relajados sustancialmente mayores que el lumen de los vasos en los que el dispositivo se implanta debería también ser suficiente para encajar el dispositivo en su lugar en el vaso sin preocuparse indebidamente de la ratio de dimensión del dispositivo. [0057] The dimension ratio (ie, the ratio of the length of the device to its maximum diameter or width) of the device 60 illustrated in Figures 5A and 5B is desirably at least about 1.0, with a preference being preferred. range from about 1.0 to about 3.0 and a dimension ratio of about 2.0 being particularly preferred. Having a higher dimension ratio will tend to prevent the device from rotating generally perpendicular to its axis, which can be called rolling. As long as the outer diameter of the expanded diameter portions 64 of the device is large enough to seat the device securely enough against the lumen of the channel in which the device is deployed, the inability of the device to rotate knocking will help maintain the device implanted precisely where it has been located within the patient's vascular system or in any other channel in the patient's body. Alternatively, having expanded diameter parts having relaxed natural diameters substantially larger than the lumen of the vessels in which the device is implanted should also be sufficient to fit the device into place in the vessel without unduly worrying about the dimension ratio of the device.
[0058] El paso y el avance del tejido metálico 10 usado para formar el dispositivo 60, así como algunos otros factores tales como el número de hilos empleados en una trenza tubular, son importantes para determinar diversas propiedades del dispositivo. Por ejemplo, cuanto mayor sea el paso y el avance del tejido, y por lo tanto cuanto mayor sea la densidad de los filamentos de hilo trenzados en el tejido, más rígido será el dispositivo. Tener una mayor densidad de hilo también proporcionará al dispositivo un área superficial mayor de hilo, lo que generalmente aumentará la tendencia del dispositivo a ocluir un vaso sanguíneo en el que se despliegue. Esta trombogenicidad puede ser o bien aumentada, por ejemplo, con un recubrimiento de un agente trombolítico, o mitigada, por ejemplo, con un recubrimiento de un compuesto lubricante antitrombogénico. [0058] The passage and advancement of the metallic fabric 10 used to form the device 60, as well as some other factors such as the number of threads used in a tubular braid, are important in determining various properties of the device. For example, the greater the pitch and advancement of the fabric, and therefore the greater the density of the strands of yarn braided in the fabric, the more rigid the device will be. Having a higher thread density will also provide the device with a larger surface area of thread, which will generally increase the tendency of the device to occlude a blood vessel in which it is deployed. This thrombogenicity can be either increased, for example, with a coating of a thrombolytic agent, or mitigated, for example, with a coating of an antithrombogenic lubricating compound.
[0059] Cuando el dispositivo se implanta en el vaso de un paciente, los trombos tenderán a acumularse en la superficie de los hilos. Al tener una mayor densidad de hilo, el área superficial total de los hilos aumentará, aumentando la actividad trombótica del dispositivo y permitiéndole ocluir de manera relativamente rápida el vaso en el que se despliega. Se cree que formar el dispositivo de oclusión 60 a partir de una trenza tubular de 4 mm de diámetro con un avance de al menos unos 40 y un paso de al menos unos 30° proporcionará área superficial suficiente para ocluir completamente de manera sustancial un vaso sanguíneo de 2 mm hasta unos 4 mm de diámetro interior, en un periodo de tiempo adecuado. Si se desea incrementar la velocidad a la que el dispositivo 60 ocluye el vaso en el que está desplegado, puede aplicarse al dispositivo cualquiera de una amplia variedad de agentes trombóticos conocidos. [0059] When the device is implanted in a patient's vessel, the thrombi will tend to accumulate on the surface of the threads. By having a higher thread density, the total surface area of the threads will increase, increasing the thrombotic activity of the device and allowing it to relatively quickly occlude the vessel in which it is deployed. It is believed that forming occlusion device 60 from a 4 mm diameter tubular braid with an advance of at least about 40 and a passage of at least about 30 ° will provide sufficient surface area to substantially completely occlude a blood vessel from 2 mm to about 4 mm inside diameter, in a suitable period of time. If it is desired to increase the rate at which the device 60 occludes the vessel in which it is deployed, any of a wide variety of known thrombotic agents can be applied to the device.
[0060] Las figuras 6A-6C ilustran una realización alternativa de un dispositivo médico no de acuerdo con la presente invención. Este dispositivo 80 tiene un cuerpo 52 de forma generalmente acampanada y un extremo delantero que se extiende hacia afuera 84. Una aplicación para la que este dispositivo es particularmente adecuado es ocluir defectos conocidos en la técnica como puentes centrales o ductus arteriosos permeables (PDA). El PDA es básicamente una afección en la que dos vasos sanguíneos, más comúnmente la aorta y la arteria pulmonar adyacente al corazón, tienen una comunicación entre sus lúmenes. La sangre puede fluir directamente entre estos dos vasos sanguíneos a través del puente, comprometiendo el flujo normal de la sangre a través de los vasos del paciente. [0060] Figures 6A-6C illustrate an alternative embodiment of a medical device not in accordance with the present invention. This device 80 has a generally flared body 52 and an outwardly extending front end 84. An application for which this device is particularly suitable is to occlude defects known in the art such as central bridges or patent ductus arteriosus (PDA). PDA is basically a condition in which two blood vessels, most commonly the aorta and the pulmonary artery adjacent to the heart, have a communication between their lumens. Blood can flow directly between these two blood vessels across the bridge, compromising the normal flow of blood through the patient's vessels.
[0061] Como se explica más completamente más adelante en relación con la figura 8, el cuerpo acampanado 82 está adaptado para desplegarse dentro del puente entre los vasos, mientras que el extremo delantero 84 está adaptado para ser posicionado dentro de la aorta para ayudar a asentar el cuerpo en el puente. Los tamaños del cuerpo 82 y del extremo 84 pueden variarse como se desee para puentes de diferente tamaño. Por ejemplo, el cuerpo puede tener un diámetro a lo largo de su parte media generalmente cilíndrica 86 de unos 10 mm y una longitud a lo largo de su eje de unos 25 mm. En tal dispositivo, la base 88 del cuerpo puede ensancharse hacia fuera de forma generalmente radial hasta que alcanza un diámetro exterior igual al del extremo delantero 84, que puede ser del orden de unos 20 mm de diámetro. [0061] As explained more fully below in relation to Figure 8, the flared body 82 is adapted to deploy within the bridge between the vessels, while the front end 84 is adapted to be positioned within the aorta to help settle the body on the bridge. The sizes of body 82 and end 84 can be varied as desired for bridges of different sizes. For example, the body can have a diameter along its generally cylindrical middle portion 86 of about 10 mm and a length along its axis of about 25 mm. In such a device, the base 88 of the body can widen out generally radially until it reaches an outside diameter equal to that of the front end 84, which can be of the order of about 20 mm in diameter.
[0062] La base 88 se ensancha deseablemente hacia fuera de forma relativamente rápida para definir un resalte que disminuye radialmente hacia afuera desde la mitad 86 del cuerpo. Cuando el dispositivo se despliega en un vaso, este resalte hará tope con el lumen de los vasos tratados con mayor presión. El extremo delantero 84 es retenido dentro del vaso y obliga a la base 88 del cuerpo a abrirse para asegurar que el resalte se encaja a la pared del vaso para impedir que el dispositivo 80 acabe desplazado del interior del puente. [0062] The base 88 desirably widens out relatively quickly to define a projection that decreases radially outwardly from the middle 86 of the body. When the device is deployed in a vessel, this protrusion will abut the lumen of the vessels treated with greater pressure. The front end 84 is retained inside the vessel and forces the base 88 of the body to open to ensure that the shoulder fits into the wall of the vessel to prevent the device 80 from being displaced from inside the bridge.
[0063] Como se ha detallado antes, al hacer tal dispositivo es deseable unir entre sí los extremos de los filamentos de hilo que forman el tejido metálico 10 para evitar que el tejido se deshaga. En las ilustraciones de las figuras 6A6C, se usa una sujeción 15 para atar los extremos de los filamentos de hilo adyacentes al extremo frontal 84 del dispositivo. Sin embargo, debe entenderse que esta sujeción 15 es simplemente una ilustración esquemática y que los extremos pueden ser unidos de otras maneras, tal como por soldadura fuerte, blanda, uso de material de cemento biocompatible o de cualquier otra forma adecuada. [0063] As detailed above, in making such a device it is desirable to join together the ends of the filaments of yarn that form the metallic fabric 10 to prevent the tissue from falling apart. In the illustrations of Figures 6A6C, a fastener 15 is used to tie the ends of the filaments of thread adjacent to the front end 84 of the device. However, it should be understood that this fastener 15 is simply a schematic illustration and that the ends can be joined in other ways, such as by brazing, soft welding, use of biocompatible cement material or any other suitable form.
[0064] Los extremos posteriores de los filamentos de hilo se muestran unidos entre sí por un elemento alternativo de sujeción 90. Esta sujeción 90 sirve para el mismo propósito que la sujeción 15 esquemáticamente ilustrada, concretamente para conectar los extremos de los hilos entre si. Sin embargo, la sujeción 90 también sirve para conectar el dispositivo 80 a un sistema portador (no mostrado). En la realización mostrada, la sujeción 90 es generalmente de forma cilíndrica y tiene un rebaje para recibir los extremos de los hilos para fundamentalmente impedir que los hilos se muevan relativamente entre sí, y una superficie exterior roscada. La superficie exterior roscada está adaptada para ser recibida dentro de un rebaje cilíndrico (no mostrado) en un extremo distal de un dispositivo portador y para acoplarse a la superficie interior roscada del rebaje del dispositivo portador. [0064] The rear ends of the thread filaments are shown joined together by an alternative fastener 90. This fastener 90 serves the same purpose as the fastener 15 schematically illustrated, specifically to connect the ends of the threads to each other. However, the clamp 90 also serves to connect the device 80 to a carrier system (not shown). In the embodiment shown, the fastener 90 is generally cylindrical in shape and has a recess to receive the ends of the threads to fundamentally prevent the threads from moving relative to each other, and a threaded outer surface. The threaded outer surface is adapted to be received inside a cylindrical recess (not shown) at a distal end of a carrier device and to engage the threaded inner surface of the carrier device recess.
[0065] El dispositivo portador (no mostrado) puede adoptar cualquier forma adecuada, pero deseablemente comprende un eje metálico flexible alargado que tiene un rebaje, como el mencionado, en su extremo distal. El dispositivo portador puede usarse para impulsar el dispositivo de oclusión PDA 80 a lo largo del lumen de un catéter para despliegue en un canal del cuerpo del paciente, como antes se ha descrito. Cuando el dispositivo se despliega fuera del extremo distal del catéter, el dispositivo será todavía retenido por el dispositivo portador. Una vez que se confirma la posición correcta del dispositivo 80 en el puente, el eje del dispositivo portador puede ser girado alrededor de su eje para desenroscar la sujeción 90 del rebaje en el elemento portador. [0065] The carrier device (not shown) may take any suitable form, but desirably comprises an elongated flexible metal shaft having a recess, as mentioned, at its distal end. The carrier device can be used to drive the PDA 80 occlusion device along the lumen of a catheter for deployment in a channel of the patient's body, as described above. When the device is deployed outside the distal end of the catheter, the device will still be retained by the carrier device. Once the correct position of the device 80 on the bridge is confirmed, the axis of the carrier device can be rotated around its axis to unscrew the fastener 90 of the recess in the carrier element.
[0066] Manteniendo al dispositivo PDA 80 unido al elemento portador, el operador aún podría replegar el dispositivo para reposicionarlo si se determina que el dispositivo no se ha situado correctamente en el primer intento. Esta unión roscada también permitirá al operador controlar la manera en la que se despliega el dispositivo 80 fuera del extremo distal del catéter. Como se ha explicado antes, cuando el dispositivo sale del catéter tenderá a volver elásticamente a una forma preferida expandida que se fija cuando el tejido se trata térmicamente. Cuando el dispositivo recupera elásticamente su forma, puede tender a actuar contra el extremo distal del catéter, impulsándose eficazmente hacia delante más allá del extremo del catéter. Esta acción de muelle podría previsiblemente dar lugar a un posicionamiento incorrecto del dispositivo si la situación del dispositivo dentro de un canal es crítica, tal como donde está situándose en un puente entre dos vasos. Puesto que la sujeción roscada 90 puede capacitar al operador para mantener sujeto el dispositivo durante el despliegue, la acción de muelle del dispositivo puede controlarse y el operador puede controlar el despliegue para asegurar el posicionamiento correcto. [0066] By keeping the PDA device 80 attached to the carrier element, the operator could still fold back the device to reposition it if it is determined that the device was not positioned correctly on the first attempt. This threaded joint will also allow the operator to control the manner in which the device 80 is deployed outside the distal end of the catheter. As explained above, when the device exits the catheter it will tend to return elastically to an expanded preferred form that is fixed when the tissue is heat treated. When the device elastically recovers its shape, it can tend to act against the distal end of the catheter, effectively pushing forward beyond the end of the catheter. This spring action could foreseeably result in an incorrect positioning of the device if the situation of the device within a channel is critical, such as where it is located on a bridge between two vessels. Since the threaded fastener 90 can enable the operator to hold the device during deployment, the spring action of the device can be controlled and the operator can control the deployment to ensure correct positioning.
[0067] Un dispositivo de oclusión PDA 80 de esta realización de la invención puede ventajosamente hacerse de acuerdo con el método antes descrito, concretamente deformando un tejido metálico para ajustarse en general a una superficie de moldeo de un elemento de moldeo y tratando térmicamente el tejido para fijar sustancialmente el tejido en su estado deformado. La figura 7 muestra un elemento de moldeo 100 que puede ser adecuado para formar un dispositivo de oclusión de PDA 80 tal como el mostrado en las figuras 6A-6C. [0067] A PDA occlusion device 80 of this embodiment of the invention can advantageously be made in accordance with the method described above, namely by deforming a metal fabric to generally conform to a molding surface of a molding element and heat treating the tissue. to substantially fix the tissue in its deformed state. Figure 7 shows a molding element 100 that may be suitable for forming a PDA occlusion device 80 such as that shown in Figures 6A-6C.
[0068] El elemento de moldeo 100 comprende, en general, una parte de cuerpo 110 y una placa final 120. La parte de cuerpo 110 está adaptada para recibir y formar el cuerpo 82 del dispositivo 80, mientras que la placa final está adaptada para comprimir contra el tejido metálico para formar el extremo delantero 84. La parte de cuerpo 110 incluye un segmento central alargado generalmente tubular 112 que está dimensionado para recibir el cuerpo alargado 82 del dispositivo. El segmento central 112 del elemento de moldeo 100 tiene óptimamente un diámetro interno ligeramente menor que el diámetro natural exterior relajado de la trenza tubular de la que está formado el dispositivo. Esta compresión de la trenza ayudará a producir dispositivos con cuerpos 82 de tamaño reproducible. El extremo delantero de la parte de cuerpo 110 incluye una placa posterior 114 que tiene una pared, generalmente anular, lateral 116 y que depende de ella hacia abajo. La pared lateral define un rebaje 118 que es generalmente de forma circular. [0068] The molding element 100 generally comprises a body part 110 and an end plate 120. The body part 110 is adapted to receive and form the body 82 of the device 80, while the end plate is adapted to compressing against the metallic fabric to form the front end 84. The body part 110 includes an elongate generally tubular central segment 112 that is sized to receive the elongate body 82 of the device. The central segment 112 of the molding element 100 optimally has an internal diameter slightly smaller than the relaxed outer natural diameter of the tubular braid from which the device is formed. This braid compression will help produce devices with reproducible size bodies 82. The front end of the body part 110 includes a back plate 114 that has a wall, generally annular, side 116 and that depends on it downwards. The side wall defines a recess 118 that is generally circular in shape.
[0069] La placa final 120 del elemento de moldeo 100 tiene una cara con forma general de disco 122, que deseablemente tiene una abertura de sujeción 124, centrada aproximadamente en el mismo, para recibir una sujeción 15 unida al tejido metálico, como antes se ha indicado. La placa final tiene también una pared lateral anular 126, que se extiende generalmente hacia arriba desde la cara 122, para definir un rebaje generalmente cilíndrico 128 en la placa final 120. La pared lateral 116 de la parte de cuerpo 110 está dimensionada para ser recibida dentro del rebaje 128 de la placa final. [0069] The end plate 120 of the molding element 100 has a generally disc-shaped face 122, which desirably has a fastener opening 124, centered approximately thereon, to receive a fastener 15 attached to the metal fabric, as before has indicated. The end plate also has an annular side wall 126, which generally extends upwardly from the face 122, to define a generally cylindrical recess 128 in the end plate 120. The side wall 116 of the body part 110 is sized to be received. inside recess 128 of the end plate.
[0070] En uso, el tejido metálico se coloca en el elemento de moldeo y la parte de cuerpo 110 y la placa final 120 se acercan entre sí. La cara interior de la placa trasera 114 encajará el tejido y tenderá a obligarlo bajo compresión hacia fuera generalmente de manera radial. El tejido será entonces confinado generalmente dentro del rebaje 118 de la parte de cuerpo y se ajustará en general a la superficie interior de ese rebaje. Si se impide que la sujeción completa 15 pase a través de la abertura de sujeción 124, el tejido se separará ligeramente de la superficie interior de la cara 122, dando lugar a una leve forma de cúpula en el extremo delantero 84 del dispositivo, como se ilustra en la figura 6. Aunque la realización ilustrada incluye tal extremo delantero en forma de cúpula, debe entenderse que el extremo delantero puede ser básicamente plano (excepto por la sujeción 15), lo que puede conseguirse permitiendo que la sujeción sea recibida completamente dentro de la abertura de sujeción 124 en la placa final. [0070] In use, the metallic fabric is placed in the molding element and the body part 110 and the end plate 120 approach each other. The inner face of the back plate 114 will fit the tissue and will tend to force it under compression out generally radially. The tissue will then generally be confined within the recess 118 of the body part and will generally conform to the inner surface of that recess. If the complete fastener 15 is prevented from passing through the fastening opening 124, the fabric will separate slightly from the inner surface of the face 122, resulting in a slight dome shape at the front end 84 of the device, as illustrated in Figure 6. Although the illustrated embodiment includes such a dome-shaped front end, it should be understood that the front end can be basically flat (except for the fastener 15), which can be achieved by allowing the fastener to be fully received within the clamping opening 124 in the end plate.
[0071] Una vez que el tejido se comprime en el elemento de moldeo 100, de tal modo que se ajuste en general a la superficie de moldeo del elemento de moldeo, el tejido puede someterse a un tratamiento térmico tal como se ha descrito antes. Cuando el elemento de moldeo se abre de nuevo separando entre sí otra vez la parte de cuerpo 110 y la placa final 120, el tejido retendrá en general su configuración deformada comprimida. El dispositivo puede ser entonces plegado, por ejemplo, obligando a las sujeciones 15, 90 a separarse entre sí de forma generalmente axial, lo que tenderá a plegar al dispositivo hacia su eje. El dispositivo plegado 80 puede entonces ser pasado mediante de un catéter para despliegue en un canal en el sistema vascular de un paciente. [0071] Once the fabric is compressed in the molding element 100, so that it generally conforms to the molding surface of the molding element, the fabric can be subjected to a heat treatment as described above. When the molding element is opened again by separating the body part 110 and the end plate 120 from each other again, the fabric will generally retain its compressed deformed configuration. The device can then be folded, for example, forcing the fasteners 15, 90 to separate from each other generally axially, which will tend to fold the device towards its axis. The folded device 80 can then be passed through a catheter for deployment in a channel in a patient's vascular system.
[0072] La figura 8 ilustra esquemáticamente cómo un dispositivo médico 80, generalmente como se ha descrito antes, puede ser usado para ocluir un ductus arteriosus permeable. En este caso, hay un puente, al que antes se ha hecho referencia como un PDA, que se extiende entre la aorta A y la arteria pulmonar P de un paciente. El dispositivo 80 puede pasarse a través del PDA, tal como manteniendo el dispositivo plegado dentro de un catéter (no mostrado), y puede permitirse que el extremo delantero 84 del dispositivo se expanda elásticamente para recuperar sustancialmente su forma “recordada” fijada térmicamente a partir del proceso de tratamiento térmico, tal como obligando distalmente al dispositivo a extenderse más allá del extremo distal del catéter. Este extremo delantero 84 debería ser mayor que el lumen del puente del PDA. [0072] Figure 8 schematically illustrates how a medical device 80, generally as described above, can be used to occlude a patent ductus arteriosus. In this case, there is a bridge, referred to earlier as a PDA, that extends between the aorta A and the pulmonary artery P of a patient. The device 80 can be passed through the PDA, such as by keeping the device folded inside a catheter (not shown), and the front end 84 of the device can be allowed to expand elastically to substantially recover its "remembered" thermally fixed form from of the heat treatment process, such as forcing the device distally to extend beyond the distal end of the catheter. This leading end 84 should be greater than the lumen of the PDA bridge.
[0073] El dispositivo puede luego ser replegado de modo que el extremo delantero 84 conecte con la pared de la arteria pulmonar P. Si se continúa replegando el catéter, la conexión del dispositivo con la pared del PDA tenderá a sacar naturalmente del catéter la parte de cuerpo 82 del dispositivo, lo que permitirá a la parte de cuerpo regresar a su configuración expandida. La parte de cuerpo debería estar dimensionada de modo que se enganche por fricción al lumen del puente del PDA. El dispositivo 80 se mantendrá entonces en su sitio por la combinación de la fricción entre la parte de cuerpo y el lumen del puente y la presión sanguínea aórtica contra el extremo delantero 84 del dispositivo. En un periodo de tiempo relativamente corto, se formarán trombos dentro y sobre el dispositivo 80 y los trombos ocluirán el PDA. Los expertos en la técnica apreciarán que, a fin de acelerar la oclusión del dispositivo PDA o ASD, el dispositivo puede ser recubierto con un agente trombogénico adecuado, relleno de una fibra de poliéster o trenzado con un número incrementado de filamentos de hilo. [0073] The device can then be retracted so that the front end 84 connects to the wall of the pulmonary artery P. If the catheter continues to be retracted, the connection of the device with the wall of the PDA will tend to naturally remove the part from the catheter. of body 82 of the device, which will allow the body part to return to its expanded configuration. The body part should be sized so that it frictionally engages the lumen of the PDA bridge. The device 80 will then be held in place by the combination of friction between the body part and the bridge lumen and the aortic blood pressure against the leading end 84 of the device. In a relatively short period of time, thrombi will form inside and on the device 80 and the thrombi will occlude the PDA. Those skilled in the art will appreciate that, in order to accelerate the occlusion of the PDA or ASD device, the device may be coated with a suitable thrombogenic agent, filled with a polyester fiber or braided with an increased number of strands of yarn.
[0074] Las figuras 9A y 9B son una vista lateral y una vista de extremo, respectivamente, de otro dispositivo adicional. Este dispositivo 180 puede usarse para una variedad de aplicaciones en los vasos sanguíneos de un paciente. Por ejemplo, si para hacer el dispositivo se usa un tejido con un avance relativamente alto (es decir, en el que la densidad del hilo es bastante grande), el dispositivo puede usarse para ocluir vasos sanguíneos. En otras aplicaciones, puede servir como un filtro dentro de un canal del cuerpo de un paciente, bien en un vaso sanguíneo o en otro canal, tal como en un tracto urinario o conducto biliar. Con el fin de aumentar o reducir más la tendencia del dispositivo a ocluir el vaso, puede aplicarse al dispositivo una adecuada cobertura antitrombogénica conocida, dependiendo de la aplicación del dispositivo. [0074] Figures 9A and 9B are a side view and an end view, respectively, of another additional device. This device 180 can be used for a variety of applications in a patient's blood vessels. For example, if a tissue with a relatively high feed is used to make the device (i.e., in which the thread density is quite large), the device can be used to occlude blood vessels. In other applications, it can serve as a filter within a channel of a patient's body, either in a blood vessel or in another channel, such as in a urinary tract or bile duct. In order to further increase or reduce the tendency of the device to occlude the vessel, adequate known antithrombogenic coverage may be applied to the device, depending on the application of the device.
[0075] Este filtro 180 tiene una configuración en general cónica, menguando, de manera general, radialmente hacia fuera desde su extremo posterior 182 a su extremo delantero 184. Un tramo del dispositivo adyacente a su extremo delantero está adaptado para conectarse a las paredes de un lumen de un canal. El diámetro máximo del dispositivo de filtro 180 es, por lo tanto, al menos tan grande como el diámetro interior del canal en el que va a colocarse de modo que al menos el extremo delantero se conectará a la pared del vaso para básicamente sujetar el dispositivo en su lugar. [0075] This filter 180 has a generally conical configuration, generally decreasing radially outwardly from its rear end 182 to its front end 184. A section of the device adjacent to its front end is adapted to connect to the walls of A lumen of a channel. The maximum diameter of the filter device 180 is, therefore, at least as large as the inside diameter of the channel in which it is to be placed so that at least the front end will be connected to the vessel wall to basically hold the device instead.
[0076] Tener una serie de extremos 185 sin fijar de los filamentos de hilo adyacentes al extremo delantero del dispositivo ayudará a asentar el dispositivo en el canal porque los extremos de los hilos tenderán a clavarse dentro de la pared del vaso ligeramente a medida que el extremo delantero del dispositivo se impulsa hacia su configuración completamente expandida dentro del vaso. La combinación de la fricción entre el extremo delantero del dispositivo que se impulsa hacia afuera y la tendencia de los extremos del hilo a clavarse dentro de las paredes del vaso ayudará a asegurar que el dispositivo permanezca en el lugar donde se despliega en lugar de flotar libremente dentro de un vaso para alcanzar una localización indeseada. [0076] Having a series of unsealed ends 185 of the thread filaments adjacent to the front end of the device will help to seat the device in the channel because the ends of the threads will tend to dig into the vessel wall slightly as the front end of the device is driven towards its fully expanded configuration inside the vessel. The combination of friction between the front end of the device that is driven outward and the tendency of the ends of the wire to stick inside the walls of the vessel will help ensure that the device remains in the place where it is deployed instead of floating freely inside a glass to reach an unwanted location.
[0077] El método por el que se despliega el dispositivo 180 puede variar dependiendo de la naturaleza de la afección fisiológica a tratar. Por ejemplo, al tratar una fístula arteriovenosa, el dispositivo puede ser cuidadosamente posicionado, como antes se ha descrito, para ocluir el flujo de sangre en una localización bastante específica. Al tratar otras afecciones (por ejemplo, una malformación arterio-venosa), sin embargo, puede desearse simplemente liberar un número de estos dispositivos corriente arriba de la malformación en un vaso que tiene un lumen mayor y simplemente permitir que los dispositivos vayan a la deriva desde el sitio del tratamiento para alojarse en vasos más pequeños corriente abajo. [0077] The method by which the device 180 is deployed may vary depending on the nature of the physiological condition to be treated. For example, when treating an arteriovenous fistula, the device can be carefully positioned, as described above, to occlude blood flow at a fairly specific location. When treating other conditions (for example, an arteriovenous malformation), however, it may be desired to simply release a number of these devices upstream of the malformation in a vessel that has a larger lumen and simply allow the devices to drift from the treatment site to stay in smaller vessels downstream.
[0078] La decisión de si el dispositivo 180 debería posicionarse con precisión en una localización exacta dentro del canal en el cuerpo de un paciente o si es más deseable permitir al dispositivo(s) flotar hasta su sitio de alojamiento final dependerá del tamaño de los canales involucrados y la afección específica a tratar. Esta decisión debería dejarse para que la tome el operador individual, en base a cada caso, según dicte su experiencia; no hay un modo correcto o erróneo de desplegar el dispositivo 180 sin tener en cuenta las condiciones del caso. [0078] The decision of whether device 180 should be accurately positioned in an exact location within the channel in a patient's body or if it is more desirable to allow the device (s) to float to its final accommodation site will depend on the size of the channels involved and the specific condition to be treated. This decision should be left for the individual operator to make, based on each case, as dictated by his experience; There is no right or wrong way to deploy the device 180 regardless of the conditions of the case.
[0079] En la realización mostrada en las figuras 9A y 9B, la pared del dispositivo se extiende, generalmente de forma lineal, desde una posición adyacente a la sujeción 90 al otro extremo del dispositivo, aproximándose a una forma cónica. Sin embargo, debido a la presencia de la sujeción 90, el extremo del dispositivo inmediatamente adyacente a la sujeción puede desviarse ligeramente de la forma cónica, como se indica en los dibujos. Alternativamente, la pared puede estar curvada de modo que el diámetro del dispositivo cambie más rápidamente junto al extremo posterior que junto al extremo delantero, teniendo una apariencia más como una rotación de una parábola alrededor de su eje principal que como un verdadero cono. Cualquiera de estas realizaciones debería ser suficiente para ocluir un vaso con el dispositivo 180, tal como para ocluir un vaso. [0079] In the embodiment shown in Figures 9A and 9B, the wall of the device extends, generally linearly, from a position adjacent to the fastener 90 to the other end of the device, approaching a conical shape. However, due to the presence of the fastener 90, the end of the device immediately adjacent to the fastener may deviate slightly from the conical shape, as indicated in the drawings. Alternatively, the wall may be curved so that the diameter of the device changes more rapidly next to the rear end than next to the front end, having an appearance more like a rotation of a parabola around its main axis than a true cone. Any of these embodiments should be sufficient to occlude a vessel with the device 180, such as to occlude a vessel.
[0080] Los extremos de los filamentos de hilo en el extremo posterior 182 del dispositivo están fijados entre sí, tal como por medio de una sujeción roscada 90 como la antes descrita en relación con las figuras 6A-6C. Partes de los filamentos de hilo adyacentes al extremo delantero 184 pueden también ser fijados contra movimiento relativo, por ejemplo soldando por puntos los hilos entre sí donde se cruzan cerca del extremo delantero. Esta soldadura por puntos se ilustra esquemáticamente en 186 en las figuras 9A y 9B. [0080] The ends of the filaments of yarn at the rear end 182 of the device are fixed to each other, such as by means of a threaded fastener 90 such as the one described above in relation to Figures 6A-6C. Parts of the wire filaments adjacent to the front end 184 can also be fixed against relative movement, for example by welding the threads to each other where they intersect near the front end. This spot welding is schematically illustrated in 186 in Figures 9A and 9B.
[0081] Sin embargo, en la realización ilustrada en las figuras 9, los extremos de los filamentos de hilo adyacentes al extremo delantero 184 en el dispositivo acabado no necesitan fijarse entre sí en forma alguna. Estos filamentos se sujetan en una posición fija durante el proceso de formación para impedir que el tejido metálico se deshaga antes de que se configure en un dispositivo acabado. Mientras los extremos de los filamentos de hilo adyacentes al extremo delantero permanezcan fijos entre sí, pueden ser tratados térmicamente, como antes se ha descrito. El tratamiento térmico tenderá a fijar las formas de los hilos en su configuración deformada en la que el dispositivo se ajusta en general a una superficie de moldeo del elemento de moldeo. Cuando el dispositivo se retira del contacto con el elemento de moldeo, los hilos mantendrán su forma y tenderán a permanecer entrelazados. En consecuencia, cuando el dispositivo es liberado del contacto con el elemento de moldeo, incluso si los extremos de los hilos son liberados de cualquier restricción, el dispositivo debería todavía mantener sustancialmente su forma. [0081] However, in the embodiment illustrated in Figs. 9, the ends of the thread filaments adjacent the leading end 184 in the finished device need not be fixed to each other in any way. These filaments are held in a fixed position during the formation process to prevent the metallic tissue from falling apart before it is configured in a finished device. As long as the ends of the thread filaments adjacent to the front end remain fixed with each other, they can be heat treated, as described above. The heat treatment will tend to fix the shapes of the wires in their deformed configuration in which the device generally adjusts to a molding surface of the molding element. When the device is removed from contact with the molding element, the threads will maintain their shape and tend to remain intertwined. Consequently, when the device is released from contact with the molding element, even if the ends of the threads are released from any restriction, the device should still substantially maintain its shape.
[0082] Las figuras 10A-10C ilustran tres moldes adecuados para usar al formar el filtro 180 de las figuras 9A y 9B. En la figura 10A, el elemento de moldeo 200 es una pieza única que define un par de piezas generalmente cónicas que hacen tope entre sí. En otra realización similar (no mostrada), el elemento de moldeo 200 puede ser en general ovoide, con forma no diferente a un balón de fútbol americano o de rugby. En la realización ilustrada en la figura 10A, sin embargo, el elemento de moldeo es un poco menos redondeado. Este elemento de moldeo comprende dos segmentos cónicos 202 que hacen tope entre sí por sus bases, definiendo un diámetro mayor en el medio 204 del elemento que puede disminuir, de manera relativamente uniforme, hacia los extremos 206 del elemento 200. [0082] Figures 10A-10C illustrate three molds suitable for use in forming filter 180 of Figures 9A and 9B. In Figure 10A, the molding element 200 is a single piece that defines a pair of generally conical pieces that abut each other. In another similar embodiment (not shown), the molding element 200 may be generally ovoid, with a shape not unlike a football or rugby ball. In the embodiment illustrated in Figure 10A, however, the molding element is slightly less rounded. This molding element comprises two conical segments 202 that abut each other by their bases, defining a larger diameter in the middle 204 of the element that can decrease, relatively evenly, towards the ends 206 of the element 200.
[0083] Cuando se usa una trenza tubular al formar este dispositivo, el tejido metálico tubular puede ser aplicado al elemento de moldeo, colocando el elemento de moldeo dentro de la trenza tubular y sujetando los extremos de la trenza alrededor del elemento de moldeo antes de cortar la trenza a la longitud deseada. Con el fin de facilitar mejor la unión de las sujeciones 90 a los extremos de la trenza tubular, los extremos 206 del elemento de moldeo pueden ser redondeados, como se muestra, mejor que en disminución hasta un punto más afilado en los extremos del elemento de moldeo. Con el fin de asegurar que la trenza se ajusta de forma más estrecha a la superficie exterior del elemento de moldeo 200, es decir, la superficie de moldeo del elemento de moldeo, el diámetro natural relajado de la trenza debería ser menor que el diámetro máximo del elemento, lo que sucede en su zona media 204. Esto colocará el tejido metálico en tensión alrededor de la zona media del elemento y, en combinación con las sujeciones en los extremos de la trenza, hará que la trenza se ajuste en general a la superficie de moldeo. [0083] When a tubular braid is used when forming this device, the tubular metallic fabric can be applied to the molding element, placing the molding element inside the tubular braid and holding the ends of the braid around the molding element before Cut the braid to the desired length. In order to better facilitate the attachment of the fasteners 90 to the ends of the tubular braid, the ends 206 of the molding element may be rounded, as shown, better than decreasing to a sharper point at the ends of the element of molding In order to ensure that the braid fits more closely to the outer surface of the molding element 200, that is, the molding surface of the molding element, the relaxed natural diameter of the braid should be less than the maximum diameter of the element, what happens in its middle zone 204. This will place the tension metal fabric around the middle area of the element and, in combination with the fasteners at the ends of the braid, will cause the braid to fit in general with the molding surface
[0084] La figura 10B ilustra un elemento de moldeo alternativo 210 para formar un dispositivo básicamente como se muestra en las figuras 9A y 9B. Mientras que se pretende que el elemento de moldeo 200 esté ideado para ser recibido dentro de un rebaje en el tejido metálico, tal como dentro del lumen de un tramo de trenza tubular, el elemento de moldeo 210 tiene una cavidad interna 212 adaptada para recibir el tejido. En esta realización, el elemento de moldeo puede comprender un par de secciones de moldeo 214, 216 y estas secciones del molde pueden ser sustancialmente idénticas en forma. Cada una de las secciones de moldeo 214, 216 generalmente comprende una superficie interna cónica 220 definida por una pared 222. Cada sección puede también estar provista de un rebaje axial generalmente cilíndrico 224 para recibir una sujeción 15 (ó 90) llevada por un extremo del tejido metálico. [0084] Figure 10B illustrates an alternative molding element 210 for forming a device basically as shown in Figures 9A and 9B. While it is intended that the molding element 200 is designed to be received within a recess in the metallic fabric, such as within the lumen of a section of tubular braid, the molding element 210 has an internal cavity 212 adapted to receive the tissue. In this embodiment, the molding element may comprise a pair of molding sections 214, 216 and these mold sections may be substantially identical in shape. Each of the molding sections 214, 216 generally comprises a conical internal surface 220 defined by a wall 222. Each section may also be provided with a generally cylindrical axial recess 224 to receive a fastener 15 (or 90) carried by one end of the metallic fabric
[0085] Las dos secciones de moldeo deberían unirse fácilmente entre sí, con los extremos mayores abiertos 226 de las secciones haciendo tope entre sí. Las secciones del molde pueden simplemente ser unidas entre sí, por ejemplo, disponiendo una fijación reutilizable (no mostrada) que puede usarse para posicionar correctamente las secciones 214, 216 entre sí. Si se desea así, pueden disponerse agujeros pasantes 228 o similares para permitir a un tornillo y tuerca, o cualquier sistema de unión similar, pasar a través de los agujeros y unir entre sí las secciones 214, 216. [0085] The two molding sections should be easily joined together, with the larger open ends 226 of the sections abutting each other. The sections of the mold can simply be joined together, for example, by providing a reusable fastener (not shown) that can be used to correctly position the sections 214, 216 with each other. If so desired, through holes 228 or the like can be arranged to allow a screw and nut, or any similar joint system, to pass through the holes and join together sections 214, 216.
[0086] En la práctica, una pieza de tamaño adecuado de un tejido metálico, óptimamente un tramo de una trenza tubular, se coloca en el rebaje 212 del elemento de moldeo y las dos secciones de moldeo 214, 216 se presionan una hacia la otra. El tejido debería tener una longitud axial relajada más larga que la longitud axial del rebaje 212, de tal modo que llevar las secciones una hacia otra comprimirá axialmente el tejido. Esta compresión axial tenderá a obligar los filamentos de hilo de la trenza radialmente hacia afuera del eje de la trenza y hacia un encaje con la superficie de moldeo del elemento 210, lo que se define por la superficie del rebaje 212. [0086] In practice, a piece of suitable size of a metallic fabric, optimally a section of a tubular braid, is placed in the recess 212 of the molding element and the two molding sections 214, 216 are pressed towards each other . The tissue should have a relaxed axial length longer than the axial length of the recess 212, such that bringing the sections toward each other will axially compress the tissue. This axial compression will tend to bind the strands of braid thread radially outward from the braid shaft and into a socket with the molding surface of the element 210, which is defined by the surface of the recess 212.
[0087] Una vez que el tejido metálico se ha deformado para ajustarse generalmente a la superficie de moldeo de cualquier elemento de moldeo 200 ó 210, el tejido puede ser tratado térmicamente para fijar sustancialmente la forma del tejido en su estado deformado. Si se usa el elemento de moldeo 200, puede luego ser retirado del interior del tejido metálico. Si hay suficiente espacio entre los filamentos de hilo elásticos, el elemento de moldeo puede simplemente retirarse abriendo la tela de araña de filamentos de hilo y extrayendo el elemento de moldeo del interior del tejido metálico. Si se usa el elemento de moldeo 210, las dos secciones de moldeo 214, 216 pueden separarse entre sí y el tejido moldeado puede recuperarse del rebaje 212. Dependiendo de la forma de la superficie de moldeo, la forma configurada resultante puede parecerse bien a un par de conos huecos encarados o, como se ha indicado arriba, a un balón de fútbol, con sujeciones, soldaduras o similares, provistas en uno y otro extremo de la configuración. [0087] Once the metal fabric has been deformed to generally conform to the molding surface of any molding element 200 or 210, the fabric can be heat treated to substantially fix the shape of the fabric in its deformed state. If the molding element 200 is used, it can then be removed from within the metal fabric. If there is enough space between the elastic thread filaments, the molding element can simply be removed by opening the spider web of thread filaments and removing the molding element from the inside of the metal fabric. If the molding element 210 is used, the two molding sections 214, 216 can be separated from each other and the molded fabric can be recovered from the recess 212. Depending on the shape of the molding surface, the resulting shaped shape may resemble a pair of hollow cones facing or, as indicated above, a soccer ball, with fasteners, welds or the like, provided at either end of the configuration.
[0088] Esta configuración puede luego cortarse en dos mitades cortando los hilos en una dirección generalmente perpendicular al eje compartido de los conos (o el eje principal de la forma ovoidal) en una posición hacia la mitad de su longitud. Esto producirá dos dispositivos de filtro separados 180 esencialmente como se ilustra en las figuras 9A y 9B. Si los filamentos de hilo van a ser unidos adyacentes al extremo delantero del dispositivo (tal como por las soldaduras mostradas como 186 en las figuras 9A y 9B), esto puede hacerse antes de que la forma cónica u ovoidal se corte en dos mitades. Podría conseguirse casi la misma configuración final cortando el tejido metálico en mitades mientras está todavía en el elemento de moldeo 200. Las mitades separadas con la forma deseada podrían entonces distanciarse, dejando el elemento de moldeo listo para formar dispositivos adicionales. [0088] This configuration can then be cut in two halves by cutting the threads in a direction generally perpendicular to the shared axis of the cones (or the main axis of the ovoidal shape) in a position towards the middle of its length. This will produce two separate filter devices 180 essentially as illustrated in Figures 9A and 9B. If the wire filaments are to be attached adjacent to the front end of the device (such as by the welds shown as 186 in Figures 9A and 9B), this can be done before the conical or ovoidal shape is cut in two halves. Almost the same final configuration could be achieved by cutting the metal fabric in halves while still in the molding element 200. The halves separated with the desired shape could then be distanced, leaving the molding element ready to form additional devices.
[0089] En un método alternativo, el elemento de moldeo 200 está formado de un material seleccionado para permitir que el elemento de moldeo sea destruido para retirarlo del interior del tejido metálico. Por ejemplo, el elemento de moldeo puede estar formado de un material frágil o quebradizo, tal como vidrio. Una vez que el material ha sido tratado térmicamente en contacto con la superficie de moldeo del elemento de moldeo, el elemento de moldeo puede romperse en piezas más pequeñas que pueden ser fácilmente retiradas de dentro del tejido metálico. Si el material es vidrio, por ejemplo, el elemento de moldeo y el tejido metálico pueden golpearse contra una superficie dura, causando que el cristal se haga pedazos. Los fragmentos de vidrio pueden entonces ser retirados del recinto del tejido metálico. La forma resultante puede usarse en su forma generalmente cónica, o puede ser cortada en dos mitades separadas para producir un dispositivo básicamente como se muestra en las figuras 9A y 9B. [0089] In an alternative method, the molding element 200 is formed of a material selected to allow the molding element to be destroyed to remove it from inside the metal fabric. For example, the molding element may be formed of a brittle or brittle material, such as glass. Once the material has been heat treated in contact with the molding surface of the molding element, the molding element can be broken into smaller pieces that can be easily removed from within the metal fabric. If the material is glass, for example, the molding element and the metallic fabric can hit a hard surface, causing the glass to break apart. The glass fragments can then be removed from the metal tissue enclosure. The resulting form can be used in its generally conical form, or it can be cut into two separate halves to produce a device basically as shown in Figures 9A and 9B.
[0090] Alternativamente, el elemento de moldeo 200 puede estar formado de un material que puede ser químicamente disuelto, o descompuesto de otra manera, por un agente químico que no afecte básicamente de forma adversa a las propiedades de los filamentos de hilo metálicos. Por ejemplo, el elemento de moldeo puede estar formado de una resina de plástico resistente a la temperatura que sea capaz de disolverse con un disolvente orgánico adecuado. El tejido y el elemento de moldeo pueden someterse a un tratamiento térmico para fijar sustancialmente la forma del tejido en conformidad con la superficie del elemento de moldeo, con lo cual el elemento de moldeo y el tejido metálico pueden sumergirse en el disolvente. Una vez que el elemento de moldeo está sustancialmente disuelto, el tejido metálico puede retirarse y, o bien usarse en su configuración actual, o cortarse en mitades separadas, como se ha descrito antes. [0090] Alternatively, the molding element 200 may be formed of a material that can be chemically dissolved, or otherwise decomposed, by a chemical agent that does not basically adversely affect the properties of the metal wire filaments. For example, the molding element may be formed of a temperature resistant plastic resin that is capable of dissolving with a suitable organic solvent. The fabric and the molding element can be subjected to a heat treatment to substantially fix the shape of the fabric in accordance with the surface of the molding element, whereby the molding element and the metallic fabric can be immersed in the solvent. Once the molding element is substantially dissolved, the metal fabric can be removed and either used in its current configuration, or cut into separate halves, as described above.
[0091] Debería tenerse cuidado para asegurar que el material seleccionado para formar el elemento de moldeo sea capaz de aguantar el tratamiento térmico sin perder su forma, al menos hasta que la forma del tejido haya sido fijada. Por ejemplo, el elemento de moldeo podría estar formado de un material con un punto de fusión por encima de la temperatura necesaria para fijar la forma de los filamentos de hilo, pero por debajo del punto de fusión del metal que forma los filamentos. El elemento de moldeo y el tejido metálico pueden entonces tratarse térmicamente para fijar la forma del tejido metálico, con lo cual la temperatura puede aumentarse para derretir de forma sustancialmente completa el elemento de moldeo, retirando de ese modo el elemento de moldeo de dentro del tejido metálico. [0091] Care should be taken to ensure that the material selected to form the molding element is able to withstand the heat treatment without losing its shape, at least until the shape of the fabric has been fixed. For example, the molding element could be formed of a material with a melting point above the temperature necessary to fix the shape of the filaments of yarn, but below the melting point of the metal that forms the filaments. The molding element and the metal fabric can then be heat treated to fix the shape of the metal fabric, whereby the temperature can be increased to melt the molding element substantially completely, thereby removing the molding element from within the fabric. metal.
[0092] Debería entenderse que los métodos que se acaban de describir para retirar el tejido metálico 10 del elemento de moldeo 200 pueden usarse también en relación con otras configuraciones. Aunque estos métodos pueden no ser necesarios o deseables si el elemento de moldeo va por el exterior del tejido metálico (tal como van los elementos 30-40 del elemento de moldeo 20 de las figuras 2-4), si el elemento de moldeo o alguna parte del mismo está encerrado dentro del tejido metálico formado (tal como la sección moldeadora interna del elemento de moldeo 20), estos métodos pueden usarse para retirar eficazmente al elemento de moldeo sin afectar negativamente al dispositivo médico en formación. [0092] It should be understood that the methods just described for removing the metallic fabric 10 from the molding element 200 can also be used in relation to other configurations. Although these methods may not be necessary or desirable if the molding element goes outside the metal fabric (such as elements 30-40 of the molding element 20 of Figures 2-4), if the molding element or any part thereof is enclosed within the formed metal tissue (such as the internal molding section of the molding element 20), these methods can be used to effectively remove the molding element without adversely affecting the medical device in formation.
[0093] La figura 10C ilustra otro elemento de moldeo más 230 que puede ser usado para formar un dispositivo médico tal como el ilustrado en las figuras 9A y 9B. Este elemento de moldeo comprende una sección de moldeo externa 232 que define una superficie interna en disminución 234 y una sección de moldeo interna 236 con una superficie externa 238 de básicamente la misma forma que la superficie interna en disminución 234 de la sección de moldeo externa. La sección de moldeo interna 236 debería dimensionarse para ser recibida dentro de la sección de moldeo externa, estando dispuesta una parte del tejido metálico (no mostrado) entre las secciones de moldeo interna y externa. Puede considerarse que la superficie de moldeo de este elemento de moldeo 230, a la que el tejido generalmente se ajustará, incluye tanto la superficie interna 234 de la sección externa de moldeo como la superficie externa 238 de la sección interna de moldeo. [0093] Figure 10C illustrates another molding element plus 230 that can be used to form a medical device such as that illustrated in Figures 9A and 9B. This molding element comprises an external molding section 232 that defines a decreasing internal surface 234 and an internal molding section 236 with an external surface 238 in basically the same way as the decreasing internal surface 234 of the external molding section. The internal molding section 236 should be sized to be received within the external molding section, a part of the metal fabric (not shown) being disposed between the internal and external molding sections. It can be considered that the molding surface of this molding element 230, to which the fabric will generally fit, includes both the internal surface 234 of the external molding section and the external surface 238 of the internal molding section.
[0094] Este elemento de moldeo 230 puede usarse con un tejido metálico que está en forma de una trenza tubular. Si se usa tal tejido y se dispone una sujeción 15 (no mostrada en este dibujo) o una sujeción similar para conectar los extremos de los filamentos de hilo adyacentes a un extremo del dispositivo, puede disponerse un rebaje (no mostrado) análogo a la cavidad 46 en la cara del disco de compresión 44 del elemento de moldeo 20 (figuras 2-4) para recibir la sujeción. [0094] This molding element 230 can be used with a metallic fabric that is in the form of a tubular braid. If such a fabric is used and a fastener 15 (not shown in this drawing) or a similar fastener is provided to connect the ends of the strands of thread adjacent to one end of the device, a recess (not shown) analogous to the cavity can be provided 46 on the face of the compression disc 44 of the molding element 20 (Figures 2-4) to receive the fastener.
[0095] Sin embargo, el presente elemento de moldeo 230 puede usarse bastante fácilmente con una pieza plana tejida de tejido metálico, tal como se ilustra en la figura 1B. Al usar este tejido, se corta un trozo de tejido de la dimensión y en la forma adecuadas; al usar el elemento de moldeo 230 para producir un dispositivo 180 análogo al mostrado en las figuras 9A y 9B, por ejemplo, puede usarse una pieza del tejido metálico 10’ con forma generalmente de disco. El tejido metálico se coloca entonces entre las dos secciones 232, 236 del elemento de moldeo y las secciones son movidas conjuntamente para deformar el tejido entre ellas. Después del tratamiento térmico, el tejido puede ser retirado y retendrá básicamente la misma forma que tenía cuando se deformó entre las dos secciones de moldeo. [0095] However, the present molding element 230 can be used quite easily with a flat woven piece of metallic fabric, as illustrated in Figure 1B. When using this fabric, a piece of tissue of the appropriate size and shape is cut; by using the molding element 230 to produce a device 180 analogous to that shown in FIGS. 9A and 9B, for example, a piece of metal fabric 10 ’generally with a disk shape can be used. The metallic fabric is then placed between the two sections 232, 236 of the molding element and the sections are moved together to deform the tissue between them. After heat treatment, the tissue can be removed and will retain basically the same shape as it had when deformed between the two molding sections.
[0096] Como puede verse por la explicación de los diversos elementos de moldeo 200, 210 y 230 en las figuras 10A10C, debería estar claro que un número de diferentes elementos de moldeo puede lograr esencialmente la misma forma deseada. Estos elementos de moldeo pueden estar totalmente alojados dentro de un segmento cerrado de tejido y depender de la tensión y/o compresión del tejido para hacer que éste se ajuste en general a la superficie de moldeo del elemento de moldeo, como con el elemento 200 de la figura 10A. El elemento de moldeo 210 de la figura 10B básicamente encierra el tejido dentro de un rebaje en el molde y depende de la compresión del tejido (en este caso, compresión axial de una trenza tubular) para deformar el tejido a la configuración deseada. Finalmente, el tejido puede ser comprimido entre dos partes de recubrimiento del elemento de moldeo para deformar el tejido, tal como entre las dos secciones 232, 236 del elemento de moldeo 230 en la figura 10C. Una cualquiera o más de estas técnicas pueden usarse para conseguir un producto acabado con una forma deseada. [0096] As can be seen from the explanation of the various molding elements 200, 210 and 230 in Figures 10A10C, it should be clear that a number of different molding elements can achieve essentially the same desired shape. These molding elements can be fully housed within a closed segment of tissue and depend on the tension and / or compression of the fabric to make it generally fit the molding surface of the molding element, as with the element 200 of Figure 10A The molding element 210 of Figure 10B basically encloses the tissue within a recess in the mold and depends on the compression of the tissue (in this case, axial compression of a tubular braid) to deform the tissue to the desired configuration. Finally, the fabric can be compressed between two covering parts of the molding element to deform the fabric, such as between the two sections 232, 236 of the molding element 230 in Figure 10C. Any one or more of these techniques can be used to achieve a finished product with a desired shape.
[0097] Las figuras 11 y 13-15 ilustran una realización preferida alternativa de un dispositivo médico de acuerdo con la presente invención para corregir un defecto septal auricular (ASD). Con referencia a las figuras 13 y 15, el dispositivo 300 en su estado relajado no estirado tiene dos discos 302 y 304, alineados en relación espaciada, unidos entre sí por un cilindro corto 306. Se propone que este dispositivo 300 puede ser también muy adecuado para ocluir defectos conocidos en la materia como foramen oval permeable (de ahora en adelante PFO). El ASD es una anomalía congénita del tabique auricular caracterizada por una deficiencia estructural del tabique auricular. Un puente puede darse en el tabique auricular, permitiendo flujo entre las aurículas derecha e izquierda. En defectos grandes con puentes significativos de izquierda a derecha a través del defecto, la aurícula derecha y el ventrículo derecho se sobrecargan en volumen y el volumen aumentado se expulsa adentro de un cauce vascular pulmonar de baja resistencia. [0097] Figures 11 and 13-15 illustrate an alternative preferred embodiment of a medical device according to the present invention for correcting an atrial septal defect (ASD). With reference to Figures 13 and 15, the device 300 in its relaxed unstretched state has two discs 302 and 304, aligned in spaced relationship, joined together by a short cylinder 306. It is proposed that this device 300 may also be very suitable to occlude defects known in the art as patent foramen ovale (hereinafter PFO). ASD is a congenital anomaly of the atrial septum characterized by a structural deficiency of the atrial septum. A bridge can occur in the atrial septum, allowing flow between the right and left atria. In large defects with significant bridges from left to right through the defect, the right atrium and right ventricle are overloaded in volume and the increased volume is expelled into a pulmonary vascular channel of low resistance.
[0098] La enfermedad oclusiva vascular pulmonar y la hipertensión auricular pulmonar se desarrollan en la edad adulta. Los pacientes con ASD secundum con un puente significativo (definido como un ratio de flujo sanguíneo pulmonar al flujo sanguíneo sistémico mayor que 1,5) se operan idealmente a los cinco años de edad o cuando se hace un diagnóstico en años posteriores. Con la llegada del ecocardiograma bidimensional y la cartografía Doppler de flujo coloreado, puede visualizarse la anatomía exacta del defecto. El tamaño del defecto se corresponderá con el tamaño seleccionado del dispositivo ASD a usar. [0098] Pulmonary vascular occlusive disease and pulmonary atrial hypertension develop in adulthood. Patients with ASD secundum with a significant bridge (defined as a ratio of pulmonary blood flow to systemic blood flow greater than 1.5) are ideally operated at five years of age or when a diagnosis is made in later years. With the arrival of the two-dimensional echocardiogram and colored flow Doppler mapping, the exact anatomy of the defect can be visualized. The default size will correspond to the selected size of the ASD device to use.
[0099] El dispositivo 300, mostrado en su estado no confinado o relajado en la figura 13, está adaptado para ser desplegado dentro del puente que comprende un ASD o un PFO. Con fines de ejemplo, se describirá en adelante el uso del dispositivo 300 en un procedimiento de cierre de ASD. Atendiendo primero a las características constructivas del dispositivo 300, el oclusor de ASD 300 se dimensiona en proporción al puente a ocluir. En la orientación relajada, el tejido metálico se conforma de tal modo que dos discos como los elementos 302 y 304 están alineados axialmente y vinculados entre sí por un segmento cilíndrico corto 306. La longitud del segmento cilíndrico 306 se aproxima preferiblemente al grosor del tabique auricular, y es de 2 a 20 mm. Los discos proximal 302 y distal 304 tienen preferiblemente un diámetro externo suficientemente mayor que el puente para evitar la descolocación del dispositivo. El disco proximal 302 tiene una configuración relativamente plana, mientras que el disco distal 304 tiene forma de copa hacia el extremo proximal solapando ligeramente el disco proximal 302. [0099] The device 300, shown in its unconfined state or relaxed in Figure 13, is adapted to be deployed within the bridge comprising an ASD or a PFO. For example, the use of the device 300 in an ASD closure procedure will be described hereinafter. Following first the constructive characteristics of the device 300, the ASD 300 occluder is sized in proportion to the bridge to be occluded. In the relaxed orientation, the metallic fabric is shaped such that two discs such as elements 302 and 304 are axially aligned and linked to each other by a short cylindrical segment 306. The length of the cylindrical segment 306 preferably approximates the thickness of the atrial septum , and is 2 to 20 mm. The proximal 302 and distal 304 discs preferably have an external diameter sufficiently larger than the bridge to avoid discoloration of the device. The proximal disk 302 has a relatively flat configuration, while the distal disk 304 is cup-shaped towards the proximal end by slightly overlapping the proximal disk 302.
[0100] Los extremos de este dispositivo de tejido metálico trenzado 300 son soldados o sujetados conjuntamente con sujeciones 308 y 310, como se ha descrito antes, para evitar que se deshilachen. Por supuesto, los extremos pueden, alternativamente, mantenerse unidos por otros medios fácilmente conocidos por los expertos en la técnica. La sujeción 310 que une conjuntamente los filamentos de hilo en el extremo proximal, también sirve para conectar el dispositivo a un sistema portador (ver figura 11). En la realización mostrada; la sujeción 310 es de forma generalmente cilíndrica y tiene un rebaje para recibir los extremos del tejido metálico para evitar esencialmente que los hilos que comprenden la tela tejida se muevan relativamente entre ellos. La sujeción 310 también tiene una superficie roscada dentro del rebaje. El rebaje roscado está adaptado para recibir y acoplar el extremo distal roscado de un dispositivo portador 312. [0100] The ends of this braided metal fabric device 300 are welded or held together with fasteners 308 and 310, as described above, to prevent fraying. Of course, the ends may, alternatively, be held together by other means readily known to those skilled in the art. The fastener 310 that joins the thread filaments together at the proximal end also serves to connect the device to a carrier system (see figure 11). In the embodiment shown; The fastener 310 is generally cylindrical in shape and has a recess to receive the ends of the metal fabric to essentially prevent the threads comprising the woven fabric from moving relatively between them. The fastener 310 also has a threaded surface within the recess. The threaded recess is adapted to receive and couple the threaded distal end of a carrier device 312.
[0101] El dispositivo de oclusión ASD 300 de esta realización de la invención puede, ventajosamente, hacerse de acuerdo con el método antes descrito. El dispositivo 300 está preferiblemente hecho de una malla metálica de nitinol de 0,005 pulgadas. El trenzado de la malla metálica puede realizarse con 28 avances por pulgada, en un ángulo de orientación de unos 64 grados, usando un trenzador Maypole con 72 portahilos. La rigidez del dispositivo ASD 300 puede aumentarse o reducirse cambiando el tamaño del hilo, el ángulo de orientación, el tamaño del avance, el número de portahilos o el proceso de tratamiento térmico. [0101] The ASD 300 occlusion device of this embodiment of the invention can advantageously be made in accordance with the method described above. The device 300 is preferably made of a 0.005 inch nitinol metal mesh. The braiding of the metal mesh can be done with 28 advances per inch, at an orientation angle of about 64 degrees, using a Maypole braid with 72 thread holders. The stiffness of the ASD 300 device can be increased or reduced by changing the thread size, the orientation angle, the size of the feed, the number of thread holders or the heat treatment process.
[0102] Los expertos en la técnica reconocerán de la explicación precedente que las cavidades del molde deben ser configuradas coherentemente con la configuración deseada del dispositivo ASD. También, se reconocerá que ciertas configuraciones deseadas pueden requerir que partes de las cavidades sean irregulares. Las figuras 17 y 18 ilustran un dispositivo de ASD según la invención que tiene una configuración modificada. El disco proximal 302 es una imagen especular del disco distal 304. La distancia que separa los discos proximal y distal 302 y 304 es menor que la longitud del segmento cilíndrico 306. La forma de copa del disco, como se ilustra en las figuras 13, 14, 16 y 17, asegura contacto completo entre el dispositivo de oclusión 300 y el tabique auricular. En virtud de ello, se forma una capa endotelial de neo endocardio sobre el dispositivo de oclusión 300, reduciendo por ello la posibilidad de endocarditis bacteriana. [0102] Those skilled in the art will recognize from the foregoing explanation that mold cavities must be configured consistent with the desired configuration of the ASD device. Also, it will be recognized that certain desired configurations may require that parts of the cavities be irregular. Figures 17 and 18 illustrate an ASD device according to the invention having a modified configuration. The proximal disk 302 is a mirror image of the distal disk 304. The distance between the proximal and distal discs 302 and 304 is less than the length of the cylindrical segment 306. The disk cup shape, as illustrated in Figures 13, 14, 16 and 17, ensures full contact between the occlusion device 300 and the atrial septum. Accordingly, an endothelial layer of neo endocardium is formed on occlusion device 300, thereby reducing the possibility of bacterial endocarditis.
[0103] A continuación, en relación con las figuras 11, 14-16 y 18, el uso del dispositivo será ahora tratado en mayor detalle. El dispositivo puede ser entregado y colocado apropiadamente usando ecocardiografías bidimensionales y cartografía Doppler de flujo coloreado. Como se indicó anteriormente, el dispositivo portador 312 puede tomar cualquier forma adecuada, preferiblemente comprendiendo un eje metálico flexible alargado similar a un alambre de guía convencional. El dispositivo portador 312 se usa para avanzar el dispositivo de oclusión ASD 300 a través del lumen de un tubo cilíndrico de diámetro pequeño 314, tal como un catéter portador, para el despliegue. El dispositivo ASD 300 se carga en el tubo cilíndrico de diámetro pequeño 314 estirando el mismo para ponerlo en un estado alargado. El dispositivo puede ser insertado dentro del lumen del tubo 314 durante el procedimiento o premontado en una instalación de fabricación, porque los dispositivos de la presente invención no toman una forma permanente cuando se mantienen en un estado comprimido. [0103] Next, in relation to Figures 11, 14-16 and 18, the use of the device will now be discussed in greater detail. The device can be properly delivered and placed using two-dimensional echocardiography and colored flow Doppler mapping. As indicated above, the carrier device 312 may take any suitable form, preferably comprising an elongated flexible metal shaft similar to a conventional guidewire. The carrier device 312 is used to advance the ASD 300 occlusion device through the lumen of a small diameter cylindrical tube 314, such as a carrier catheter, for deployment. The ASD device 300 is loaded into the small diameter cylindrical tube 314 by stretching it to put it in an elongated state. The device can be inserted into the lumen of tube 314 during the procedure or pre-assembled in a manufacturing facility, because the devices of the present invention do not take a permanent form when they are kept in a compressed state.
[0104] Desde un enfoque de vena femoral, el catéter o tubo portador 314 se pasa por el ASD. El dispositivo 300 es avanzado a lo largo del catéter portador hasta que el extremo distal 304 deja de estar retenido al salir del extremo del catéter, con lo cual asume su forma de disco en la aurícula izquierda. El catéter portador 314 se retira entonces en la dirección proximal a lo largo del ASD y se tira del dispositivo portador 312 de la misma manera, en una dirección proximal, obligando al disco distal 304 contra el tabique 318. El catéter portador 314 es entonces extraído adicionalmente, separándolo del tabique 318, permitiendo al disco proximal 302 extenderse fuera del catéter portador 314, donde vuelve elásticamente a su forma predefinida de disco expandido (ver figura 15). De esta manera, el dispositivo ASD 300 es posicionado de tal modo que el disco distal 304 presiona contra un lado del tabique 318 mientras el disco proximal 302 presiona contra el otro lado del tabique 318. Con el fin de incrementar su capacidad oclusiva, el dispositivo puede contener fibras de poliéster 316 (ver las figuras 15 y 18). En ejemplos donde el dispositivo se despliega incorrectamente en un primer intento, el dispositivo 300 puede ser recuperado sacando el dispositivo portador 312 proximalmente, retirando por ello el dispositivo 300 de vuelta al catéter portador 314, antes de un segundo intento de posicionar el dispositivo 300 respecto al defecto. [0104] From a femoral vein approach, the catheter or carrier tube 314 is passed through the ASD. The device 300 is advanced along the carrier catheter until the distal end 304 is no longer retained upon exiting the catheter end, thereby assuming its disk shape in the left atrium. The carrier catheter 314 is then removed in the proximal direction along the ASD and the carrier device 312 is pulled in the same way, in a proximal direction, forcing the distal disc 304 against the partition 318. The carrier catheter 314 is then removed additionally, separating it from the partition 318, allowing the proximal disc 302 to extend out of the carrier catheter 314, where it elastically returns to its predefined form of expanded disc (see Figure 15). Thus, the ASD device 300 is positioned such that the distal disc 304 presses against one side of the partition 318 while the proximal disk 302 presses against the other side of the partition 318. In order to increase its occlusive capacity, the device It may contain 316 polyester fibers (see Figures 15 and 18). In examples where the device is incorrectly deployed in a first attempt, the device 300 can be recovered by removing the carrier device 312 proximally, thereby removing the device 300 back to the carrier catheter 314, before a second attempt to position the device 300 with respect to to default.
[0105] Cuando el dispositivo de oclusión ASD 300 es colocado correctamente, el médico gira el dispositivo portador 312, desenroscando el dispositivo portador 312 de la sujeción 310 del dispositivo oclusor 300. El roscado de la sujeción 310 es de tal tipo que el giro del dispositivo portador 312 desenrosca el dispositivo portador 312 de la sujeción 310 del dispositivo oclusor 300, más que meramente girar el dispositivo oclusor 300. Como se ha indicado antes en realizaciones alternativas, la sujeción roscada puede capacitar al operador para mantener una sujeción del dispositivo durante el despliegue, o capacita al operador para controlar la acción de muelle durante el despliegue del dispositivo para asegurar el posicionamiento correcto. [0105] When the ASD 300 occlusion device is correctly positioned, the doctor rotates the carrier device 312, unscrewing the carrier device 312 from the fastener 310 of the occluder device 300. The threading of the fastener 310 is such that the rotation of the carrier device 312 unscrews the carrier device 312 from the fastener 310 of the occluder device 300, rather than merely rotating the occluder device 300. As indicated above in alternative embodiments, the threaded fastener can enable the operator to maintain a fastener of the device during the deployment, or enables the operator to control the spring action during the deployment of the device to ensure correct positioning.
[0106] Generalmente, el método incluye además un método de tratar una afección fisiológica de un paciente. De acuerdo con este método, se selecciona un dispositivo médico adecuado para tratar la afección, el cual puede estar sustancialmente de acuerdo con una de las realizaciones anteriormente descritas. Por ejemplo, si hay que tratar un ductus arterioso permeable, puede seleccionarse el dispositivo de oclusión PDA 80 de las figuras 6A-6C. Una vez que se selecciona el dispositivo médico apropiado puede situarse un catéter dentro de un canal en el cuerpo de un paciente para colocar el extremo distal del catéter adyacente al lugar deseado de tratamiento, tal como inmediatamente adyacente (o incluso dentro de) el puente del PDA. [0106] Generally, the method also includes a method of treating a physiological condition of a patient. According to this method, a suitable medical device is selected to treat the condition, which may be substantially in accordance with one of the previously described embodiments. For example, if a patent ductus arteriosus must be treated, the PDA 80 occlusion device can be selected from Figures 6A-6C. Once the appropriate medical device is selected a catheter can be placed within a channel in a patient's body to place the distal end of the catheter adjacent to the desired treatment site, such as immediately adjacent (or even within) the bridge of the PDA
[0107] Los dispositivos médicos realizados de acuerdo con el método anteriormente descrito tienen una configuración expandida prefijada y una configuración plegada que permite que el dispositivo sea pasado mediante un catéter (ver figura 12). La configuración expandida se define en general por la forma del tejido médico cuando se deforma para ajustarse en general a la superficie de moldeo del elemento de moldeo. El tratamiento térmico del tejido metálico fija esencialmente las configuraciones de los filamentos de hilo en las posiciones reorientadas relativas cuando el tejido se ajusta a la superficie de moldeo. Cuando el tejido metálico es luego extraído del elemento de moldeo, el tejido puede definir un dispositivo médico en su configuración expandida prefijada. [0107] Medical devices made according to the method described above have a preset expanded configuration and a folded configuration that allows the device to be passed through a catheter (see Figure 12). The expanded configuration is generally defined by the shape of the medical tissue when it is deformed to generally conform to the molding surface of the molding element. The heat treatment of the metallic fabric essentially sets the thread filament configurations in the relative reoriented positions when the fabric adjusts to the molding surface. When the metallic tissue is then removed from the molding element, the tissue can define a medical device in its preset expanded configuration.
[0108] El dispositivo médico puede luego plegarse en su configuración plegada e insertarse dentro del lumen del catéter. La configuración plegada del dispositivo puede ser de cualquier forma adecuada para un avance fácil a lo largo del lumen de un catéter y un despliegue correcto fuera del extremo distal del catéter. Por ejemplo, los dispositivos mostrados en las figuras 5A-5B, 6A-6C, y 13 pueden tener una configuración plegada relativamente alargada en la que los dispositivos se estiran a lo largo de sus ejes (ver figuras 11 y 12). Esta configuración plegada puede conseguirse estirando el dispositivo generalmente a lo largo de su eje, por ejemplo, sujetando manualmente las sujeciones 15 y separándolas, lo que tenderá a plegar las partes de diámetro expandido 64 del dispositivo 60 hacia dentro, hacia el eje del dispositivo. El dispositivo de oclusión PDA 80 de las figuras 6 también funciona de manera muy similar y puede plegarse a su configuración plegada para inserción en el catéter aplicando tensión generalmente a lo largo del eje del dispositivo. A este respecto, estos dispositivos 60 y 80 no son diferentes a las "esposas chinas", las cuales tienden a estrecharse en diámetro bajo tensión axial. [0108] The medical device can then be folded into its folded configuration and inserted into the lumen of the catheter. The folded configuration of the device can be of any form suitable for easy advancement along the lumen of a catheter and a correct deployment outside the distal end of the catheter. For example, the devices shown in Figures 5A-5B, 6A-6C, and 13 may have a relatively elongated folded configuration in which the devices are stretched along their axes (see Figures 11 and 12). This folded configuration can be achieved by stretching the device generally along its axis, for example, by manually holding the fasteners 15 and separating them, which will tend to fold the expanded diameter portions 64 of the device 60 inwards, towards the axis of the device. The PDA occlusion device 80 of Figs. 6 also functions very similarly and can be folded to its folded configuration for insertion into the catheter by applying tension generally along the axis of the device. In this regard, these devices 60 and 80 are not different from "Chinese wives", which tend to narrow in diameter under axial tension.
[0109] Una vez el dispositivo médico está plegado e insertado dentro del catéter, puede ser conducido a lo largo del lumen del catéter hacia el extremo distal del catéter. Esto puede lograrse usando un alambre guía o similar para hacer tope contra el dispositivo, e impulsarlo a lo largo del catéter. Cuando el dispositivo comienza a salir del extremo distal del catéter, que está situado adyacente al sitio deseado de tratamiento, tenderá a retornar elásticamente de forma esencialmente completa a su configuración expandida prefijada. Las aleaciones superelásticas, como el nitinol, son particularmente útiles en esta aplicación a causa de su capacidad para volver fácilmente a una configuración particular tras ser elásticamente deformada en gran medida. De ahí, que simplemente empujar el dispositivo médico fuera del extremo distal del catéter tiende a desplegar correctamente el dispositivo en el sitio de tratamiento. [0109] Once the medical device is folded and inserted into the catheter, it can be conducted along the lumen of the catheter to the distal end of the catheter. This can be achieved using a guidewire or similar to butt against the device, and propel it along the catheter. When the device begins to exit the distal end of the catheter, which is located adjacent to the desired treatment site, it will tend to return elastically essentially completely to its predetermined expanded configuration. Super-elastic alloys, such as nitinol, are particularly useful in this application because of their ability to easily return to a particular configuration after being greatly elastically deformed. Hence, simply pushing the medical device out of the distal end of the catheter tends to correctly deploy the device at the treatment site.
[0110] Aunque el dispositivo tenderá a volver elásticamente a su configuración inicial expandida (es decir, su forma anterior a su plegado para pasar a lo largo del catéter), debería entenderse que puede no volver siempre completamente a esa forma. Por ejemplo, se pretende que el dispositivo 60 de la figura 5 tenga un diámetro exterior máximo en su configuración expandida al menos tan grande como, y preferiblemente mayor que, el diámetro interior del lumen en el que va a ser desplegado. Si tal dispositivo se despliega en un vaso que tiene un lumen pequeño, el lumen impedirá que el dispositivo vuelva totalmente a su forma expandida. No obstante, el dispositivo se desplegaría correctamente porque conectaría el interior de la pared del lumen para asentar el dispositivo en él, como se ha detallado anteriormente. [0110] Although the device will tend to return elastically to its initial expanded configuration (ie, its pre-folded form to pass along the catheter), it should be understood that it may not always return completely to that form. For example, the device 60 of Figure 5 is intended to have a maximum outside diameter in its expanded configuration at least as large as, and preferably greater than, the inner diameter of the lumen in which it is to be deployed. If such a device is deployed in a vessel that has a small lumen, the lumen will prevent the device from fully returning to its expanded form. However, the device would be deployed correctly because it would connect the inside of the lumen wall to seat the device on it, as detailed above.
[0111] Si el dispositivo va a usarse para ocluir permanentemente un canal en el cuerpo del paciente, tal como pueden ser los dispositivos 60 y 80 descritos anteriormente, simplemente se puede retraer el catéter y retirarlo del cuerpo del paciente. Esto dejará el dispositivo médico desplegado en el sistema vascular del paciente de tal modo que pueda ocluir el vaso sanguíneo u otro canal en el cuerpo del paciente. En algunas circunstancias, el dispositivo médico puede unirse a un sistema portador de tal manera que fije el dispositivo al extremo del elemento portador, tal como cuando la sujeción roscada 90, mostrada en las figuras 6 y 9, se une a un extremo distal del elemento portador, como se ha explicado antes. Antes de extraer el catéter en este sistema, puede ser necesario separar el dispositivo médico del elemento portador antes de extraer el catéter y dicho elemento portador. [0111] If the device is to be used to permanently occlude a channel in the patient's body, such as devices 60 and 80 described above, the catheter can simply be retracted and removed from the patient's body. This will leave the medical device deployed in the patient's vascular system so that it can occlude the blood vessel or other channel in the patient's body. In some circumstances, the medical device may be attached to a carrier system such that it fixes the device to the end of the carrier element, such as when the threaded fastener 90, shown in Figures 6 and 9, is attached to a distal end of the element. carrier, as explained before. Before removing the catheter in this system, it may be necessary to separate the medical device from the carrier element before removing the catheter and said carrier element.
[0112] Aunque una realización preferida de la presente invención ha sido descrita, debe entenderse que pueden hacerse diversos cambios, adaptaciones y modificaciones sin abandonar el ámbito de las reivindicaciones adjuntas. [0112] Although a preferred embodiment of the present invention has been described, it should be understood that various changes, adaptations and modifications can be made without leaving the scope of the appended claims.
Claims (9)
- 2. 2.
- Dispositivo médico (300), según la reivindicación 1, en el que dicha configuración expandida prefijada tiene una forma de unas pesas de gimnasio. Medical device (300) according to claim 1, wherein said preset expanded configuration has a shape of gym weights.
- 3. 3.
- Dispositivo médico (300), según la reivindicación 1, que incluye además elementos para sujetar los extremos de los hilos de la trenza tubular, incluyendo dichos elementos de sujeción una rosca para su unión por giro a un dispositivo portador. Medical device (300) according to claim 1, further including elements for fastening the ends of the threads of the tubular braid, said fasteners including a thread for connection by rotation to a carrier device.
- 4. Four.
- Dispositivo médico (300), según la reivindicación 1, en el que el tejido metálico está fabricado a partir de una aleación seleccionada del grupo consistente en acero inoxidable, níquel-titanio y cobalto-cromo-níquel. Medical device (300) according to claim 1, wherein the metallic fabric is manufactured from an alloy selected from the group consisting of stainless steel, nickel-titanium and cobalt-chromium-nickel.
- 5. 5.
- Dispositivo médico (300), según la reivindicación 1, en el que la parte de diámetro reducido (306) tiene una dimensión de longitud de entre 2 a 20 milímetros. Medical device (300) according to claim 1, wherein the part of reduced diameter (306) has a length dimension of between 2 to 20 millimeters.
- 6. 6.
- Dispositivo médico (300), según la reivindicación 1, en el que la fibra de oclusión comprende fibras de poliéster (318). Medical device (300) according to claim 1, wherein the occlusion fiber comprises polyester fibers (318).
- 7. 7.
- Dispositivo médico (300), según la reivindicación 1, que incluye además medios para sujetar los hilos del trenzado tubular en un extremo del dispositivo. Medical device (300) according to claim 1, further including means for securing the threads of the tubular braid at one end of the device.
- 8. 8.
- Dispositivo médico (300), según la reivindicación 7, en el que los medios para sujetar un extremo del dispositivo comprenden una sujeción (90). Medical device (300) according to claim 7, wherein the means for securing one end of the device comprise a fastener (90).
- 9. 9.
- Dispositivo médico (300), según la reivindicación 1, comprendiendo dicha fibra de oclusión (316) en ambas de dichas primera y segunda partes de diámetro expandido (302, 304). Medical device (300) according to claim 1, said occlusion fiber (316) comprising both of said first and second expanded diameter parts (302, 304).
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US647712 | 1996-05-14 | ||
US08/647,712 US5725552A (en) | 1994-07-08 | 1996-05-14 | Percutaneous catheter directed intravascular occlusion devices |
PCT/US1997/006194 WO1997042878A1 (en) | 1996-05-14 | 1997-04-14 | Percutaneous catheter directed intravascular occlusion devices |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2395213T3 true ES2395213T3 (en) | 2013-02-11 |
Family
ID=24597996
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES97922307T Expired - Lifetime ES2395213T3 (en) | 1996-05-14 | 1997-04-14 | Intravascular occlusion devices guided by a percutaneous catheter |
Country Status (12)
Country | Link |
---|---|
US (1) | US5725552A (en) |
EP (1) | EP0957773B1 (en) |
JP (1) | JP3742113B2 (en) |
CN (1) | CN1106828C (en) |
AT (1) | ATE511796T1 (en) |
AU (1) | AU711677B2 (en) |
CA (1) | CA2252913C (en) |
DK (1) | DK0957773T3 (en) |
EA (1) | EA001480B1 (en) |
ES (1) | ES2395213T3 (en) |
PT (1) | PT957773E (en) |
WO (1) | WO1997042878A1 (en) |
Families Citing this family (682)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
USRE42756E1 (en) | 1990-03-13 | 2011-09-27 | The Regents Of The University Of California | Endovascular electrolytically detachable wire and tip for the formation of thrombus in arteries, veins, aneurysms, vascular malformations and arteriovenous fistulas |
USRE42625E1 (en) | 1990-03-13 | 2011-08-16 | The Regents Of The University Of California | Endovascular electrolytically detachable wire and tip for the formation of thrombus in arteries, veins, aneurysms, vascular malformations and arteriovenous fistulas |
US6083220A (en) | 1990-03-13 | 2000-07-04 | The Regents Of The University Of California | Endovascular electrolytically detachable wire and tip for the formation of thrombus in arteries, veins, aneurysms, vascular malformations and arteriovenous fistulas |
US6123715A (en) * | 1994-07-08 | 2000-09-26 | Amplatz; Curtis | Method of forming medical devices; intravascular occlusion devices |
US5879366A (en) * | 1996-12-20 | 1999-03-09 | W.L. Gore & Associates, Inc. | Self-expanding defect closure device and method of making and using |
US5645558A (en) | 1995-04-20 | 1997-07-08 | Medical University Of South Carolina | Anatomically shaped vasoocclusive device and method of making the same |
US6638291B1 (en) | 1995-04-20 | 2003-10-28 | Micrus Corporation | Three dimensional, low friction vasoocclusive coil, and method of manufacture |
US6171326B1 (en) | 1998-08-27 | 2001-01-09 | Micrus Corporation | Three dimensional, low friction vasoocclusive coil, and method of manufacture |
US8790363B2 (en) * | 1995-04-20 | 2014-07-29 | DePuy Synthes Products, LLC | Three dimensional, low friction vasoocclusive coil, and method of manufacture |
US6168622B1 (en) | 1996-01-24 | 2001-01-02 | Microvena Corporation | Method and apparatus for occluding aneurysms |
JP2000504594A (en) * | 1996-02-02 | 2000-04-18 | トランスバスキュラー インコーポレイテッド | Method and apparatus for blocking flow in a blood vessel |
US5885258A (en) * | 1996-02-23 | 1999-03-23 | Memory Medical Systems, Inc. | Medical instrument with slotted memory metal tube |
US6066158A (en) * | 1996-07-25 | 2000-05-23 | Target Therapeutics, Inc. | Mechanical clot encasing and removal wire |
US5972019A (en) * | 1996-07-25 | 1999-10-26 | Target Therapeutics, Inc. | Mechanical clot treatment device |
US6096071A (en) * | 1998-03-26 | 2000-08-01 | Yadav; Jay S. | Ostial stent |
AU6784598A (en) * | 1997-04-23 | 1998-11-13 | Vascular Science Inc. | Medical plug |
US7569066B2 (en) * | 1997-07-10 | 2009-08-04 | Boston Scientific Scimed, Inc. | Methods and devices for the treatment of aneurysms |
US6174322B1 (en) | 1997-08-08 | 2001-01-16 | Cardia, Inc. | Occlusion device for the closure of a physical anomaly such as a vascular aperture or an aperture in a septum |
FR2767672B1 (en) * | 1997-08-27 | 1999-11-26 | Ethnor | PROSTHESES FOR SEALING HERNIA CANALS |
US6066149A (en) | 1997-09-30 | 2000-05-23 | Target Therapeutics, Inc. | Mechanical clot treatment device with distal filter |
US6159178A (en) | 1998-01-23 | 2000-12-12 | Heartport, Inc. | Methods and devices for occluding the ascending aorta and maintaining circulation of oxygenated blood in the patient when the patient's heart is arrested |
DE69833882T2 (en) * | 1998-01-30 | 2006-08-17 | St. Jude Medical ATG, Inc., Maple Grove | MEDICAL TRANSPLANTER CONNECTOR OR STOPPING AND PROCESS FOR THEIR MANUFACTURE |
US5944738A (en) | 1998-02-06 | 1999-08-31 | Aga Medical Corporation | Percutaneous catheter directed constricting occlusion device |
JP2003522550A (en) * | 1998-02-10 | 2003-07-29 | アーテミス・メディカル・インコーポレイテッド | Occlusion, fixation, tensioning, and diverting devices and methods of use |
WO1999042036A1 (en) * | 1998-02-20 | 1999-08-26 | General Surgical Innovations, Inc. | Bendable, reusable medical instruments with improved fatigue life |
US6168615B1 (en) | 1998-05-04 | 2001-01-02 | Micrus Corporation | Method and apparatus for occlusion and reinforcement of aneurysms |
US7004962B2 (en) * | 1998-07-27 | 2006-02-28 | Schneider (Usa), Inc. | Neuroaneurysm occlusion and delivery device and method of using same |
US7410482B2 (en) | 1998-09-04 | 2008-08-12 | Boston Scientific-Scimed, Inc. | Detachable aneurysm neck bridge |
US7044134B2 (en) * | 1999-11-08 | 2006-05-16 | Ev3 Sunnyvale, Inc | Method of implanting a device in the left atrial appendage |
US6152144A (en) | 1998-11-06 | 2000-11-28 | Appriva Medical, Inc. | Method and device for left atrial appendage occlusion |
US7128073B1 (en) * | 1998-11-06 | 2006-10-31 | Ev3 Endovascular, Inc. | Method and device for left atrial appendage occlusion |
US7713282B2 (en) | 1998-11-06 | 2010-05-11 | Atritech, Inc. | Detachable atrial appendage occlusion balloon |
US7018401B1 (en) | 1999-02-01 | 2006-03-28 | Board Of Regents, The University Of Texas System | Woven intravascular devices and methods for making the same and apparatus for delivery of the same |
US7842048B2 (en) * | 2006-08-18 | 2010-11-30 | Abbott Laboratories | Articulating suture device and method |
US6964668B2 (en) | 1999-03-04 | 2005-11-15 | Abbott Laboratories | Articulating suturing device and method |
US20040092964A1 (en) * | 1999-03-04 | 2004-05-13 | Modesitt D. Bruce | Articulating suturing device and method |
US7001400B1 (en) * | 1999-03-04 | 2006-02-21 | Abbott Laboratories | Articulating suturing device and method |
US7235087B2 (en) | 1999-03-04 | 2007-06-26 | Abbott Park | Articulating suturing device and method |
US8137364B2 (en) | 2003-09-11 | 2012-03-20 | Abbott Laboratories | Articulating suturing device and method |
US6309350B1 (en) | 1999-05-03 | 2001-10-30 | Tricardia, L.L.C. | Pressure/temperature/monitor device for heart implantation |
US6206907B1 (en) | 1999-05-07 | 2001-03-27 | Cardia, Inc. | Occlusion device with stranded wire support arms |
US6656206B2 (en) | 1999-05-13 | 2003-12-02 | Cardia, Inc. | Occlusion device with non-thrombogenic properties |
US6379368B1 (en) | 1999-05-13 | 2002-04-30 | Cardia, Inc. | Occlusion device with non-thrombogenic properties |
US7637905B2 (en) * | 2003-01-15 | 2009-12-29 | Usgi Medical, Inc. | Endoluminal tool deployment system |
US7955340B2 (en) * | 1999-06-25 | 2011-06-07 | Usgi Medical, Inc. | Apparatus and methods for forming and securing gastrointestinal tissue folds |
US7618426B2 (en) * | 2002-12-11 | 2009-11-17 | Usgi Medical, Inc. | Apparatus and methods for forming gastrointestinal tissue approximations |
US6626899B2 (en) * | 1999-06-25 | 2003-09-30 | Nidus Medical, Llc | Apparatus and methods for treating tissue |
US7416554B2 (en) * | 2002-12-11 | 2008-08-26 | Usgi Medical Inc | Apparatus and methods for forming and securing gastrointestinal tissue folds |
US6312465B1 (en) | 1999-07-23 | 2001-11-06 | Sulzer Carbomedics Inc. | Heart valve prosthesis with a resiliently deformable retaining member |
EP1210014A1 (en) | 1999-09-07 | 2002-06-05 | Microvena Corporation | Retrievable septal defect closure device |
US8083766B2 (en) * | 1999-09-13 | 2011-12-27 | Rex Medical, Lp | Septal defect closure device |
US6231561B1 (en) | 1999-09-20 | 2001-05-15 | Appriva Medical, Inc. | Method and apparatus for closing a body lumen |
US6964674B1 (en) * | 1999-09-20 | 2005-11-15 | Nuvasive, Inc. | Annulotomy closure device |
US6939361B1 (en) | 1999-09-22 | 2005-09-06 | Nmt Medical, Inc. | Guidewire for a free standing intervascular device having an integral stop mechanism |
US7951201B2 (en) * | 1999-10-20 | 2011-05-31 | Anulex Technologies, Inc. | Method and apparatus for the treatment of the intervertebral disc annulus |
US8128698B2 (en) | 1999-10-20 | 2012-03-06 | Anulex Technologies, Inc. | Method and apparatus for the treatment of the intervertebral disc annulus |
US8632590B2 (en) | 1999-10-20 | 2014-01-21 | Anulex Technologies, Inc. | Apparatus and methods for the treatment of the intervertebral disc |
US7935147B2 (en) | 1999-10-20 | 2011-05-03 | Anulex Technologies, Inc. | Method and apparatus for enhanced delivery of treatment device to the intervertebral disc annulus |
US20020123807A1 (en) * | 1999-10-20 | 2002-09-05 | Cauthen Joseph C. | Spinal disc annulus reconstruction method and spinal disc annulus stent |
US20030153976A1 (en) * | 1999-10-20 | 2003-08-14 | Cauthen Joseph C. | Spinal disc annulus reconstruction method and spinal disc annulus stent |
US7004970B2 (en) | 1999-10-20 | 2006-02-28 | Anulex Technologies, Inc. | Methods and devices for spinal disc annulus reconstruction and repair |
US6592625B2 (en) * | 1999-10-20 | 2003-07-15 | Anulex Technologies, Inc. | Spinal disc annulus reconstruction method and spinal disc annulus stent |
US7615076B2 (en) | 1999-10-20 | 2009-11-10 | Anulex Technologies, Inc. | Method and apparatus for the treatment of the intervertebral disc annulus |
US7052516B2 (en) * | 1999-10-20 | 2006-05-30 | Anulex Technologies, Inc. | Spinal disc annulus reconstruction method and deformable spinal disc annulus stent |
US8414543B2 (en) | 1999-10-22 | 2013-04-09 | Rex Medical, L.P. | Rotational thrombectomy wire with blocking device |
US6551303B1 (en) | 1999-10-27 | 2003-04-22 | Atritech, Inc. | Barrier device for ostium of left atrial appendage |
US6689150B1 (en) | 1999-10-27 | 2004-02-10 | Atritech, Inc. | Filter apparatus for ostium of left atrial appendage |
US6652555B1 (en) | 1999-10-27 | 2003-11-25 | Atritech, Inc. | Barrier device for covering the ostium of left atrial appendage |
US6994092B2 (en) * | 1999-11-08 | 2006-02-07 | Ev3 Sunnyvale, Inc. | Device for containing embolic material in the LAA having a plurality of tissue retention structures |
US6458153B1 (en) * | 1999-12-31 | 2002-10-01 | Abps Venture One, Ltd. | Endoluminal cardiac and venous valve prostheses and methods of manufacture and delivery thereof |
US7195641B2 (en) | 1999-11-19 | 2007-03-27 | Advanced Bio Prosthetic Surfaces, Ltd. | Valvular prostheses having metal or pseudometallic construction and methods of manufacture |
US6391048B1 (en) | 2000-01-05 | 2002-05-21 | Integrated Vascular Systems, Inc. | Integrated vascular device with puncture site closure component and sealant and methods of use |
US9579091B2 (en) | 2000-01-05 | 2017-02-28 | Integrated Vascular Systems, Inc. | Closure system and methods of use |
US6942674B2 (en) * | 2000-01-05 | 2005-09-13 | Integrated Vascular Systems, Inc. | Apparatus and methods for delivering a closure device |
US7842068B2 (en) | 2000-12-07 | 2010-11-30 | Integrated Vascular Systems, Inc. | Apparatus and methods for providing tactile feedback while delivering a closure device |
US6461364B1 (en) | 2000-01-05 | 2002-10-08 | Integrated Vascular Systems, Inc. | Vascular sheath with bioabsorbable puncture site closure apparatus and methods of use |
US8758400B2 (en) | 2000-01-05 | 2014-06-24 | Integrated Vascular Systems, Inc. | Closure system and methods of use |
US6719717B1 (en) | 2000-03-17 | 2004-04-13 | Advanced Research & Technology Institute, Inc. | Thrombectomy treatment system and method |
US6468303B1 (en) * | 2000-03-27 | 2002-10-22 | Aga Medical Corporation | Retrievable self expanding shunt |
US6468301B1 (en) | 2000-03-27 | 2002-10-22 | Aga Medical Corporation | Repositionable and recapturable vascular stent/graft |
US6402750B1 (en) * | 2000-04-04 | 2002-06-11 | Spinlabs, Llc | Devices and methods for the treatment of spinal disorders |
US6805695B2 (en) | 2000-04-04 | 2004-10-19 | Spinalabs, Llc | Devices and methods for annular repair of intervertebral discs |
US6214029B1 (en) * | 2000-04-26 | 2001-04-10 | Microvena Corporation | Septal defect occluder |
US6551344B2 (en) | 2000-04-26 | 2003-04-22 | Ev3 Inc. | Septal defect occluder |
US6482214B1 (en) | 2000-04-27 | 2002-11-19 | Medtronic, Inc. | Intravascular seal with mesh reinforcement and method for using same |
DE60138880D1 (en) | 2000-05-03 | 2009-07-16 | Bard Inc C R | DEVICE FOR MULTI-DIMENSIONAL PRESENTATION AND ABLATION IN ELECTROPHYSIOLOGICAL PROCEDURES |
US6334864B1 (en) | 2000-05-17 | 2002-01-01 | Aga Medical Corp. | Alignment member for delivering a non-symmetric device with a predefined orientation |
US6440152B1 (en) * | 2000-07-28 | 2002-08-27 | Microvena Corporation | Defect occluder release assembly and method |
US20040266983A1 (en) * | 2000-08-17 | 2004-12-30 | Reeve Lorraine E | Purified polyoxyalkylene block copolymers |
EP1309289A2 (en) * | 2000-08-18 | 2003-05-14 | Atritech, Inc. | Expandable implant devices for filtering blood flow from atrial appendages |
US6776770B1 (en) | 2000-09-07 | 2004-08-17 | Advanced Research & Technology Institute | Thromboaspiration valve-filter device and methods |
CA2421856A1 (en) * | 2000-09-08 | 2002-03-14 | James E. Coleman | Surgical staple |
EP1318766A2 (en) | 2000-09-21 | 2003-06-18 | Atritech, Inc. | Apparatus for implanting devices in atrial appendages |
US6626918B1 (en) | 2000-10-06 | 2003-09-30 | Medical Technology Group | Apparatus and methods for positioning a vascular sheath |
US7211101B2 (en) | 2000-12-07 | 2007-05-01 | Abbott Vascular Devices | Methods for manufacturing a clip and clip |
US8690910B2 (en) | 2000-12-07 | 2014-04-08 | Integrated Vascular Systems, Inc. | Closure device and methods for making and using them |
US7905900B2 (en) | 2003-01-30 | 2011-03-15 | Integrated Vascular Systems, Inc. | Clip applier and methods of use |
US6623510B2 (en) | 2000-12-07 | 2003-09-23 | Integrated Vascular Systems, Inc. | Closure device and methods for making and using them |
US7806904B2 (en) | 2000-12-07 | 2010-10-05 | Integrated Vascular Systems, Inc. | Closure device |
US6969397B2 (en) * | 2000-12-14 | 2005-11-29 | Ensure Medical, Inc. | Guide wire element for positioning vascular closure devices and methods for use |
US6746404B2 (en) * | 2000-12-18 | 2004-06-08 | Biosense, Inc. | Method for anchoring a medical device between tissue |
US6658300B2 (en) | 2000-12-18 | 2003-12-02 | Biosense, Inc. | Telemetric reader/charger device for medical sensor |
US6638231B2 (en) | 2000-12-18 | 2003-10-28 | Biosense, Inc. | Implantable telemetric medical sensor and method |
US6652464B2 (en) | 2000-12-18 | 2003-11-25 | Biosense, Inc. | Intracardiac pressure monitoring method |
US6783499B2 (en) * | 2000-12-18 | 2004-08-31 | Biosense, Inc. | Anchoring mechanism for implantable telemetric medical sensor |
US6636769B2 (en) | 2000-12-18 | 2003-10-21 | Biosense, Inc. | Telemetric medical system and method |
US7029480B2 (en) * | 2001-01-24 | 2006-04-18 | Abott Laboratories | Device and method for suturing of internal puncture sites |
US6681773B2 (en) | 2001-02-28 | 2004-01-27 | Chase Medical, Inc. | Kit and method for use during ventricular restoration |
US20020133227A1 (en) * | 2001-02-28 | 2002-09-19 | Gregory Murphy | Ventricular restoration patch apparatus and method of use |
US20030181940A1 (en) * | 2001-02-28 | 2003-09-25 | Gregory Murphy | Ventricular restoration shaping apparatus and method of use |
CA2441119A1 (en) * | 2001-03-08 | 2002-09-19 | Atritech, Inc. | Atrial filter implants |
EP2957265A1 (en) * | 2001-03-13 | 2015-12-23 | Medinol Ltd. | An expandable medical device and a kit comprising an expandable medical device and a delivery balloon |
US8091556B2 (en) | 2001-04-20 | 2012-01-10 | V-Wave Ltd. | Methods and apparatus for reducing localized circulatory system pressure |
IL143007A0 (en) * | 2001-05-07 | 2002-04-21 | Rafael Medical Technologies In | Retrievable intravascular support structures |
US20030032976A1 (en) * | 2001-05-21 | 2003-02-13 | Boucek Mark M. | Catheter deployed partial occlusion devices and methods |
US7338514B2 (en) | 2001-06-01 | 2008-03-04 | St. Jude Medical, Cardiology Division, Inc. | Closure devices, related delivery methods and tools, and related methods of use |
WO2002098282A2 (en) * | 2001-06-04 | 2002-12-12 | Albert Einstein Healthcare Network | Cardiac stimulating apparatus having a blood clot filter and atrial pacer |
IES20010547A2 (en) | 2001-06-07 | 2002-12-11 | Christy Cummins | Surgical Staple |
WO2002101118A2 (en) * | 2001-06-11 | 2002-12-19 | Ev3 Inc. | A method of training nitinol wire |
US7179275B2 (en) * | 2001-06-18 | 2007-02-20 | Rex Medical, L.P. | Vein filter |
US8282668B2 (en) * | 2001-06-18 | 2012-10-09 | Rex Medical, L.P. | Vein filter |
US6783538B2 (en) | 2001-06-18 | 2004-08-31 | Rex Medical, L.P | Removable vein filter |
US6623506B2 (en) * | 2001-06-18 | 2003-09-23 | Rex Medical, L.P | Vein filter |
CA2455349C (en) * | 2001-06-18 | 2011-02-15 | Rex Medical, L.P. | Vein filter |
US6793665B2 (en) * | 2001-06-18 | 2004-09-21 | Rex Medical, L.P. | Multiple access vein filter |
BR0210509A (en) * | 2001-06-20 | 2004-06-22 | Park Medical Llc | Anastomotic device |
US7115136B2 (en) * | 2001-06-20 | 2006-10-03 | Park Medical Llc | Anastomotic device |
US7011671B2 (en) * | 2001-07-18 | 2006-03-14 | Atritech, Inc. | Cardiac implant device tether system and method |
GB2378137A (en) * | 2001-07-31 | 2003-02-05 | John Reece Jenkins | A stent comprising a framework of shape memory metal |
US7288105B2 (en) | 2001-08-01 | 2007-10-30 | Ev3 Endovascular, Inc. | Tissue opening occluder |
US20040243170A1 (en) * | 2001-09-05 | 2004-12-02 | Mitta Suresh | Method and device for percutaneous surgical ventricular repair |
US7485088B2 (en) * | 2001-09-05 | 2009-02-03 | Chase Medical L.P. | Method and device for percutaneous surgical ventricular repair |
US20090054912A1 (en) * | 2001-09-06 | 2009-02-26 | Heanue Taylor A | Systems and Methods for Treating Septal Defects |
US20050267495A1 (en) * | 2004-05-17 | 2005-12-01 | Gateway Medical, Inc. | Systems and methods for closing internal tissue defects |
US6702835B2 (en) | 2001-09-07 | 2004-03-09 | Core Medical, Inc. | Needle apparatus for closing septal defects and methods for using such apparatus |
US20070129755A1 (en) * | 2005-12-05 | 2007-06-07 | Ovalis, Inc. | Clip-based systems and methods for treating septal defects |
US20070112358A1 (en) * | 2001-09-06 | 2007-05-17 | Ryan Abbott | Systems and Methods for Treating Septal Defects |
US7226466B2 (en) * | 2001-09-06 | 2007-06-05 | Nmt Medical, Inc. | Flexible delivery system |
US20060052821A1 (en) * | 2001-09-06 | 2006-03-09 | Ovalis, Inc. | Systems and methods for treating septal defects |
US6776784B2 (en) * | 2001-09-06 | 2004-08-17 | Core Medical, Inc. | Clip apparatus for closing septal defects and methods of use |
US6596013B2 (en) | 2001-09-20 | 2003-07-22 | Scimed Life Systems, Inc. | Method and apparatus for treating septal defects |
US7318833B2 (en) | 2001-12-19 | 2008-01-15 | Nmt Medical, Inc. | PFO closure device with flexible thrombogenic joint and improved dislodgement resistance |
AU2002360695A1 (en) * | 2001-12-19 | 2003-07-09 | Nmt Medical, Inc. | Septal occluder and associated methods |
AU2003210510A1 (en) * | 2002-01-14 | 2003-07-30 | Nmt Medical, Inc. | Patent foramen ovale (pfo) closure method and device |
CA2474324C (en) | 2002-01-25 | 2011-09-20 | Atritech, Inc. | Atrial appendage blood filtration systems |
US6749621B2 (en) | 2002-02-21 | 2004-06-15 | Integrated Vascular Systems, Inc. | Sheath apparatus and methods for delivering a closure device |
US6638257B2 (en) * | 2002-03-01 | 2003-10-28 | Aga Medical Corporation | Intravascular flow restrictor |
US7192434B2 (en) * | 2002-03-08 | 2007-03-20 | Ev3 Inc. | Vascular protection devices and methods of use |
DK1487357T3 (en) * | 2002-03-15 | 2012-03-19 | Gore & Ass | Coupling system useful for placement of implants |
JP2005521447A (en) | 2002-03-25 | 2005-07-21 | エヌエムティー メディカル インコーポレイテッド | Closure clip of patent foramen ovale (PFO) |
US20030195553A1 (en) | 2002-04-12 | 2003-10-16 | Scimed Life Systems, Inc. | System and method for retaining vaso-occlusive devices within an aneurysm |
US7976564B2 (en) | 2002-05-06 | 2011-07-12 | St. Jude Medical, Cardiology Division, Inc. | PFO closure devices and related methods of use |
CA2486919C (en) * | 2002-06-03 | 2011-03-15 | Nmt Medical, Inc. | Device with biological tissue scaffold for percutaneous closure of an intracardiac defect and methods thereof |
US7850709B2 (en) | 2002-06-04 | 2010-12-14 | Abbott Vascular Inc. | Blood vessel closure clip and delivery device |
WO2003103476A2 (en) | 2002-06-05 | 2003-12-18 | Nmt Medical, Inc. | Patent foramen ovale (pfo) closure device with radial and circumferential support |
US7274876B2 (en) * | 2002-06-06 | 2007-09-25 | At&T Corp. | Integrated electrical/optical hybrid communication system with revertive hitless switch |
US8348963B2 (en) * | 2002-07-03 | 2013-01-08 | Hlt, Inc. | Leaflet reinforcement for regurgitant valves |
US7060075B2 (en) * | 2002-07-18 | 2006-06-13 | Biosense, Inc. | Distal targeting of locking screws in intramedullary nails |
US8118833B2 (en) * | 2002-07-31 | 2012-02-21 | Abbott Laboratories Vascular Enterprises Limited | Apparatus for sealing surgical punctures |
EP1592367B1 (en) | 2002-08-28 | 2016-04-13 | HLT, Inc. | Method and device for treating diseased valve |
AU2003272323A1 (en) * | 2002-09-23 | 2004-04-08 | Nmt Medical, Inc. | Septal puncture device |
US7615010B1 (en) | 2002-10-03 | 2009-11-10 | Integrated Sensing Systems, Inc. | System for monitoring the physiologic parameters of patients with congestive heart failure |
AU2003284976A1 (en) | 2002-10-25 | 2004-05-13 | Nmt Medical, Inc. | Expandable sheath tubing |
AU2003287554A1 (en) * | 2002-11-06 | 2004-06-03 | Nmt Medical, Inc. | Medical devices utilizing modified shape memory alloy |
US20040098121A1 (en) * | 2002-11-07 | 2004-05-20 | Nmt Medical, Inc. | Patent foramen ovale (PFO) closure with magnetic force |
FR2847150B1 (en) * | 2002-11-15 | 2005-01-21 | Claude Mialhe | OCCLUSIVE DEVICE WITH MEDICAL OR SURGICAL DESTINATION |
AU2003294682A1 (en) * | 2002-12-09 | 2004-06-30 | Nmt Medical, Inc. | Septal closure devices |
US7942884B2 (en) | 2002-12-11 | 2011-05-17 | Usgi Medical, Inc. | Methods for reduction of a gastric lumen |
US7942898B2 (en) | 2002-12-11 | 2011-05-17 | Usgi Medical, Inc. | Delivery systems and methods for gastric reduction |
US7160309B2 (en) | 2002-12-31 | 2007-01-09 | Laveille Kao Voss | Systems for anchoring a medical device in a body lumen |
DE10362223B4 (en) * | 2003-01-21 | 2010-02-04 | pfm Produkte für die Medizin AG | Basic coil shape |
US7087072B2 (en) * | 2003-01-22 | 2006-08-08 | Cardia, Inc. | Articulated center post |
US20040143294A1 (en) * | 2003-01-22 | 2004-07-22 | Cardia, Inc. | Septal stabilization device |
US7115135B2 (en) * | 2003-01-22 | 2006-10-03 | Cardia, Inc. | Occlusion device having five or more arms |
US6960224B2 (en) * | 2003-01-22 | 2005-11-01 | Cardia, Inc. | Laminated sheets for use in a fully retrievable occlusion device |
US6960220B2 (en) * | 2003-01-22 | 2005-11-01 | Cardia, Inc. | Hoop design for occlusion device |
US20040254594A1 (en) * | 2003-01-24 | 2004-12-16 | Arthur Alfaro | Cardiac defect occlusion device |
US8905937B2 (en) | 2009-02-26 | 2014-12-09 | Integrated Vascular Systems, Inc. | Methods and apparatus for locating a surface of a body lumen |
US7857828B2 (en) * | 2003-01-30 | 2010-12-28 | Integrated Vascular Systems, Inc. | Clip applier and methods of use |
US8202293B2 (en) | 2003-01-30 | 2012-06-19 | Integrated Vascular Systems, Inc. | Clip applier and methods of use |
US8758398B2 (en) | 2006-09-08 | 2014-06-24 | Integrated Vascular Systems, Inc. | Apparatus and method for delivering a closure element |
US8821534B2 (en) | 2010-12-06 | 2014-09-02 | Integrated Vascular Systems, Inc. | Clip applier having improved hemostasis and methods of use |
US8398656B2 (en) | 2003-01-30 | 2013-03-19 | Integrated Vascular Systems, Inc. | Clip applier and methods of use |
US7780700B2 (en) * | 2003-02-04 | 2010-08-24 | ev3 Endovascular, Inc | Patent foramen ovale closure system |
US8021359B2 (en) * | 2003-02-13 | 2011-09-20 | Coaptus Medical Corporation | Transseptal closure of a patent foramen ovale and other cardiac defects |
US7257450B2 (en) * | 2003-02-13 | 2007-08-14 | Coaptus Medical Corporation | Systems and methods for securing cardiovascular tissue |
US7618435B2 (en) * | 2003-03-04 | 2009-11-17 | Nmt Medical, Inc. | Magnetic attachment systems |
US20040176788A1 (en) * | 2003-03-07 | 2004-09-09 | Nmt Medical, Inc. | Vacuum attachment system |
US7658747B2 (en) * | 2003-03-12 | 2010-02-09 | Nmt Medical, Inc. | Medical device for manipulation of a medical implant |
US7473266B2 (en) | 2003-03-14 | 2009-01-06 | Nmt Medical, Inc. | Collet-based delivery system |
EP1605865B1 (en) * | 2003-03-17 | 2008-12-10 | ev3 Endovascular, Inc. | Stent with thin film composite laminate |
AU2004224439B2 (en) * | 2003-03-24 | 2010-07-15 | Genzyme Corporation | Temporary embolization using inverse thermosensitive polymers |
US20040267306A1 (en) | 2003-04-11 | 2004-12-30 | Velocimed, L.L.C. | Closure devices, related delivery methods, and related methods of use |
US8372112B2 (en) * | 2003-04-11 | 2013-02-12 | St. Jude Medical, Cardiology Division, Inc. | Closure devices, related delivery methods, and related methods of use |
US7597704B2 (en) * | 2003-04-28 | 2009-10-06 | Atritech, Inc. | Left atrial appendage occlusion device with active expansion |
US7331976B2 (en) | 2003-04-29 | 2008-02-19 | Rex Medical, L.P. | Distal protection device |
US6913614B2 (en) * | 2003-05-08 | 2005-07-05 | Cardia, Inc. | Delivery system with safety tether |
DE602004025814D1 (en) * | 2003-05-19 | 2010-04-15 | Septrx Inc | TISSUE EXPANSION DEVICE AND RELATED METHODS FOR THERAPEUTIC INTERVENTION |
US9861346B2 (en) | 2003-07-14 | 2018-01-09 | W. L. Gore & Associates, Inc. | Patent foramen ovale (PFO) closure device with linearly elongating petals |
US8480706B2 (en) * | 2003-07-14 | 2013-07-09 | W.L. Gore & Associates, Inc. | Tubular patent foramen ovale (PFO) closure device with catch system |
US7678123B2 (en) * | 2003-07-14 | 2010-03-16 | Nmt Medical, Inc. | Tubular patent foramen ovale (PFO) closure device with catch system |
US20050055050A1 (en) * | 2003-07-24 | 2005-03-10 | Alfaro Arthur A. | Intravascular occlusion device |
US8216252B2 (en) | 2004-05-07 | 2012-07-10 | Usgi Medical, Inc. | Tissue manipulation and securement system |
US7735493B2 (en) * | 2003-08-15 | 2010-06-15 | Atritech, Inc. | System and method for delivering a left atrial appendage containment device |
WO2005018728A2 (en) * | 2003-08-19 | 2005-03-03 | Nmt Medical, Inc. | Expandable sheath tubing |
DE10338702B9 (en) * | 2003-08-22 | 2007-04-26 | Occlutech Gmbh | Occlusioninstrument |
EP1663011A1 (en) * | 2003-09-11 | 2006-06-07 | NMT Medical, Inc. | Devices, systems, and methods for suturing tissue |
DE602004015807D1 (en) * | 2003-09-11 | 2008-09-25 | Nmt Medical Inc | CUTTING TUBE FOR SURGICAL SEAMS |
US7192435B2 (en) * | 2003-09-18 | 2007-03-20 | Cardia, Inc. | Self centering closure device for septal occlusion |
US7144410B2 (en) | 2003-09-18 | 2006-12-05 | Cardia Inc. | ASD closure device with self centering arm network |
US7658748B2 (en) * | 2003-09-23 | 2010-02-09 | Cardia, Inc. | Right retrieval mechanism |
US7462188B2 (en) | 2003-09-26 | 2008-12-09 | Abbott Laboratories | Device and method for suturing intracardiac defects |
US7608086B2 (en) * | 2003-09-30 | 2009-10-27 | Ethicon Endo-Surgery, Inc. | Anastomosis wire ring device |
CA2542089A1 (en) * | 2003-10-10 | 2005-04-21 | Proximare, Inc. | Patent foramen ovale (pfo) closure devices, delivery apparatus and related methods and systems |
US20050192627A1 (en) * | 2003-10-10 | 2005-09-01 | Whisenant Brian K. | Patent foramen ovale closure devices, delivery apparatus and related methods and systems |
US7419498B2 (en) * | 2003-10-21 | 2008-09-02 | Nmt Medical, Inc. | Quick release knot attachment system |
US8292910B2 (en) | 2003-11-06 | 2012-10-23 | Pressure Products Medical Supplies, Inc. | Transseptal puncture apparatus |
CA2542280A1 (en) | 2003-11-06 | 2005-05-26 | Nmt Medical, Inc. | Transseptal puncture apparatus |
WO2005046438A2 (en) * | 2003-11-06 | 2005-05-26 | Pluromed, Inc. | Internal clamp for surgical procedures |
US7056286B2 (en) | 2003-11-12 | 2006-06-06 | Adrian Ravenscroft | Medical device anchor and delivery system |
WO2005055834A1 (en) * | 2003-11-20 | 2005-06-23 | Nmt Medical, Inc. | Device, with electrospun fabric, for a percutaneous transluminal procedure, and methods thereof |
US7566336B2 (en) * | 2003-11-25 | 2009-07-28 | Cardia, Inc. | Left atrial appendage closure device |
US20050273119A1 (en) | 2003-12-09 | 2005-12-08 | Nmt Medical, Inc. | Double spiral patent foramen ovale closure clamp |
US7347863B2 (en) | 2004-05-07 | 2008-03-25 | Usgi Medical, Inc. | Apparatus and methods for manipulating and securing tissue |
US20050251189A1 (en) * | 2004-05-07 | 2005-11-10 | Usgi Medical Inc. | Multi-position tissue manipulation assembly |
US7361180B2 (en) | 2004-05-07 | 2008-04-22 | Usgi Medical, Inc. | Apparatus for manipulating and securing tissue |
US7449024B2 (en) | 2003-12-23 | 2008-11-11 | Abbott Laboratories | Suturing device with split arm and method of suturing tissue |
US7572228B2 (en) * | 2004-01-13 | 2009-08-11 | Remon Medical Technologies Ltd | Devices for fixing a sensor in a lumen |
US7338512B2 (en) * | 2004-01-22 | 2008-03-04 | Rex Medical, L.P. | Vein filter |
US8062326B2 (en) | 2004-01-22 | 2011-11-22 | Rex Medical, L.P. | Vein filter |
US8162972B2 (en) | 2004-01-22 | 2012-04-24 | Rex Medical, Lp | Vein filter |
US9510929B2 (en) | 2004-01-22 | 2016-12-06 | Argon Medical Devices, Inc. | Vein filter |
US7976562B2 (en) | 2004-01-22 | 2011-07-12 | Rex Medical, L.P. | Method of removing a vein filter |
US8211140B2 (en) | 2004-01-22 | 2012-07-03 | Rex Medical, L.P. | Vein filter |
US8500774B2 (en) | 2004-01-22 | 2013-08-06 | Rex Medical, L.P. | Vein filter |
US7704266B2 (en) | 2004-01-22 | 2010-04-27 | Rex Medical, L.P. | Vein filter |
US20110208233A1 (en) * | 2004-01-22 | 2011-08-25 | Mcguckin Jr James F | Device for preventing clot migration from left atrial appendage |
US8262694B2 (en) * | 2004-01-30 | 2012-09-11 | W.L. Gore & Associates, Inc. | Devices, systems, and methods for closure of cardiac openings |
CA2553869A1 (en) * | 2004-01-30 | 2005-08-18 | Nmt Medical, Inc. | Welding systems for closure of cardiac openings |
JP2007527742A (en) * | 2004-02-03 | 2007-10-04 | アトリア メディカル インク | Apparatus and method for controlling pressure in a living body |
CN100413472C (en) * | 2004-02-04 | 2008-08-27 | 卡拉格股份公司 | Implant for blocking body passage |
US20050187568A1 (en) * | 2004-02-20 | 2005-08-25 | Klenk Alan R. | Devices and methods for closing a patent foramen ovale with a coil-shaped closure device |
WO2005094729A1 (en) * | 2004-03-01 | 2005-10-13 | Chase Medical L.P. | Method and device for percutaneous surgical ventricular repair |
US7871419B2 (en) * | 2004-03-03 | 2011-01-18 | Nmt Medical, Inc. | Delivery/recovery system for septal occluder |
US7976539B2 (en) * | 2004-03-05 | 2011-07-12 | Hansen Medical, Inc. | System and method for denaturing and fixing collagenous tissue |
US7703459B2 (en) * | 2004-03-09 | 2010-04-27 | Usgi Medical, Inc. | Apparatus and methods for mapping out endoluminal gastrointestinal surgery |
US20050203488A1 (en) * | 2004-03-09 | 2005-09-15 | Usgi Medical Inc. | Apparatus and methods for mapping out endoluminal gastrointestinal surgery |
US9039724B2 (en) * | 2004-03-19 | 2015-05-26 | Aga Medical Corporation | Device for occluding vascular defects |
US8777974B2 (en) * | 2004-03-19 | 2014-07-15 | Aga Medical Corporation | Multi-layer braided structures for occluding vascular defects |
US8398670B2 (en) | 2004-03-19 | 2013-03-19 | Aga Medical Corporation | Multi-layer braided structures for occluding vascular defects and for occluding fluid flow through portions of the vasculature of the body |
US8313505B2 (en) * | 2004-03-19 | 2012-11-20 | Aga Medical Corporation | Device for occluding vascular defects |
US8747453B2 (en) * | 2008-02-18 | 2014-06-10 | Aga Medical Corporation | Stent/stent graft for reinforcement of vascular abnormalities and associated method |
US20050228434A1 (en) | 2004-03-19 | 2005-10-13 | Aga Medical Corporation | Multi-layer braided structures for occluding vascular defects |
US20050234509A1 (en) * | 2004-03-30 | 2005-10-20 | Mmt Medical, Inc. | Center joints for PFO occluders |
EP2856949B2 (en) | 2004-04-08 | 2019-09-11 | Aga Medical Corporation | Flanged occlusion devices |
US20050267524A1 (en) * | 2004-04-09 | 2005-12-01 | Nmt Medical, Inc. | Split ends closure device |
US8425539B2 (en) | 2004-04-12 | 2013-04-23 | Xlumena, Inc. | Luminal structure anchoring devices and methods |
US8361110B2 (en) * | 2004-04-26 | 2013-01-29 | W.L. Gore & Associates, Inc. | Heart-shaped PFO closure device |
US8801746B1 (en) | 2004-05-04 | 2014-08-12 | Covidien Lp | System and method for delivering a left atrial appendage containment device |
US8308760B2 (en) * | 2004-05-06 | 2012-11-13 | W.L. Gore & Associates, Inc. | Delivery systems and methods for PFO closure device with two anchors |
US7842053B2 (en) | 2004-05-06 | 2010-11-30 | Nmt Medical, Inc. | Double coil occluder |
US20050251208A1 (en) * | 2004-05-07 | 2005-11-10 | Usgi Medical Inc. | Linear anchors for anchoring to tissue |
US20050250985A1 (en) * | 2004-05-07 | 2005-11-10 | Usgi Medical Inc. | Self-locking removable apparatus and methods for manipulating and securing tissue |
US8444657B2 (en) | 2004-05-07 | 2013-05-21 | Usgi Medical, Inc. | Apparatus and methods for rapid deployment of tissue anchors |
US8257394B2 (en) * | 2004-05-07 | 2012-09-04 | Usgi Medical, Inc. | Apparatus and methods for positioning and securing anchors |
US20050251176A1 (en) * | 2004-05-07 | 2005-11-10 | Usgi Medical Inc. | System for treating gastroesophageal reflux disease |
US7390329B2 (en) * | 2004-05-07 | 2008-06-24 | Usgi Medical, Inc. | Methods for grasping and cinching tissue anchors |
US7704268B2 (en) * | 2004-05-07 | 2010-04-27 | Nmt Medical, Inc. | Closure device with hinges |
US8057511B2 (en) * | 2004-05-07 | 2011-11-15 | Usgi Medical, Inc. | Apparatus and methods for positioning and securing anchors |
US7736374B2 (en) * | 2004-05-07 | 2010-06-15 | Usgi Medical, Inc. | Tissue manipulation and securement system |
US7842069B2 (en) | 2004-05-07 | 2010-11-30 | Nmt Medical, Inc. | Inflatable occluder |
CA2563298A1 (en) | 2004-05-07 | 2005-11-24 | Nmt Medical, Inc. | Catching mechanisms for tubular septal occluder |
US20060135971A1 (en) * | 2004-05-07 | 2006-06-22 | Usgi Medical Inc. | System for treating gastroesophageal reflux disease |
US7918869B2 (en) | 2004-05-07 | 2011-04-05 | Usgi Medical, Inc. | Methods and apparatus for performing endoluminal gastroplasty |
WO2005112813A1 (en) | 2004-05-17 | 2005-12-01 | C.R. Bard, Inc. | Method and apparatus for mapping and7or ablation of cardiac tissue |
GB0411348D0 (en) * | 2004-05-21 | 2004-06-23 | Univ Cranfield | Fabrication of polymeric structures using laser initiated polymerisation |
US8267985B2 (en) | 2005-05-25 | 2012-09-18 | Tyco Healthcare Group Lp | System and method for delivering and deploying an occluding device within a vessel |
US8206417B2 (en) * | 2004-06-09 | 2012-06-26 | Usgi Medical Inc. | Apparatus and methods for optimizing anchoring force |
US7736379B2 (en) * | 2004-06-09 | 2010-06-15 | Usgi Medical, Inc. | Compressible tissue anchor assemblies |
US7678135B2 (en) | 2004-06-09 | 2010-03-16 | Usgi Medical, Inc. | Compressible tissue anchor assemblies |
US7695493B2 (en) * | 2004-06-09 | 2010-04-13 | Usgi Medical, Inc. | System for optimizing anchoring force |
US20060020276A1 (en) * | 2004-07-23 | 2006-01-26 | Usgi Medical Inc. | Apparatus and methods for achieving prolonged maintenance of gastrointestinal tissue folds |
ES2873101T3 (en) * | 2004-08-02 | 2021-11-03 | V V T Medical Ltd | Device for treating a glass |
EP1793743B1 (en) | 2004-09-22 | 2009-11-18 | Dendron GmbH | Micro-spiral implantation device |
ES2321300T3 (en) | 2004-09-22 | 2009-06-04 | Dendron Gmbh | MEDICAL IMPLANT |
CA2581677C (en) * | 2004-09-24 | 2014-07-29 | Nmt Medical, Inc. | Occluder device double securement system for delivery/recovery of such occluder device |
WO2006036457A2 (en) * | 2004-09-27 | 2006-04-06 | Rex Medical, L.P. | Vein filter |
US20090326578A1 (en) * | 2004-09-30 | 2009-12-31 | Usgi Medical, Inc. | Interlocking tissue anchor apparatus and methods |
US8535345B2 (en) | 2004-10-07 | 2013-09-17 | DePuy Synthes Products, LLC | Vasoocclusive coil with biplex windings to improve mechanical properties |
US7473252B2 (en) * | 2004-10-07 | 2009-01-06 | Coaptus Medical Corporation | Systems and methods for shrinking and/or securing cardiovascular tissue |
US7905901B2 (en) * | 2004-11-29 | 2011-03-15 | Cardia, Inc. | Self-centering occlusion device |
US20060122522A1 (en) * | 2004-12-03 | 2006-06-08 | Abhi Chavan | Devices and methods for positioning and anchoring implantable sensor devices |
US7582104B2 (en) * | 2004-12-08 | 2009-09-01 | Cardia, Inc. | Daisy design for occlusion device |
JP5111112B2 (en) | 2004-12-08 | 2012-12-26 | エックスルミナ, インコーポレイテッド | Device for performing needle-guided therapy |
US9545300B2 (en) | 2004-12-22 | 2017-01-17 | W. L. Gore & Associates, Inc. | Filament-wound implantable devices |
US7854747B2 (en) | 2005-01-03 | 2010-12-21 | Crux Biomedical, Inc. | Endoluminal filter |
US20080147111A1 (en) * | 2005-01-03 | 2008-06-19 | Eric Johnson | Endoluminal Filter With Fixation |
US20060173300A1 (en) * | 2005-01-11 | 2006-08-03 | Aga Medical Corp. | Open structure sizing device |
US10390714B2 (en) | 2005-01-12 | 2019-08-27 | Remon Medical Technologies, Ltd. | Devices for fixing a sensor in a lumen |
JP2008534032A (en) * | 2005-02-09 | 2008-08-28 | アンジオダイナミックス,インク. | Reinforcing balloon for catheter |
US7998164B2 (en) * | 2005-03-11 | 2011-08-16 | Boston Scientific Scimed, Inc. | Intravascular filter with centering member |
US20060241687A1 (en) * | 2005-03-16 | 2006-10-26 | Glaser Erik N | Septal occluder with pivot arms and articulating joints |
US20060217760A1 (en) * | 2005-03-17 | 2006-09-28 | Widomski David R | Multi-strand septal occluder |
EP1868507A1 (en) | 2005-03-18 | 2007-12-26 | NMT Medical, Inc. | Catch member for pfo occluder |
US8372113B2 (en) * | 2005-03-24 | 2013-02-12 | W.L. Gore & Associates, Inc. | Curved arm intracardiac occluder |
US20060224175A1 (en) * | 2005-03-29 | 2006-10-05 | Vrba Anthony C | Methods and apparatuses for disposition of a medical device onto an elongate medical device |
US20060229670A1 (en) * | 2005-04-01 | 2006-10-12 | Bates Brian L | Method and a medical closure system for sealing a puncture |
US20060253184A1 (en) * | 2005-05-04 | 2006-11-09 | Kurt Amplatz | System for the controlled delivery of stents and grafts |
US8273101B2 (en) | 2005-05-25 | 2012-09-25 | Tyco Healthcare Group Lp | System and method for delivering and deploying an occluding device within a vessel |
CN101180006B (en) | 2005-05-25 | 2010-09-22 | 切斯纳特医药技术公司 | System and method for delivering and deploying and occluding device within a vessel |
US8298291B2 (en) * | 2005-05-26 | 2012-10-30 | Usgi Medical, Inc. | Methods and apparatus for securing and deploying tissue anchors |
US9585651B2 (en) * | 2005-05-26 | 2017-03-07 | Usgi Medical, Inc. | Methods and apparatus for securing and deploying tissue anchors |
US8777967B2 (en) | 2005-06-09 | 2014-07-15 | Xlumena, Inc. | Methods and devices for anchoring to tissue |
US8784437B2 (en) | 2005-06-09 | 2014-07-22 | Xlumena, Inc. | Methods and devices for endosonography-guided fundoplexy |
CN1883401B (en) * | 2005-06-23 | 2010-12-15 | 东莞科威医疗器械有限公司 | Atrial septal defect occlusive device dedicated for surgical department and method for manufacturing same |
US8926633B2 (en) | 2005-06-24 | 2015-01-06 | Abbott Laboratories | Apparatus and method for delivering a closure element |
US8313497B2 (en) | 2005-07-01 | 2012-11-20 | Abbott Laboratories | Clip applier and methods of use |
US8579936B2 (en) * | 2005-07-05 | 2013-11-12 | ProMed, Inc. | Centering of delivery devices with respect to a septal defect |
AU2005334555A1 (en) * | 2005-07-19 | 2007-01-25 | Stout Medical Group L.P. | Embolic filtering method and apparatus |
US8029522B2 (en) * | 2005-08-05 | 2011-10-04 | Ethicon Endo-Surgery, Inc. | Method and apparatus for sealing a gastric opening |
US7883517B2 (en) | 2005-08-08 | 2011-02-08 | Abbott Laboratories | Vascular suturing device |
US8083754B2 (en) | 2005-08-08 | 2011-12-27 | Abbott Laboratories | Vascular suturing device with needle capture |
US8267947B2 (en) | 2005-08-08 | 2012-09-18 | Abbott Laboratories | Vascular suturing device |
US8920442B2 (en) | 2005-08-24 | 2014-12-30 | Abbott Vascular Inc. | Vascular opening edge eversion methods and apparatuses |
US20070060895A1 (en) | 2005-08-24 | 2007-03-15 | Sibbitt Wilmer L Jr | Vascular closure methods and apparatuses |
US9456811B2 (en) | 2005-08-24 | 2016-10-04 | Abbott Vascular Inc. | Vascular closure methods and apparatuses |
US7846179B2 (en) * | 2005-09-01 | 2010-12-07 | Ovalis, Inc. | Suture-based systems and methods for treating septal defects |
US9259267B2 (en) | 2005-09-06 | 2016-02-16 | W.L. Gore & Associates, Inc. | Devices and methods for treating cardiac tissue |
WO2007030433A2 (en) * | 2005-09-06 | 2007-03-15 | Nmt Medical, Inc. | Removable intracardiac rf device |
US7972359B2 (en) * | 2005-09-16 | 2011-07-05 | Atritech, Inc. | Intracardiac cage and method of delivering same |
US20070088388A1 (en) * | 2005-09-19 | 2007-04-19 | Opolski Steven W | Delivery device for implant with dual attachment sites |
US20070123934A1 (en) * | 2005-09-26 | 2007-05-31 | Whisenant Brian K | Delivery system for patent foramen ovale closure device |
US20070100324A1 (en) * | 2005-10-17 | 2007-05-03 | Coaptus Medical Corporation | Systems and methods for applying vacuum to a patient, including via a disposable liquid collection unit |
JP2009512521A (en) * | 2005-10-24 | 2009-03-26 | エヌエムティー メディカル, インコーポレイティッド | Radiopaque bioabsorbable occluder |
JP2009514625A (en) * | 2005-11-11 | 2009-04-09 | オクルテク ゲーエムベーハー | Self-expanding medical occlusion device |
CA2627412A1 (en) * | 2005-11-11 | 2007-05-18 | Occlutech Gmbh | Occlusion device and surgical instrument and method for implanting or explanting the same |
US7955354B2 (en) * | 2005-11-14 | 2011-06-07 | Occlutech Gmbh | Occlusion device and surgical instrument and method for its implantation/explantation |
US7665466B2 (en) * | 2005-11-14 | 2010-02-23 | Occlutech Gmbh | Self-expanding medical occlusion device |
US8100938B2 (en) * | 2005-11-14 | 2012-01-24 | Occlutech Holding Ag | Occlusion device for occluding an atrial auricula and method for producing same |
US7632308B2 (en) * | 2005-11-23 | 2009-12-15 | Didier Loulmet | Methods, devices, and kits for treating mitral valve prolapse |
US20070135826A1 (en) | 2005-12-01 | 2007-06-14 | Steve Zaver | Method and apparatus for delivering an implant without bias to a left atrial appendage |
WO2007073566A1 (en) | 2005-12-22 | 2007-06-28 | Nmt Medical, Inc. | Catch members for occluder devices |
US8060214B2 (en) * | 2006-01-05 | 2011-11-15 | Cardiac Pacemakers, Inc. | Implantable medical device with inductive coil configurable for mechanical fixation |
WO2007083288A2 (en) | 2006-01-23 | 2007-07-26 | Atria Medical Inc. | Heart anchor device |
US8726909B2 (en) | 2006-01-27 | 2014-05-20 | Usgi Medical, Inc. | Methods and apparatus for revision of obesity procedures |
CA2637450A1 (en) * | 2006-01-31 | 2007-08-09 | Cook Biotech Incorporated | Fistula grafts and related methods and systems for treating fistulae |
US8162974B2 (en) | 2006-02-02 | 2012-04-24 | Boston Scientific Scimed, Inc. | Occlusion apparatus, system, and method |
US20070233258A1 (en) * | 2006-02-28 | 2007-10-04 | Zimmer Spine, Inc. | Vertebroplasty- device and method |
DE102006013770A1 (en) | 2006-03-24 | 2007-09-27 | Occlutech Gmbh | Occlusion instrument and method for its production |
US8551135B2 (en) | 2006-03-31 | 2013-10-08 | W.L. Gore & Associates, Inc. | Screw catch mechanism for PFO occluder and method of use |
US8870913B2 (en) | 2006-03-31 | 2014-10-28 | W.L. Gore & Associates, Inc. | Catch system with locking cap for patent foramen ovale (PFO) occluder |
US8814947B2 (en) * | 2006-03-31 | 2014-08-26 | W.L. Gore & Associates, Inc. | Deformable flap catch mechanism for occluder device |
CN101049268B (en) * | 2006-04-03 | 2011-09-14 | 孟坚 | Medical use obstruction appliance |
US8777979B2 (en) | 2006-04-17 | 2014-07-15 | Covidien Lp | System and method for mechanically positioning intravascular implants |
EP2015683B1 (en) | 2006-04-17 | 2015-12-09 | Covidien LP | System for mechanically positioning intravascular implants |
US20080027533A1 (en) * | 2006-04-19 | 2008-01-31 | Abbott Laboratories | Dedicated bifurcation stent apparatus and method |
US8808310B2 (en) | 2006-04-20 | 2014-08-19 | Integrated Vascular Systems, Inc. | Resettable clip applier and reset tools |
WO2007127802A2 (en) * | 2006-04-27 | 2007-11-08 | Wilfrido Castaneda | Methods and apparatus for extraluminal femoropoliteal bypass graft |
US20070265658A1 (en) * | 2006-05-12 | 2007-11-15 | Aga Medical Corporation | Anchoring and tethering system |
WO2007147127A2 (en) | 2006-06-15 | 2007-12-21 | Cook Incorporated | Methods, systems, and devices for the delivery of endoluminal prostheses |
US7927351B2 (en) * | 2006-06-19 | 2011-04-19 | Cardia, Inc. | Occlusion device with flexible wire connector |
US7691115B2 (en) * | 2006-06-19 | 2010-04-06 | Cardia, Inc. | Occlusion device with flexible fabric connector |
US7749238B2 (en) * | 2006-06-19 | 2010-07-06 | Cardia, Inc. | Occlusion device with flexible polymeric connector |
US7972361B2 (en) * | 2006-06-19 | 2011-07-05 | Cardia, Inc. | Occlusion device with flexible spring connector |
US8556930B2 (en) | 2006-06-28 | 2013-10-15 | Abbott Laboratories | Vessel closure device |
US8870916B2 (en) * | 2006-07-07 | 2014-10-28 | USGI Medical, Inc | Low profile tissue anchors, tissue anchor systems, and methods for their delivery and use |
CN101120893B (en) * | 2006-08-08 | 2010-05-12 | 先健科技(深圳)有限公司 | Heart septal defect blocking device |
US9220487B2 (en) * | 2006-08-09 | 2015-12-29 | Coherex Medical, Inc. | Devices for reducing the size of an internal tissue opening |
US8529597B2 (en) | 2006-08-09 | 2013-09-10 | Coherex Medical, Inc. | Devices for reducing the size of an internal tissue opening |
US20090270840A1 (en) * | 2008-03-28 | 2009-10-29 | Coherex Medical, Inc. | Delivery systems for a medical device and related methods |
US8864809B2 (en) | 2006-08-09 | 2014-10-21 | Coherex Medical, Inc. | Systems and devices for reducing the size of an internal tissue opening |
US20080039897A1 (en) * | 2006-08-10 | 2008-02-14 | Kluge Stanley E | Trans-Septal Left Ventricular Pressure Measurement |
CA2660851A1 (en) * | 2006-08-17 | 2008-02-21 | Nfocus Neuromedical, Inc. | Isolation devices for the treatment of aneurysms |
US8075576B2 (en) * | 2006-08-24 | 2011-12-13 | Boston Scientific Scimed, Inc. | Closure device, system, and method |
DE102006040415B3 (en) * | 2006-08-29 | 2008-01-24 | Peter Osypka Stiftung Stiftung des bürgerlichen Rechts | Closure element for an occlusion instrument for closing openings in a heart comprises a double-walled tubular braiding having a first braided section with a small cross-section and a second braided section surrounding the first section |
US10076401B2 (en) | 2006-08-29 | 2018-09-18 | Argon Medical Devices, Inc. | Vein filter |
US8870914B2 (en) * | 2006-09-12 | 2014-10-28 | Cook Medical Technologies Llc | Medical device and a method for sealing a puncture or an opening |
US8676349B2 (en) * | 2006-09-15 | 2014-03-18 | Cardiac Pacemakers, Inc. | Mechanism for releasably engaging an implantable medical device for implantation |
ES2369203T3 (en) * | 2006-09-15 | 2011-11-28 | Cardiac Pacemakers, Inc. | ANCHORAGE FOR AN IMPLANTABLE MEDICAL DEVICE. |
US20080071248A1 (en) * | 2006-09-15 | 2008-03-20 | Cardiac Pacemakers, Inc. | Delivery stystem for an implantable physiologic sensor |
DE102006045545A1 (en) * | 2006-09-25 | 2008-04-03 | Peter Osypka Stiftung Stiftung des bürgerlichen Rechts | Medical device |
US20080077180A1 (en) * | 2006-09-26 | 2008-03-27 | Nmt Medical, Inc. | Scaffold for tubular septal occluder device and techniques for attachment |
US20080082083A1 (en) * | 2006-09-28 | 2008-04-03 | Forde Sean T | Perforated expandable implant recovery sheath |
DE102006050385A1 (en) * | 2006-10-05 | 2008-04-10 | pfm Produkte für die Medizin AG | Implantable mechanism for use in human and/or animal body for e.g. closing atrium septum defect, has partial piece that is folded back on another partial piece from primary form into secondary form of carrying structure |
WO2008051935A1 (en) | 2006-10-22 | 2008-05-02 | Idev Technologies, Inc. | Methods for securing strand ends and the resulting devices |
US8882697B2 (en) | 2006-11-07 | 2014-11-11 | Dc Devices, Inc. | Apparatus and methods to create and maintain an intra-atrial pressure relief opening |
US10624621B2 (en) | 2006-11-07 | 2020-04-21 | Corvia Medical, Inc. | Devices and methods for the treatment of heart failure |
US8460372B2 (en) | 2006-11-07 | 2013-06-11 | Dc Devices, Inc. | Prosthesis for reducing intra-cardiac pressure having an embolic filter |
US10413284B2 (en) | 2006-11-07 | 2019-09-17 | Corvia Medical, Inc. | Atrial pressure regulation with control, sensing, monitoring and therapy delivery |
US20110257723A1 (en) | 2006-11-07 | 2011-10-20 | Dc Devices, Inc. | Devices and methods for coronary sinus pressure relief |
US9232997B2 (en) | 2006-11-07 | 2016-01-12 | Corvia Medical, Inc. | Devices and methods for retrievable intra-atrial implants |
US20080108904A1 (en) * | 2006-11-08 | 2008-05-08 | Cardiac Pacemakers, Inc. | Implant for securing a sensor in a vessel |
US20080161825A1 (en) * | 2006-11-20 | 2008-07-03 | Stout Medical Group, L.P. | Anatomical measurement tool |
US20080140113A1 (en) * | 2006-12-07 | 2008-06-12 | Cierra, Inc. | Method for sealing a pfo using an energy delivery device |
US20080167682A1 (en) * | 2007-01-09 | 2008-07-10 | Cardia, Inc. | Bioabsorbable occlusion device |
US20080188892A1 (en) * | 2007-02-01 | 2008-08-07 | Cook Incorporated | Vascular occlusion device |
US8801747B2 (en) | 2007-03-13 | 2014-08-12 | Covidien Lp | Implant, a mandrel, and a method of forming an implant |
JP5249249B2 (en) * | 2007-03-13 | 2013-07-31 | コヴィディエン リミテッド パートナーシップ | Implant including a coil and a stretch resistant member |
US20080228256A1 (en) * | 2007-03-13 | 2008-09-18 | Medtronic Vascular, Inc. | Braided Flange Branch Graft for Branch Vessel |
WO2008124603A1 (en) | 2007-04-05 | 2008-10-16 | Nmt Medical, Inc. | Septal closure device with centering mechanism |
ES2856081T3 (en) | 2007-04-16 | 2021-09-27 | Occlutech Holding Ag | Occlusor for the occlusion of an atrial appendage and its production procedure |
WO2008131167A1 (en) | 2007-04-18 | 2008-10-30 | Nmt Medical, Inc. | Flexible catheter system |
US8204599B2 (en) * | 2007-05-02 | 2012-06-19 | Cardiac Pacemakers, Inc. | System for anchoring an implantable sensor in a vessel |
US20080283066A1 (en) * | 2007-05-17 | 2008-11-20 | Cardiac Pacemakers, Inc. | Delivery device for implantable sensors |
WO2008151204A1 (en) * | 2007-06-04 | 2008-12-11 | Sequent Medical Inc. | Methods and devices for treatment of vascular defects |
WO2008149355A2 (en) * | 2007-06-04 | 2008-12-11 | Mor Research Applications Ltd. | Cardiac valve leaflet augmentation |
US8915958B2 (en) * | 2007-06-08 | 2014-12-23 | St. Jude Medical, Inc. | Devices for transcatheter prosthetic heart valve implantation and access closure |
JP2010528814A (en) | 2007-06-14 | 2010-08-26 | カーディアック ペースメイカーズ, インコーポレイテッド | Multi-element acoustic recharging system |
US8226681B2 (en) | 2007-06-25 | 2012-07-24 | Abbott Laboratories | Methods, devices, and apparatus for managing access through tissue |
US8574244B2 (en) | 2007-06-25 | 2013-11-05 | Abbott Laboratories | System for closing a puncture in a vessel wall |
US8048147B2 (en) | 2007-06-27 | 2011-11-01 | Aga Medical Corporation | Branched stent/graft and method of fabrication |
US8034061B2 (en) | 2007-07-12 | 2011-10-11 | Aga Medical Corporation | Percutaneous catheter directed intravascular occlusion devices |
US8361138B2 (en) * | 2007-07-25 | 2013-01-29 | Aga Medical Corporation | Braided occlusion device having repeating expanded volume segments separated by articulation segments |
US20090112251A1 (en) * | 2007-07-25 | 2009-04-30 | Aga Medical Corporation | Braided occlusion device having repeating expanded volume segments separated by articulation segments |
EP2324775B1 (en) | 2007-08-02 | 2012-06-20 | Occlutech Holding AG | Method of producing a medical implantable device |
US8366741B2 (en) | 2007-09-13 | 2013-02-05 | Cardia, Inc. | Occlusion device with centering arm |
US20090082803A1 (en) * | 2007-09-26 | 2009-03-26 | Aga Medical Corporation | Braided vascular devices having no end clamps |
WO2009046441A1 (en) * | 2007-10-05 | 2009-04-09 | Coaptus Medical Corporation | Systems and methods for transeptal cardiac procedures |
US9414842B2 (en) * | 2007-10-12 | 2016-08-16 | St. Jude Medical, Cardiology Division, Inc. | Multi-component vascular device |
US20100262183A1 (en) * | 2007-11-07 | 2010-10-14 | Ovalis Inc. | Systems devices and methods for achieving transverse orientation in the treatment of septal defects |
US8893947B2 (en) | 2007-12-17 | 2014-11-25 | Abbott Laboratories | Clip applier and methods of use |
US20090157101A1 (en) | 2007-12-17 | 2009-06-18 | Abbott Laboratories | Tissue closure system and methods of use |
US7841502B2 (en) | 2007-12-18 | 2010-11-30 | Abbott Laboratories | Modular clip applier |
US20090171386A1 (en) * | 2007-12-28 | 2009-07-02 | Aga Medical Corporation | Percutaneous catheter directed intravascular occlusion devices |
US9743918B2 (en) * | 2008-01-18 | 2017-08-29 | St. Jude Medical, Cardiology Division, Inc. | Percutaneous catheter directed intravascular occlusion device |
US9259225B2 (en) | 2008-02-19 | 2016-02-16 | St. Jude Medical, Cardiology Division, Inc. | Medical devices for treating a target site and associated method |
US20130165967A1 (en) | 2008-03-07 | 2013-06-27 | W.L. Gore & Associates, Inc. | Heart occlusion devices |
CA2720206C (en) * | 2008-04-04 | 2016-10-04 | Curaseal, Inc. | Implantable fistula closure device |
AU2009239424B9 (en) * | 2008-04-21 | 2014-10-09 | Covidien Lp | Braid-ball embolic devices and delivery systems |
US9597087B2 (en) | 2008-05-02 | 2017-03-21 | Sequent Medical, Inc. | Filamentary devices for treatment of vascular defects |
WO2009137755A2 (en) * | 2008-05-09 | 2009-11-12 | University Of Pittsburgh- Commonwealth System Of Higher Education | Biologic matrix for cardiac repair |
US20090281379A1 (en) * | 2008-05-12 | 2009-11-12 | Xlumena, Inc. | System and method for transluminal access |
US8454632B2 (en) | 2008-05-12 | 2013-06-04 | Xlumena, Inc. | Tissue anchor for securing tissue layers |
WO2009140437A1 (en) | 2008-05-13 | 2009-11-19 | Nfocus Neuromedical, Inc. | Braid implant delivery systems |
US9282965B2 (en) | 2008-05-16 | 2016-03-15 | Abbott Laboratories | Apparatus and methods for engaging tissue |
AU2009249063A1 (en) * | 2008-05-20 | 2009-11-26 | Ovalis, Inc. | Wire-like and other devices for treating septal defects and systems and methods for delivering the same |
JP2011526803A (en) * | 2008-07-01 | 2011-10-20 | ボストン サイエンティフィック サイムド, インコーポレイテッド | Incision-Stapling surgical stapling device and method of use |
US8934987B2 (en) * | 2008-07-15 | 2015-01-13 | Cardiac Pacemakers, Inc. | Implant assist apparatus for acoustically enabled implantable medical device |
WO2010011694A1 (en) | 2008-07-22 | 2010-01-28 | Micro Therapeutics, Inc. | Vascular remodeling device |
US9351715B2 (en) * | 2008-07-24 | 2016-05-31 | St. Jude Medical, Cardiology Division, Inc. | Multi-layered medical device for treating a target site and associated method |
US9232992B2 (en) * | 2008-07-24 | 2016-01-12 | Aga Medical Corporation | Multi-layered medical device for treating a target site and associated method |
US20100030321A1 (en) * | 2008-07-29 | 2010-02-04 | Aga Medical Corporation | Medical device including corrugated braid and associated method |
KR101772089B1 (en) | 2008-09-04 | 2017-08-28 | 앤덜스 존슨 | Temporary embolic protection device and medical procedure for delivery thereof |
US8177809B2 (en) * | 2008-09-04 | 2012-05-15 | Curaseal Inc. | Inflatable device for enteric fistula treatment |
US8163022B2 (en) | 2008-10-14 | 2012-04-24 | Anulex Technologies, Inc. | Method and apparatus for the treatment of the intervertebral disc annulus |
US9241696B2 (en) | 2008-10-30 | 2016-01-26 | Abbott Vascular Inc. | Closure device |
US8940015B2 (en) * | 2008-11-11 | 2015-01-27 | Aga Medical Corporation | Asymmetrical medical devices for treating a target site and associated method |
US8905961B2 (en) * | 2008-12-19 | 2014-12-09 | St. Jude Medical, Inc. | Systems, apparatuses, and methods for cardiovascular conduits and connectors |
US8323312B2 (en) | 2008-12-22 | 2012-12-04 | Abbott Laboratories | Closure device |
US8858594B2 (en) | 2008-12-22 | 2014-10-14 | Abbott Laboratories | Curved closure device |
US20110011917A1 (en) * | 2008-12-31 | 2011-01-20 | Hansen Medical, Inc. | Methods, devices, and kits for treating valve prolapse |
US9414820B2 (en) | 2009-01-09 | 2016-08-16 | Abbott Vascular Inc. | Closure devices, systems, and methods |
US9486191B2 (en) | 2009-01-09 | 2016-11-08 | Abbott Vascular, Inc. | Closure devices |
US9173644B2 (en) | 2009-01-09 | 2015-11-03 | Abbott Vascular Inc. | Closure devices, systems, and methods |
US9089311B2 (en) | 2009-01-09 | 2015-07-28 | Abbott Vascular Inc. | Vessel closure devices and methods |
US20100179589A1 (en) | 2009-01-09 | 2010-07-15 | Abbott Vascular Inc. | Rapidly eroding anchor |
US20100185234A1 (en) | 2009-01-16 | 2010-07-22 | Abbott Vascular Inc. | Closure devices, systems, and methods |
US8694129B2 (en) | 2009-02-13 | 2014-04-08 | Cardiac Pacemakers, Inc. | Deployable sensor platform on the lead system of an implantable device |
US10702275B2 (en) * | 2009-02-18 | 2020-07-07 | St. Jude Medical Cardiology Division, Inc. | Medical device with stiffener wire for occluding vascular defects |
GB2469072A (en) * | 2009-03-31 | 2010-10-06 | Royal Brompton & Harefield Nhs | Guidewire with Anchor for a catheter |
ES2527685T3 (en) | 2009-04-16 | 2015-01-28 | Occlutech Holding Ag | Intravascular delivery device of a medical implant |
EP2248471B1 (en) | 2009-05-06 | 2012-10-24 | Occlutech Holding AG | Intravascular delivery device |
US20100268029A1 (en) * | 2009-04-21 | 2010-10-21 | Xlumena, Inc. | Methods and apparatus for advancing a device from one body lumen to another |
US9364259B2 (en) * | 2009-04-21 | 2016-06-14 | Xlumena, Inc. | System and method for delivering expanding trocar through a sheath |
CN102458316A (en) * | 2009-04-28 | 2012-05-16 | Dc设备公司 | Devices, systems and methods to treat heart failure |
EP2427143B1 (en) | 2009-05-04 | 2017-08-02 | V-Wave Ltd. | Device for regulating pressure in a heart chamber |
US10076403B1 (en) | 2009-05-04 | 2018-09-18 | V-Wave Ltd. | Shunt for redistributing atrial blood volume |
US9034034B2 (en) | 2010-12-22 | 2015-05-19 | V-Wave Ltd. | Devices for reducing left atrial pressure, and methods of making and using same |
US20210161637A1 (en) | 2009-05-04 | 2021-06-03 | V-Wave Ltd. | Shunt for redistributing atrial blood volume |
JP5535313B2 (en) | 2009-05-29 | 2014-07-02 | エックスルミナ, インコーポレイテッド | Device and method for deploying a stent across adjacent tissue layers |
US20120029556A1 (en) * | 2009-06-22 | 2012-02-02 | Masters Steven J | Sealing device and delivery system |
US8956389B2 (en) * | 2009-06-22 | 2015-02-17 | W. L. Gore & Associates, Inc. | Sealing device and delivery system |
US9381006B2 (en) * | 2009-06-22 | 2016-07-05 | W. L. Gore & Associates, Inc. | Sealing device and delivery system |
CH701394A2 (en) * | 2009-07-10 | 2011-01-14 | Carag Ag | Occluder. |
US20110054492A1 (en) | 2009-08-26 | 2011-03-03 | Abbott Laboratories | Medical device for repairing a fistula |
US9757107B2 (en) | 2009-09-04 | 2017-09-12 | Corvia Medical, Inc. | Methods and devices for intra-atrial shunts having adjustable sizes |
US9642993B2 (en) | 2011-12-22 | 2017-05-09 | Corvia Medical, Inc. | Methods and devices for intra-atrial shunts having selectable flow rates |
US20110082495A1 (en) * | 2009-10-02 | 2011-04-07 | Ruiz Carlos E | Apparatus And Methods For Excluding The Left Atrial Appendage |
EP2496189A4 (en) | 2009-11-04 | 2016-05-11 | Nitinol Devices And Components Inc | Alternating circumferential bridge stent design and methods for use thereof |
CN102639181A (en) * | 2009-11-05 | 2012-08-15 | 斯昆特医疗公司 | Multiple layer filamentary devices or treatment of vascular defects |
US20110202085A1 (en) * | 2009-11-09 | 2011-08-18 | Siddharth Loganathan | Braid Ball Embolic Device Features |
US20110144689A1 (en) * | 2009-12-15 | 2011-06-16 | Med Institute, Inc. | Occlusion Device |
US8460319B2 (en) | 2010-01-11 | 2013-06-11 | Anulex Technologies, Inc. | Intervertebral disc annulus repair system and method |
CN102770091B (en) * | 2010-01-28 | 2015-07-08 | 泰科保健集团有限合伙公司 | Vascular remodeling device |
US9468442B2 (en) * | 2010-01-28 | 2016-10-18 | Covidien Lp | Vascular remodeling device |
CA2786575A1 (en) * | 2010-01-29 | 2011-08-04 | Dc Devices, Inc. | Devices and systems for treating heart failure |
WO2011094521A2 (en) * | 2010-01-29 | 2011-08-04 | Dc Devices, Inc. | Devices and methods for reducing venous pressure |
US8303624B2 (en) | 2010-03-15 | 2012-11-06 | Abbott Cardiovascular Systems, Inc. | Bioabsorbable plug |
US8974469B2 (en) | 2010-04-22 | 2015-03-10 | Medical Device Technologies, Inc. | Snare |
EP2387950A1 (en) | 2010-05-23 | 2011-11-23 | Occlutech Holding AG | Medical implant and manufacturing method thereof |
EP2588042A4 (en) | 2010-06-29 | 2015-03-18 | Artventive Medical Group Inc | Reducing flow through a tubular structure |
US9247942B2 (en) | 2010-06-29 | 2016-02-02 | Artventive Medical Group, Inc. | Reversible tubal contraceptive device |
US8828051B2 (en) | 2010-07-02 | 2014-09-09 | Pfm Medical Ag | Left atrial appendage occlusion device |
US8758399B2 (en) | 2010-08-02 | 2014-06-24 | Abbott Cardiovascular Systems, Inc. | Expandable bioabsorbable plug apparatus and method |
US8603116B2 (en) | 2010-08-04 | 2013-12-10 | Abbott Cardiovascular Systems, Inc. | Closure device with long tines |
US8663252B2 (en) | 2010-09-01 | 2014-03-04 | Abbott Cardiovascular Systems, Inc. | Suturing devices and methods |
US9370353B2 (en) | 2010-09-01 | 2016-06-21 | Abbott Cardiovascular Systems, Inc. | Suturing devices and methods |
AU2011298843A1 (en) | 2010-09-06 | 2013-04-04 | Nonwotecc Medical Gmbh | Device for closing openings or cavities in blood vessels |
EP2613735B1 (en) | 2010-09-10 | 2018-05-09 | Covidien LP | Devices for the treatment of vascular defects |
US8998947B2 (en) | 2010-09-10 | 2015-04-07 | Medina Medical, Inc. | Devices and methods for the treatment of vascular defects |
CN101933850B (en) * | 2010-09-16 | 2012-07-18 | 先健科技(深圳)有限公司 | Stopper and manufacturing method thereof |
EP2624791B1 (en) | 2010-10-08 | 2017-06-21 | Confluent Medical Technologies, Inc. | Alternating circumferential bridge stent design |
US9149277B2 (en) | 2010-10-18 | 2015-10-06 | Artventive Medical Group, Inc. | Expandable device delivery |
US9351859B2 (en) | 2010-12-06 | 2016-05-31 | Covidien Lp | Vascular remodeling device |
DE202011001366U1 (en) | 2011-01-12 | 2011-03-24 | Osypka, Peter, Dr.-Ing. | Closure of unwanted openings in the heart |
DE202011001481U1 (en) | 2011-01-14 | 2011-03-17 | Osypka, Peter, Dr.-Ing. | Metal-free closure of unwanted openings in the heart |
DE202011001611U1 (en) | 2011-01-18 | 2011-03-24 | Osypka, Peter, Dr.-Ing. | Closure of a PFO in the heart with a brace |
JP5868432B2 (en) | 2011-02-11 | 2016-02-24 | コヴィディエン リミテッド パートナーシップ | Two-stage deployed aneurysm embolization device |
CN102139136B (en) * | 2011-03-11 | 2013-07-17 | 上海微创医疗器械(集团)有限公司 | Sacculus dilatation catheter |
EP4119095A1 (en) | 2011-03-21 | 2023-01-18 | Cephea Valve Technologies, Inc. | Disk-based valve apparatus |
US9149276B2 (en) | 2011-03-21 | 2015-10-06 | Abbott Cardiovascular Systems, Inc. | Clip and deployment apparatus for tissue closure |
US10201336B2 (en) | 2011-03-25 | 2019-02-12 | St. Jude Medical, Cardiology Division, Inc. | Device and method for delivering a vascular device |
US8821529B2 (en) | 2011-03-25 | 2014-09-02 | Aga Medical Corporation | Device and method for occluding a septal defect |
US9089332B2 (en) | 2011-03-25 | 2015-07-28 | Covidien Lp | Vascular remodeling device |
US9744033B2 (en) | 2011-04-01 | 2017-08-29 | W.L. Gore & Associates, Inc. | Elastomeric leaflet for prosthetic heart valves |
US8562643B2 (en) | 2011-04-21 | 2013-10-22 | Cook Medical Technologies Llc | Self closing occulsion device with a twist |
US10117765B2 (en) | 2011-06-14 | 2018-11-06 | W.L. Gore Associates, Inc | Apposition fiber for use in endoluminal deployment of expandable implants |
CN103874466B (en) | 2011-06-16 | 2016-10-05 | 库拉希尔公司 | Device and correlation technique for fistula treatment |
US9131941B2 (en) | 2011-06-17 | 2015-09-15 | Curaseal Inc. | Fistula treatment devices and methods |
US9629715B2 (en) | 2011-07-28 | 2017-04-25 | V-Wave Ltd. | Devices for reducing left atrial pressure having biodegradable constriction, and methods of making and using same |
US11135054B2 (en) | 2011-07-28 | 2021-10-05 | V-Wave Ltd. | Interatrial shunts having biodegradable material, and methods of making and using same |
US9770232B2 (en) | 2011-08-12 | 2017-09-26 | W. L. Gore & Associates, Inc. | Heart occlusion devices |
US9554806B2 (en) * | 2011-09-16 | 2017-01-31 | W. L. Gore & Associates, Inc. | Occlusive devices |
US9060886B2 (en) | 2011-09-29 | 2015-06-23 | Covidien Lp | Vascular remodeling device |
EP3342354B1 (en) | 2011-11-08 | 2021-03-03 | Boston Scientific Scimed, Inc. | Handle assembly for a left atrial appendage occlusion device |
US9782282B2 (en) | 2011-11-14 | 2017-10-10 | W. L. Gore & Associates, Inc. | External steerable fiber for use in endoluminal deployment of expandable devices |
US9877858B2 (en) | 2011-11-14 | 2018-01-30 | W. L. Gore & Associates, Inc. | External steerable fiber for use in endoluminal deployment of expandable devices |
US9579104B2 (en) | 2011-11-30 | 2017-02-28 | Covidien Lp | Positioning and detaching implants |
US9332976B2 (en) | 2011-11-30 | 2016-05-10 | Abbott Cardiovascular Systems, Inc. | Tissue closure device |
US10426501B2 (en) | 2012-01-13 | 2019-10-01 | Crux Biomedical, Inc. | Retrieval snare device and method |
US10548706B2 (en) | 2012-01-13 | 2020-02-04 | Volcano Corporation | Retrieval snare device and method |
US9011480B2 (en) | 2012-01-20 | 2015-04-21 | Covidien Lp | Aneurysm treatment coils |
US9005155B2 (en) | 2012-02-03 | 2015-04-14 | Dc Devices, Inc. | Devices and methods for treating heart failure |
US10213288B2 (en) | 2012-03-06 | 2019-02-26 | Crux Biomedical, Inc. | Distal protection filter |
US9375308B2 (en) | 2012-03-13 | 2016-06-28 | W. L. Gore & Associates, Inc. | External steerable fiber for use in endoluminal deployment of expandable devices |
US9687245B2 (en) | 2012-03-23 | 2017-06-27 | Covidien Lp | Occlusive devices and methods of use |
US9821145B2 (en) | 2012-03-23 | 2017-11-21 | Pressure Products Medical Supplies Inc. | Transseptal puncture apparatus and method for using the same |
US8864778B2 (en) | 2012-04-10 | 2014-10-21 | Abbott Cardiovascular Systems, Inc. | Apparatus and method for suturing body lumens |
US8858573B2 (en) | 2012-04-10 | 2014-10-14 | Abbott Cardiovascular Systems, Inc. | Apparatus and method for suturing body lumens |
US9265514B2 (en) | 2012-04-17 | 2016-02-23 | Miteas Ltd. | Manipulator for grasping tissue |
US10588611B2 (en) | 2012-04-19 | 2020-03-17 | Corvia Medical Inc. | Implant retention attachment and method of use |
ES2765184T3 (en) | 2012-05-17 | 2020-06-08 | Boston Scient Scimed Inc | Access devices through adjacent tissue layers |
US9241707B2 (en) | 2012-05-31 | 2016-01-26 | Abbott Cardiovascular Systems, Inc. | Systems, methods, and devices for closing holes in body lumens |
US9649480B2 (en) | 2012-07-06 | 2017-05-16 | Corvia Medical, Inc. | Devices and methods of treating or ameliorating diastolic heart failure through pulmonary valve intervention |
US9155647B2 (en) | 2012-07-18 | 2015-10-13 | Covidien Lp | Methods and apparatus for luminal stenting |
CA2880030A1 (en) | 2012-07-26 | 2014-01-30 | University Of Louisville Research Foundation, Inc. | Atrial appendage closure device and related methods |
US9056002B2 (en) | 2012-10-18 | 2015-06-16 | Medtronic, Inc. | Stent-graft and method for percutaneous access and closure of vessels |
US9186267B2 (en) | 2012-10-31 | 2015-11-17 | Covidien Lp | Wing bifurcation reconstruction device |
US9314248B2 (en) | 2012-11-06 | 2016-04-19 | Covidien Lp | Multi-pivot thrombectomy device |
US20140135810A1 (en) | 2012-11-13 | 2014-05-15 | Covidien Lp | Occlusive devices |
US9364209B2 (en) | 2012-12-21 | 2016-06-14 | Abbott Cardiovascular Systems, Inc. | Articulating suturing device |
US9295571B2 (en) | 2013-01-17 | 2016-03-29 | Covidien Lp | Methods and apparatus for luminal stenting |
US10828019B2 (en) | 2013-01-18 | 2020-11-10 | W.L. Gore & Associates, Inc. | Sealing device and delivery system |
US9737294B2 (en) | 2013-01-28 | 2017-08-22 | Cartiva, Inc. | Method and system for orthopedic repair |
WO2014117107A1 (en) | 2013-01-28 | 2014-07-31 | Cartiva, Inc. | Systems and methods for orthopedic repair |
US9095344B2 (en) | 2013-02-05 | 2015-08-04 | Artventive Medical Group, Inc. | Methods and apparatuses for blood vessel occlusion |
US8984733B2 (en) | 2013-02-05 | 2015-03-24 | Artventive Medical Group, Inc. | Bodily lumen occlusion |
CN105658182B (en) | 2013-02-21 | 2018-07-27 | 波士顿科学国际有限公司 | The device and method for being used to form previous anastomotic |
US10028746B2 (en) | 2013-03-08 | 2018-07-24 | St. Jude Medical, Cardiology Division, Inc. | Medical device for treating a target site |
US10973523B2 (en) * | 2013-03-08 | 2021-04-13 | Aga Medical Corporation | Medical device for treating a target site |
US9775636B2 (en) | 2013-03-12 | 2017-10-03 | Corvia Medical, Inc. | Devices, systems, and methods for treating heart failure |
US10219887B2 (en) | 2013-03-14 | 2019-03-05 | Volcano Corporation | Filters with echogenic characteristics |
US9463105B2 (en) | 2013-03-14 | 2016-10-11 | Covidien Lp | Methods and apparatus for luminal stenting |
US10292677B2 (en) | 2013-03-14 | 2019-05-21 | Volcano Corporation | Endoluminal filter having enhanced echogenic properties |
WO2014152365A2 (en) | 2013-03-14 | 2014-09-25 | Volcano Corporation | Filters with echogenic characteristics |
US8679150B1 (en) | 2013-03-15 | 2014-03-25 | Insera Therapeutics, Inc. | Shape-set textile structure based mechanical thrombectomy methods |
JP6437517B2 (en) | 2013-03-15 | 2018-12-12 | インセラ セラピューティクス,インク. | Vascular treatment apparatus and method |
US10736758B2 (en) | 2013-03-15 | 2020-08-11 | Covidien | Occlusive device |
US8715315B1 (en) | 2013-03-15 | 2014-05-06 | Insera Therapeutics, Inc. | Vascular treatment systems |
US8715314B1 (en) | 2013-03-15 | 2014-05-06 | Insera Therapeutics, Inc. | Vascular treatment measurement methods |
DK2996764T3 (en) | 2013-05-15 | 2017-10-30 | Univ Koc | BLOOD FLOW REDUCTION SYSTEM IN A TARGET ORGANIC ARTERY WITH AN ELECTRIC STIMULATION |
WO2014188279A2 (en) | 2013-05-21 | 2014-11-27 | V-Wave Ltd. | Apparatus and methods for delivering devices for reducing left atrial pressure |
US9636116B2 (en) | 2013-06-14 | 2017-05-02 | Artventive Medical Group, Inc. | Implantable luminal devices |
US10149968B2 (en) | 2013-06-14 | 2018-12-11 | Artventive Medical Group, Inc. | Catheter-assisted tumor treatment |
US9737308B2 (en) | 2013-06-14 | 2017-08-22 | Artventive Medical Group, Inc. | Catheter-assisted tumor treatment |
US9737306B2 (en) | 2013-06-14 | 2017-08-22 | Artventive Medical Group, Inc. | Implantable luminal devices |
US11911258B2 (en) | 2013-06-26 | 2024-02-27 | W. L. Gore & Associates, Inc. | Space filling devices |
US8870948B1 (en) | 2013-07-17 | 2014-10-28 | Cephea Valve Technologies, Inc. | System and method for cardiac valve repair and replacement |
US10010328B2 (en) | 2013-07-31 | 2018-07-03 | NeuVT Limited | Endovascular occlusion device with hemodynamically enhanced sealing and anchoring |
CN105899150B (en) * | 2013-07-31 | 2018-07-27 | Neuvt 有限公司 | Method and apparatus for Endovascular Embolization |
US9955976B2 (en) | 2013-08-16 | 2018-05-01 | Sequent Medical, Inc. | Filamentary devices for treatment of vascular defects |
US9078658B2 (en) | 2013-08-16 | 2015-07-14 | Sequent Medical, Inc. | Filamentary devices for treatment of vascular defects |
CN106456182B (en) | 2013-12-20 | 2021-04-09 | 泰尔茂株式会社 | Vascular occlusion device |
US10350098B2 (en) | 2013-12-20 | 2019-07-16 | Volcano Corporation | Devices and methods for controlled endoluminal filter deployment |
US9730701B2 (en) | 2014-01-16 | 2017-08-15 | Boston Scientific Scimed, Inc. | Retrieval wire centering device |
US10675450B2 (en) | 2014-03-12 | 2020-06-09 | Corvia Medical, Inc. | Devices and methods for treating heart failure |
US9629635B2 (en) | 2014-04-14 | 2017-04-25 | Sequent Medical, Inc. | Devices for therapeutic vascular procedures |
US9713475B2 (en) | 2014-04-18 | 2017-07-25 | Covidien Lp | Embolic medical devices |
US9730822B2 (en) | 2014-04-30 | 2017-08-15 | Lean Medical Technologies, LLC | Gastrointestinal device |
US10363043B2 (en) | 2014-05-01 | 2019-07-30 | Artventive Medical Group, Inc. | Treatment of incompetent vessels |
DE102014006984A1 (en) | 2014-05-08 | 2015-11-26 | Acoredis Gmbh | Occlusion device or occluder (closure device) for heart defects and their production |
US9808230B2 (en) | 2014-06-06 | 2017-11-07 | W. L. Gore & Associates, Inc. | Sealing device and delivery system |
EP3171786B1 (en) | 2014-07-23 | 2020-05-13 | Corvia Medical, Inc. | Devices for treating heart failure |
DE102014018086A1 (en) | 2014-12-04 | 2016-06-09 | Acoredis Gmbh | Multifunctional occluder for occluding PFO and ASD defects and producing them |
AU2015361260B2 (en) | 2014-12-09 | 2020-04-23 | Cephea Valve Technologies, Inc. | Replacement cardiac valves and methods of use and manufacture |
US10595840B2 (en) * | 2015-02-27 | 2020-03-24 | Surgical Innovations Llc | Wound closure apparatus and method |
US10441259B2 (en) * | 2015-02-27 | 2019-10-15 | Surgical Innovations Llc | Wound closure apparatus and method |
US9615817B2 (en) * | 2015-02-27 | 2017-04-11 | Surgical Innovations Llc | Wound closure apparatus and method |
US9375333B1 (en) | 2015-03-06 | 2016-06-28 | Covidien Lp | Implantable device detachment systems and associated devices and methods |
US20160287228A1 (en) * | 2015-03-31 | 2016-10-06 | Ruben Quintero | Amnio opening occlusion device |
WO2016178196A2 (en) * | 2015-05-07 | 2016-11-10 | Vectorious Medical Technologies Ltd. | Heart implant with septum gripper |
WO2016178171A1 (en) | 2015-05-07 | 2016-11-10 | The Medical Research Infrastructure And Health Services Fund Of The Tel-Aviv Medical Center | Temporary interatrial shunts |
US9757574B2 (en) | 2015-05-11 | 2017-09-12 | Rainbow Medical Ltd. | Dual chamber transvenous pacemaker |
CA2986047C (en) | 2015-05-14 | 2020-11-10 | W. L. Gore & Associates, Inc. | Devices and methods for occlusion of an atrial appendage |
EP4335415A3 (en) | 2015-05-14 | 2024-05-29 | Cephea Valve Technologies, Inc. | Replacement mitral valves |
EP3294220B1 (en) | 2015-05-14 | 2023-12-06 | Cephea Valve Technologies, Inc. | Cardiac valve delivery devices and systems |
CN106308867B (en) * | 2015-07-01 | 2019-02-12 | 先健科技(深圳)有限公司 | Plugging device production method and plugging device make mold |
CN110464403B (en) * | 2015-09-07 | 2021-08-31 | 先健科技(深圳)有限公司 | Absorbable plugging device |
US10478194B2 (en) | 2015-09-23 | 2019-11-19 | Covidien Lp | Occlusive devices |
US10765517B2 (en) | 2015-10-01 | 2020-09-08 | Neochord, Inc. | Ringless web for repair of heart valves |
CN106618659B (en) * | 2015-10-28 | 2019-04-26 | 先健科技(深圳)有限公司 | Occluder for left auricle |
EP3373829A1 (en) | 2015-11-13 | 2018-09-19 | Cardiac Pacemakers, Inc. | Bioabsorbable left atrial appendage closure with endothelialization promoting surface |
JP2019508201A (en) | 2016-02-16 | 2019-03-28 | インセラ セラピューティクス,インク. | Suction device and fixed blood flow bypass device |
US10813644B2 (en) | 2016-04-01 | 2020-10-27 | Artventive Medical Group, Inc. | Occlusive implant and delivery system |
US20170340460A1 (en) | 2016-05-31 | 2017-11-30 | V-Wave Ltd. | Systems and methods for making encapsulated hourglass shaped stents |
US10835394B2 (en) | 2016-05-31 | 2020-11-17 | V-Wave, Ltd. | Systems and methods for making encapsulated hourglass shaped stents |
CN106994030B (en) | 2016-06-15 | 2020-03-10 | 先健科技(深圳)有限公司 | Left auricle plugging device |
EP3471665B1 (en) | 2016-06-17 | 2023-10-11 | Cephea Valve Technologies, Inc. | Cardiac valve delivery devices |
JP2019523119A (en) | 2016-08-03 | 2019-08-22 | ピーアイ−ハーベスト ホールディング アクチェンゲゼルシャフト | System and method for non-invasively measuring body pressure, including blood pressure in blood vessels |
US10478195B2 (en) | 2016-08-04 | 2019-11-19 | Covidien Lp | Devices, systems, and methods for the treatment of vascular defects |
WO2018035105A1 (en) | 2016-08-15 | 2018-02-22 | The Cleveland Clinic Foundation | Apparatuses and methods for at least partially supporting a valve leaflet of a regurgitant heart valve |
US12011352B2 (en) | 2016-08-15 | 2024-06-18 | The Cleveland Clinic Foundation | Apparatuses and methods for at least partially supporting a valve leaflet of a regurgitant heart valve |
EP3913124A1 (en) | 2016-10-14 | 2021-11-24 | Inceptus Medical, LLC | Braiding machine and methods of use |
JP7046078B2 (en) | 2017-01-23 | 2022-04-01 | セフィア・バルブ・テクノロジーズ,インコーポレイテッド | Replacement mitral valve |
EP4209196A1 (en) | 2017-01-23 | 2023-07-12 | Cephea Valve Technologies, Inc. | Replacement mitral valves |
US10426449B2 (en) | 2017-02-16 | 2019-10-01 | Abbott Cardiovascular Systems, Inc. | Articulating suturing device with improved actuation and alignment mechanisms |
JP7296317B2 (en) | 2017-02-24 | 2023-06-22 | インセプタス メディカル リミテッド ライアビリティ カンパニー | Vascular occlusion device and method |
WO2018156897A1 (en) | 2017-02-24 | 2018-08-30 | Tc1 Llc | Minimally invasive methods and devices for ventricular assist device implantation |
WO2018158747A1 (en) | 2017-03-03 | 2018-09-07 | V-Wave Ltd. | Shunt for redistributing atrial blood volume |
US11291807B2 (en) | 2017-03-03 | 2022-04-05 | V-Wave Ltd. | Asymmetric shunt for redistributing atrial blood volume |
CN110831520B (en) | 2017-04-27 | 2022-11-15 | 波士顿科学国际有限公司 | Occlusive medical devices with fabric retention barbs |
US10925756B2 (en) | 2017-05-03 | 2021-02-23 | St. Jude Medical, Cardiology Division, Inc. | Collapsible medical device having an open lumen |
US10441258B2 (en) | 2017-06-16 | 2019-10-15 | Cardia, Inc. | Uncoupled LAA device |
US10675036B2 (en) | 2017-08-22 | 2020-06-09 | Covidien Lp | Devices, systems, and methods for the treatment of vascular defects |
BR112020013348A2 (en) | 2017-10-13 | 2020-12-01 | Sree Chitra Tirunal Institute For Medical Sciences And Technology | implantable atrial septal defect occlusion device |
CN111542657B (en) | 2017-10-14 | 2022-08-16 | 因赛普特斯医学有限责任公司 | Knitting machine and method of using the same |
US11173023B2 (en) | 2017-10-16 | 2021-11-16 | W. L. Gore & Associates, Inc. | Medical devices and anchors therefor |
EP3476365A1 (en) * | 2017-10-27 | 2019-05-01 | Keystone Heart Ltd. | A dome shaped filtering device and method of manufacturing the same |
US10993807B2 (en) | 2017-11-16 | 2021-05-04 | Medtronic Vascular, Inc. | Systems and methods for percutaneously supporting and manipulating a septal wall |
JP7013591B2 (en) | 2017-12-18 | 2022-01-31 | ボストン サイエンティフィック サイムド,インコーポレイテッド | Closure device with expandable members |
WO2019144072A1 (en) | 2018-01-19 | 2019-07-25 | Boston Scientific Scimed, Inc. | Occlusive medical device with delivery system |
EP3740163A1 (en) | 2018-01-20 | 2020-11-25 | V-Wave Ltd. | Devices and methods for providing passage between heart chambers |
US11458287B2 (en) | 2018-01-20 | 2022-10-04 | V-Wave Ltd. | Devices with dimensions that can be reduced and increased in vivo, and methods of making and using the same |
US10898698B1 (en) | 2020-05-04 | 2021-01-26 | V-Wave Ltd. | Devices with dimensions that can be reduced and increased in vivo, and methods of making and using the same |
US11272940B2 (en) * | 2018-03-16 | 2022-03-15 | Microvention, Inc. | Devices for mitigating vessel leakage |
EP3787484A1 (en) | 2018-05-02 | 2021-03-10 | Boston Scientific Scimed Inc. | Occlusive sealing sensor system |
US11241239B2 (en) | 2018-05-15 | 2022-02-08 | Boston Scientific Scimed, Inc. | Occlusive medical device with charged polymer coating |
EP3801300A1 (en) | 2018-06-08 | 2021-04-14 | Boston Scientific Scimed, Inc. | Medical device with occlusive member |
US11123079B2 (en) | 2018-06-08 | 2021-09-21 | Boston Scientific Scimed, Inc. | Occlusive device with actuatable fixation members |
WO2020010201A1 (en) | 2018-07-06 | 2020-01-09 | Boston Scientific Scimed, Inc. | Occlusive medical device |
US11596533B2 (en) | 2018-08-21 | 2023-03-07 | Boston Scientific Scimed, Inc. | Projecting member with barb for cardiovascular devices |
US10750630B2 (en) * | 2018-08-27 | 2020-08-18 | Quanta Computer Inc. | Locking mechanism for an add-on card |
PL240057B1 (en) | 2018-09-06 | 2022-02-14 | Balton Spolka Z Ograniczona Odpowiedzialnoscia | Self-expandable medical device for sealing paravalvular leaks |
JP7475020B2 (en) * | 2018-10-25 | 2024-04-26 | 株式会社東海メディカルプロダクツ | Medical Devices |
US11564692B2 (en) | 2018-11-01 | 2023-01-31 | Terumo Corporation | Occlusion systems |
US11678970B2 (en) | 2018-12-04 | 2023-06-20 | Boston Scientific Scimed, Inc. | Device for anastomotic bypass |
US11678887B2 (en) | 2018-12-17 | 2023-06-20 | Covidien Lp | Devices, systems, and methods for the treatment of vascular defects |
US11317921B2 (en) | 2019-03-15 | 2022-05-03 | Sequent Medical, Inc. | Filamentary devices for treatment of vascular defects |
WO2020190620A1 (en) | 2019-03-15 | 2020-09-24 | Sequent Medical, Inc. | Filamentary devices for treatment of vascular defects |
EP3908208A4 (en) | 2019-03-15 | 2022-10-19 | Sequent Medical, Inc. | Filamentary devices having a flexible joint for treatment of vascular defects |
US11612385B2 (en) | 2019-04-03 | 2023-03-28 | V-Wave Ltd. | Systems and methods for delivering implantable devices across an atrial septum |
CN114096205B (en) | 2019-05-20 | 2024-05-24 | V-波有限责任公司 | System and method for producing room shunt |
EP3741312A1 (en) * | 2019-05-22 | 2020-11-25 | Occlutech Holding AG | Occluder with stretchable waist |
EP3982877A1 (en) | 2019-06-17 | 2022-04-20 | Boston Scientific Scimed, Inc. | Covered endoprosthesis with improved branch access |
CN114126540A (en) | 2019-07-17 | 2022-03-01 | 波士顿科学医学有限公司 | Continuous covering left atrial appendage implant |
US11540838B2 (en) | 2019-08-30 | 2023-01-03 | Boston Scientific Scimed, Inc. | Left atrial appendage implant with sealing disk |
AU2020344679A1 (en) | 2019-09-13 | 2022-03-24 | Alleviant Medical, Inc. | Systems, devices, and methods for forming an anastomosis |
WO2021092618A1 (en) | 2019-11-04 | 2021-05-14 | Covidien Lp | Devices, systems, and methods for treatment of intracranial aneurysms |
KR20220098193A (en) | 2019-11-18 | 2022-07-11 | 보스톤 싸이엔티픽 싸이메드 인코포레이티드 | Stents with improved anti-movement properties |
US11903589B2 (en) | 2020-03-24 | 2024-02-20 | Boston Scientific Scimed, Inc. | Medical system for treating a left atrial appendage |
KR20230016048A (en) | 2020-04-28 | 2023-01-31 | 테루모 코퍼레이션 | occlusion system |
US11931041B2 (en) | 2020-05-12 | 2024-03-19 | Covidien Lp | Devices, systems, and methods for the treatment of vascular defects |
WO2022046921A1 (en) | 2020-08-25 | 2022-03-03 | Shifamed Holdings, Llc | Adjustable interatrial shunts and associated systems and methods |
WO2022051215A1 (en) * | 2020-09-01 | 2022-03-10 | Venacore Inc. | Longitudinally compressible vascular occluder |
WO2022103973A1 (en) | 2020-11-12 | 2022-05-19 | Shifamed Holdings, Llc | Adjustable implantable devices and associated methods |
US11234702B1 (en) | 2020-11-13 | 2022-02-01 | V-Wave Ltd. | Interatrial shunt having physiologic sensor |
CN112545603B (en) * | 2020-12-08 | 2021-11-26 | 北京泰杰伟业科技有限公司 | Spoiler heat treatment system |
DE102021001416A1 (en) | 2021-03-17 | 2022-09-22 | Peter Osypka | Atrial Flow Regulator |
WO2022207505A2 (en) | 2021-03-30 | 2022-10-06 | Sorin Grunwald | Devices and methods for fistula-free hemodialysis |
WO2022214870A1 (en) | 2021-04-07 | 2022-10-13 | Btl Medical Technologies S.R.O. | Pulsed field ablation device and method |
IL309432A (en) | 2021-07-06 | 2024-02-01 | Btl Medical Dev A S | Pulsed field ablation device and method |
WO2023199267A1 (en) | 2022-04-14 | 2023-10-19 | V-Wave Ltd. | Interatrial shunt with expanded neck region |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3874388A (en) * | 1973-02-12 | 1975-04-01 | Ochsner Med Found Alton | Shunt defect closure system |
US4007743A (en) * | 1975-10-20 | 1977-02-15 | American Hospital Supply Corporation | Opening mechanism for umbrella-like intravascular shunt defect closure device |
DE2821048C2 (en) * | 1978-05-13 | 1980-07-17 | Willy Ruesch Gmbh & Co Kg, 7053 Kernen | Medical instrument |
DK151404C (en) * | 1984-05-23 | 1988-07-18 | Cook Europ Aps William | FULLY FILTER FOR IMPLANTATION IN A PATIENT'S BLOOD |
DD233303A1 (en) * | 1984-12-28 | 1986-02-26 | Univ Berlin Humboldt | CLOSURE BODY FOR BLOOD OBJECTS AND METHOD FOR ITS INTRODUCTION |
SU1468511A1 (en) * | 1987-02-17 | 1989-03-30 | Целиноградский государственный медицинский институт | Arrangement for fixing |
US4836204A (en) * | 1987-07-06 | 1989-06-06 | Landymore Roderick W | Method for effecting closure of a perforation in the septum of the heart |
US4921484A (en) * | 1988-07-25 | 1990-05-01 | Cordis Corporation | Mesh balloon catheter device |
US5067489A (en) * | 1988-08-16 | 1991-11-26 | Flexmedics Corporation | Flexible guide with safety tip |
US4917089A (en) * | 1988-08-29 | 1990-04-17 | Sideris Eleftherios B | Buttoned device for the transvenous occlusion of intracardiac defects |
US4991602A (en) * | 1989-06-27 | 1991-02-12 | Flexmedics Corporation | Flexible guide wire with safety tip |
CA2057018C (en) * | 1990-04-02 | 1997-12-09 | Kanji Inoue | Device for nonoperatively occluding a defect |
US5064435A (en) * | 1990-06-28 | 1991-11-12 | Schneider (Usa) Inc. | Self-expanding prosthesis having stable axial length |
US5108420A (en) * | 1991-02-01 | 1992-04-28 | Temple University | Aperture occlusion device |
CA2082090C (en) * | 1991-11-05 | 2004-04-27 | Jack Fagan | Improved occluder for repair of cardiac and vascular defects |
EP0545091B1 (en) * | 1991-11-05 | 1999-07-07 | The Children's Medical Center Corporation | Occluder for repair of cardiac and vascular defects |
DE69229604T2 (en) * | 1991-11-29 | 2000-03-02 | William Cook Europ A S Bjaever | CLOSURE PROSTHESIS FOR CATHETER PLACEMENT |
DE69324239T2 (en) * | 1992-01-21 | 1999-11-04 | Univ Minnesota | SEPTUAL DAMAGE CLOSURE DEVICE |
AU4926193A (en) * | 1992-09-21 | 1994-04-12 | Vitaphore Corporation | Embolization plugs for blood vessels |
US5382259A (en) * | 1992-10-26 | 1995-01-17 | Target Therapeutics, Inc. | Vasoocclusion coil with attached tubular woven or braided fibrous covering |
US5466242A (en) * | 1994-02-02 | 1995-11-14 | Mori; Katsushi | Stent for biliary, urinary or vascular system |
DE69536046D1 (en) * | 1994-07-08 | 2010-04-01 | Ev3 Inc | System for performing an intravascular procedure |
US5733294A (en) * | 1996-02-28 | 1998-03-31 | B. Braun Medical, Inc. | Self expanding cardiovascular occlusion device, method of using and method of making the same |
-
1996
- 1996-05-14 US US08/647,712 patent/US5725552A/en not_active Expired - Lifetime
-
1997
- 1997-04-14 PT PT97922307T patent/PT957773E/en unknown
- 1997-04-14 EP EP97922307A patent/EP0957773B1/en not_active Revoked
- 1997-04-14 DK DK97922307.0T patent/DK0957773T3/en active
- 1997-04-14 EA EA199800922A patent/EA001480B1/en not_active IP Right Cessation
- 1997-04-14 JP JP54087197A patent/JP3742113B2/en not_active Expired - Lifetime
- 1997-04-14 ES ES97922307T patent/ES2395213T3/en not_active Expired - Lifetime
- 1997-04-14 AT AT97922307T patent/ATE511796T1/en active
- 1997-04-14 CN CN97194488A patent/CN1106828C/en not_active Ceased
- 1997-04-14 CA CA002252913A patent/CA2252913C/en not_active Expired - Lifetime
- 1997-04-14 WO PCT/US1997/006194 patent/WO1997042878A1/en active Application Filing
- 1997-04-14 AU AU28018/97A patent/AU711677B2/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
EA001480B1 (en) | 2001-04-23 |
EP0957773B1 (en) | 2011-06-08 |
EP0957773A4 (en) | 2001-03-07 |
JPH11512641A (en) | 1999-11-02 |
CN1218379A (en) | 1999-06-02 |
EA199800922A1 (en) | 1999-06-24 |
JP3742113B2 (en) | 2006-02-01 |
DK0957773T3 (en) | 2011-09-19 |
CA2252913C (en) | 2002-06-25 |
CA2252913A1 (en) | 1997-11-20 |
AU711677B2 (en) | 1999-10-21 |
AU2801897A (en) | 1997-12-05 |
ATE511796T1 (en) | 2011-06-15 |
US5725552A (en) | 1998-03-10 |
PT957773E (en) | 2011-07-29 |
WO1997042878A1 (en) | 1997-11-20 |
CN1106828C (en) | 2003-04-30 |
EP0957773A1 (en) | 1999-11-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2395213T3 (en) | Intravascular occlusion devices guided by a percutaneous catheter | |
US20210378646A1 (en) | Multi-layer braided structures for occluding vascular defects | |
ES2431563T3 (en) | Constrictive occlusion device directed by percutaneous catheter | |
ES2394954T3 (en) | Multilayer braided structures to occlude vascular defects | |
CA2302164C (en) | Percutaneous catheter directed occlusion devices | |
ES2357498T3 (en) | TRAINING METHOD OF MEDICAL DEVICES: INTRAVASCULAR OCLUSION DEVICES. |